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AN ASSESSMENT OF THE CARRIER STATE AND A NOVEL MARKER OF 
LEPTOSPIRA AND ABORTION IN CENTRAL KENTUCKY HORSES 
 
Leptospirosis is a reemerging zoonotic infection of worldwide importance 
and affects all mammals.  The bacterium is transmitted to animals and humans 
by urine, fetal membranes and body fluids.  Leptospira shedding in the urine 
contaminates both soil and water, exposing both humans and animals to the 
bacterium.  Leptospirosis in horses can cause abortion and is one of the 
etiologies of equine recurrent uveitis which can lead to blindness.  Equine 
leptospiral abortion in Central Kentucky is primarily caused by serovar Pomona, 
with occasional cases attributed to serovar Grippotyphosa.  There are a few 
reports in the literature attributing abortion to serovar Bratislava in the United 
States.  Interestingly, Bratislava has the highest seropositivity in the horse in the 
United States.  
    
Two studies were conducted that are included in this dissertation. The first 
was to determine the prevalence of leptospirosis in horses located in Central 
Kentucky submitted for necropsy to the University of Kentucky Veterinary 
Diagnostic Laboratory.  Heart, vitreous humor, kidney and urine samples were 
collected for microagglutination testing (MAT) and real-time PCR (qPCR).  Heart 
blood and vitreous were tested using MAT for serovars Grippotyphosa, Pomona 
and Bratislava.  Kidney, vitreous and urine samples were tested for pathogenic 
Leptospira by qPCR.  MAT test results for heart blood indicated an increased 
seroprevalence for Bratislava as compared to Grippotyphosa and Pomona.  
Three horses had positive titers for serovar Bratislava in vitreous and heart blood 
samples.  All urine samples tested negative by qPCR, and only one kidney 
sample had a weak positive result.  Four vitreous samples tested positive for 
leptospirosis by qPCR, but all samples were negative upon MAT testing.  No 
samples with positive MAT titers were positive by qPCR for any of the samples 
tested.  Females were more likely to have positive MAT titers and were 
considerably older than males.  MAT titers in females were also significantly 
higher as compared males.  Finally, there was widespread seroprevalence in 
horses, regardless of the reason for necropsy submission.  This suggests that 
  
exposure to Leptospira on Central Kentucky horse farms is common and the risk 
of exposure to humans and other animals is possible.   
 
The second study evaluated the enzyme heme oxygenase-1 (HO-1) and 
its potential as a marker for abortion in pregnant mares with elevated MAT titers.  
HO-1 is the rate-limiting step in the breakdown and degradation of heme to 
carbon monoxide, free iron and biliverdin, which is converted to bilirubin.  
Increased levels of HO-1 and its’ by-products are upregulated during 
inflammation and sepsis.  HO-1 together with its by-products are essential in 
protecting the body from both increased inflammation and in reducing the risk of 
sepsis in humans, mice and rats.  HO-1 together with its by-products are also 
essential in helping maintain pregnancy in humans, mice and rats.  HO-1 in the 
serum of horses has not been previously investigated.  The presence of HO-1 in 
the serum of healthy non-pregnant mares (NPM), pregnant mares throughout 
pregnancy (PMOT), pregnant mares ≥7 months pregnant with and without 
placentitis (PM) and pregnant mares with high MAT titers (MATS) was 
investigated.  HO-1 levels in both NPM and PMOT were lower than PM, and 
significantly lower than MATS.  Pregnancy alone increased HO-1, the same has 
been shown in other mammals and humans.  Additionally, mares pregnant with 
elevated leptospiral titers had significantly higher HO-1 levels compared to other 
mares.  This indicates that both pregnancy and high MAT titers increase the 
animals’ HO-1 response.  Further investigation of HO-1 in horses is needed to 
ascertain its’ importance during infection and/or pregnancy and potential 
therapeutics.   
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Leptospirosis is a zoonotic infection of global importance. Once thought to 
be contained, it has emerged as one of the most widespread zoonotic diseases 
in the world [1-3].  It is readily propagated from animal to animal and animal to 
man; however, human-to-human transmission is rare.  Leptospirosis is a major 
public health concern in South America and South East Asia and is now 
considered a re-emerging disease in most developed countries [2, 4].  An 
estimated 1 million people are infected worldwide annually, leading to over 
59,000 deaths [5].    
Leptospira spp. are found in over 160 mammals worldwide, including 
dogs, cats, ruminants, horses and sea lions [6-8].  Multivalent vaccines only exist 
for dogs, swine and cattle.  A monovalent vaccine for serovar Pomona became 
available for the horse in the United States (US) in the fall of 2015.  Vaccine 
availability is limited to a small number of species, allowing the spread of this 
disease in other mammals and humans in many countries, which can lead to a 
public health crisis.   Appendix 1 contains two tables.  Table One is a list of 
available vaccines, serovars and species by pharmaceutical company available 
in the US. Table Two is a list of available vaccines, serovars and species by 
pharmaceutical company available outside the US.    
The prevalence and economic impact of leptospirosis in humans are not 
well documented.   However, leptospirosis is estimated to infect millions of 
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humans annually with case fatality rates ranging from 5 to 25% [9].   The highest 
occupational risk for contracting the disease either through direct contact (urine 
or body fluids) or indirect contact (contaminated water or soil) are veterinarians, 
farmers, slaughterhouse workers, butchers and sewer workers [3, 10-12].  Many 
outbreaks have been related to floods caused by high rainfall events.  Clinical 
illness in both animals and humans can result in economic losses through lost 
wages, medical and veterinary bills, loss of animals and quality of life.   
 
1.2 Leptospirosis 
Leptospirosis is caused by a gram-negative bacterial spirochete in the 
order Spirochaetales, family Leptospiraceae and genus Leptospira.  
Leptospirosis was first described in 1886 by Adolph Weil and demonstrated by 
A.M. Stimson in 1907.  The first isolation in pure culture was achieved by 
Japanese scientists, led by Ryokichi Inada in 1914 [13].  Leptospires are 0.1-0.2 
µm in diameter and range from 6-25 µm in length [14]. There are both pathogenic 
and saprophytic species [6, 12].     
Spirochaetales contain three families:  Brachyspiraceae, Leptospiraceae 
and Spirochaetaceae [7, 14].  Both Borrelia and Treponema (cause of Lyme 
disease and syphilis respectively) also belong to the Spirochaetales order.  
Leptospires are unlike other members of the order in that they contain terminal 
hooks.  They are highly motile by virtue of two periplasmic flagella located at 
each end, which allow the organism to burrow into the tissue [6].  Leptospires are 
obligate aerobes and demonstrate characteristics of both gram-positive and 
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gram-negative bacteria [6, 14].  The outer envelope is composed of an antigenic 
mucopeptide and a lipopolysaccharide (LPS).  The LPS is very similar to those 
found in other gram-negative bacteria.  However, it has a significantly lower 
endotoxic activity compared to typical gram-negatives.   
Visualization of the organism is only possible by dark-field or phase-
contrast microscopy.  This is because the bacteria are extremely thin, also 
influencing the poor gram-staining characteristics of leptospires. [6, 14].  Further, 
leptospires are difficult to grow in culture and require several additives for 
enrichment [6, 14, 15].  The pathogenic species are heat sensitive; they can 
tolerate temperatures between 00-250C but not well above 42˚C.  They are 
inactivated at temperatures below freezing or above 55˚C.  Saprophytic 
Leptospira are ubiquitous in fresh water and soil  [16, 17].  Only pathogenic 
leptospires have the genetic capability of utilizing cobalamin through autotrophy 
[18].  The autotrophic ability of pathogenic leptospires possibly allows it to infect 
mammals despite the host’s ability to sequester cobalamin [18, 19].  Pathogenic 
leptospires also have a complete folate biosynthetic pathway whereas 
saprophytes do not [18].  This allows pathogenic leptospires the ability to survive 
in a nutrient poor locale within the host.  
 The incidence of leptospirosis in humans is underestimated due to several 
factors.  First, the disease mimics many commonly occurring viral and bacterial 
infections such as influenza, Dengue, rickettsial infections, viral hepatitis, 
brucellosis and malaria [15, 20].  Second,  leptospiral clinical infections can be 
short and self-limiting, with typical symptoms of fever, headache, nausea, 
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vomiting and abdominal pain [6, 9].  Early in the disease presentation, 
misdiagnosis is common.  For subacute and chronic cases, liver and kidney 
failure (16-40% of cases), and respiratory complications (range from 20-70%) 
can occur.  Other reasons for underestimation of the disease are general lack of 
clinical curiosity by healthcare professionals and a shortage of diagnostic 
laboratories with validated methods for leptospiral testing.  Finally, human 
infections commonly occur in developing countries that are unlikely to have 
diagnostic laboratories for rapid disease confirmation.   
Leptospirosis is known to occur extensively in various mammalian 
species; however, it is typically confirmed in cattle, swine and dogs [6, 14, 21].   
Bats have been diagnosed with leptospirosis but their ability to transmit 
leptospirosis to humans and other mammals is considered rare [22-24].  In 
humans and animals, the portal of entry for the bacteria are cuts and abrasions in 
the skin, conjunctiva and mucous membranes.  Another portal of entry is via 
ingestion of contaminated water or food [9, 12].  While the potential for birds as 
carriers of leptospires has been investigated, early research studies did not yield 
evidence of leptospiral infections [25].  However, a recent article demonstrated 
five different types of birds in Botswana with 27.8% renal positivity by PCR [26].  
Further studies are needed to characterize the leptospiral carrier state of birds as 
they could provide another mode of transmission of leptospirosis.     
Animals can become chronic carriers of leptospires once they have 
recovered from the acute phase of the infection.  This allows the disease to 
perpetuate in nature posing  a risk to humans and other animals [6, 21].  
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Leptospires can survive and propagate in renal tubules, can remain viable for 
years and are passed by urine into water and soil.  In some species such as 
bovine and swine, shedding is intermittent, making carriers difficult to detect [6, 9, 
15, 21].  In humans, leptospires in the urine typically present the first week  after 
clinical signs are seen [6].  Leptospires can be difficult to identify by culture or 
molecular methods due to inhibitory substances and the acidic pH of the urine in 
some species, whereas alkaline urine can foster the persistence of leptospires 
[9].  Table 1.1 lists the urine pH of several species.  Urine also tends to be 
‘contaminated’ with multiple microorganisms which may inhibit isolation of 
leptospires [27].   
                  Table 1.1:  Urinary pH Range by Species  







Humans 4.6-8  
          *[28] 
Leptospires are trophic for renal tubules but they can also remain viable in 
the genital tract, brain and eye.  Indirect modes of transmission of leptospirosis is 
by contact with contaminated urine, water or soil, making the risk of 
environmental exposure dependent on various factors.   A temperate climate and 
a slightly alkaline pH, moderate to excessive rainfall can increase survival time of 
leptospires in the environment [15, 29, 30].  Other factors such as pH of soil can 
range from 4.0-8.0 depending on vegetation, moisture and soil age [31].  
Inhibitors in soil and water such as competition with other microorganisms and 
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fungi can reduce the survival time [31, 32].  Survival time in the environment 
range from hours to months depending on the conditions [15, 32].    
 
1.3 Diagnostics 
 Due to non-specific clinical signs, a leptospirosis diagnosis requires 
laboratory confirmation. The classical method is aerobic culture of the organism 
from spinal fluid, uterine fluid, aborted fetuses, kidney, placenta, blood or urine.  
Leptospires can also be isolated from liver, spleen and lung specimens. The 
culture medium, Ellinghausen-McCullough-Johnson-Harris (EMJH), is commonly 
used to isolate leptospirae from animal samples.  Selective inhibitors such as 
antibiotics, bovine serum albumin and Tween 80 can be utilized to help promote 
the growth of leptospires.  EMJH base media and enrichment additives are listed 
in Appendix 2.  EMJH media contains either 10-15% rabbit serum or 1% bovine 
serum albumin along with long-chained fatty acids, vitamins B1 and B12 are 
required for growth.  Typically, the generation time of saprophytic leptospirae is 
five hours, whereas pathogenic strains require about twenty hours [33].  The pH 
of the media is maintained at between 6.8-7.4 with an incubation temperature of 
28-30oC.   Some leptospirae can take anywhere from a few days to a month to 
grow.  Primary cultures grow very slowly and should be retained for 13 weeks 
with no growth to be considered negative [12, 14].  Once growth is established in 
culture, the organism can stay viable for up to ten years in Korthof’s medium 
(10% hemolyzed rabbit serum, 0.08% Neopeptone and 0.14% NaCl buffered to 
pH7.2) [9, 16].  Certain species require additional additives for growth such as 
 
 7 
glycerol, pyruvate and carbon dioxide [6, 14].  A new culture medium, Hornsby-
Alt-Nally (HAN) has been developed for growth at 37oC instead of 30oC [34].  The 
medium has only been tested with two strains (strains IC:20:001 and HB15B203) 
of Leptospira, and further testing is needed with other strains.  The advantage of 
this medium is growth at 37oC which is more compatible with in vivo 
temperatures and laboratory instrumentation  [34].  The formulation for this 
culture medium is listed in Appendix 2.  Culture and identification is difficult and 
time-consuming, especially if samples are not taken within the first week after 
clinical signs occur [7].   Further, samples should be collected prior to antibiotic 
therapy.  Treatment with antibiotics can reduce the viability of leptospiral and 
other organisms present in the specimen making the organism more difficult to 
isolate.   Antibiotics can also reduce serological titers when given early in the 
infection of dogs [6].  Due to the difficulty of culturing leptospirae, most diagnostic 
laboratories do not stock EMJH culture media.   
 Other laboratory methods are used in both humans and animals for 
diagnosing leptospirosis, all with limitations. The microscopic agglutination test 
(MAT) is considered the ‘gold standard’ for serological testing because of its high 
sensitivity and specificity, 92% and 95% respectively. However, this method 
requires a high level of technical proficiency, leading to low precision across 
laboratories [6, 7, 15, 35, 36].  Further, the MAT method requires the use of live 
organisms, adding a slight risk to laboratory workers that handle them.   
MAT antibodies are not detectable until six or more days after 
exposure/infection occurs, with peak titers occurring typically by the fourth week 
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after exposure. Paired serum samples (acute and convalescent) with a four-fold 
increase in serum titers after 10 days, indicate an active leptospiral infection, with 
or without clinical signs [6].   Titers of greater than ≥800 in endemic areas along 
with symptoms of disease in humans are indicative of current or recent exposure 
or infection.  In a seven-year study,  patients diagnosed with leptospirosis were 
monitored in an endemic area of Barbados [37].  Blood samples for MAT titers 
were acquired during the acute and convalescent phases, and then annually for 
seven years.  High titers (1600-3200) were observed up to 4 years post-
convalescence.  Seroprevalence was detected in most samples during the entire 
study (Table 1.2).  This study indicates humans can be seropositive for an 
extended period.  Additional environmental exposure (quantity and number of 
exposures in a timeframe) can increase the seropositivity.  Titers of ≥800 can 
sometimes indicate active disease. Therefore, additional tests are needed to 
confirm cases of leptospirosis.  Additional papers have shown similar 
seroprevalence persistence [38, 39].  
 


















End of Study 
Ballum 25,600 (90%) 0 400 60% 
Icterohaemorrhagiae 51,200 (86.8%) 0 400 75% 
Autumnalis 51,200 (95%) 8.7 800 60.9% 
Australis 51,200 (54.9%) 2.3 800 16.3% 
*[37] 
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 Interestingly, some serovars generate low titers of 100 or less even when 
infection is present, especially in nonendemic areas [33, 40].  In general, the 
serovar with the highest titer is considered to be the infecting serovar whereas 
serovars that have lower titers are thought to be cross-reactions [6].  Cross 
reactions in humans with other bacteria have occurred with MAT in patients with 
syphilis, relapsing fever, Lyme disease and legionellosis [40].  Cross reactivity in 
animals to other bacteria has not been reported [41, 42].  
Vaccinated dogs can have an increased titer from 3-6 months following 
vaccination [6, 43].  Titers in vaccinated dogs are rarely over 300, however titers 
of 3200 have been seen.  Post-vaccination titers can increase (anamnesis)  
when natural environmental exposure occurs [43].  In one study, when post-
vaccination titers were measured in cattle, titers as high as 12,800 were seen 
and remained high (800) 4 months after vaccination [44].   
Other serological tests used are the immunoglobulin M (IgM)-enzyme-
linked immunosorbent assay (ELISA), IgM dot blot, indirect hemagglutination 
assay (IHA), IgM dot-ELISA dipstick, macroscopic slide agglutination test, 
immunofluorescence and radioimmunoassay.   All these tests have their 
limitations such as: varying degrees of sensitivity/specificity for early diagnosis 
(IgM-ELISA and dot blot, IHA); lack of laboratories capable of performing these 
tests especially in developing countries (RIA and immunofluorescence) and 
some detection only to genus level (IgM).  The use of the IgM based tests have 
become readily accepted as alternatives in laboratories for aiding in confirming a 
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diagnosis of leptospirosis, especially with the introduction of kit-based 
diagnostics [6, 15, 33, 40, 45, 46].   
Globally, the use of PCR for diagnosis of leptospirosis is becoming 
common.  But, as with the MAT method, technicians must be highly trained and 
undergo regular proficiency testing to assure accurate results.   In addition, the 
cost of equipment, kits, and hardware maintenance is high, limiting the use of 
these methods in developing countries.  PCR-based analysis is used for early, 
efficient and rapid diagnosis, based on either the 16S ribosomal ribonucleic acid 
(rRNA) or 23S rRNA [15, 33, 47-50].  Several methods such as PCR, real-time 
PCR (qPCR) and nested PCR isolate deoxyribonucleic acid (DNA) using blood, 
urine or serum for detection, although tissue and cerebrospinal fluid can be used.  
All these methods utilize primers specific to pathogenic Leptospira.  However, 
they differ on the quantification and sensitivity parameters.  PCR has been 
commercially available for over three decades [51].  PCR is widely used to detect 
leptospires and is more economical compared to qPCR, however not as sensitive 
and more time consuming [52, 53] .  Nested-PCR uses two sets of primers in 
successive runs, where the second set of primers amplifies an area within the 
first product [54].  Nested-PCR is more sensitive than PCR but takes more time 
and increases risk of false positives through amplification of contaminants.  Real-
time quantitative PCR calculates fluorescent signals after each cycle to 
determine amount of signal at specific times [51].  qPCR is more sensitive, 
reproducible and requires less time than both PCR and nested-PCR [51, 55].      
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The disadvantage of using the 16s or 23s rRNA is it will detect both the 
non-pathogenic and pathogenic Leptospira along with any other bacteria.  
Specific primers to the LipL32 outer membrane protein, which only pathogenic 
Leptospira have, is necessary to determine whether active infection is present.   
The disadvantage of PCR based methods is the need to have specific primers for 
each individual serovar, especially when desired for epidemiologic studies.  
Multilocus sequencing (MLST) is a PCR based method used in differentiating 
serogroups for epidemiological studies [56].  MLST uses PCR and sequencing to 
determine targeted genes.  MLST is robust especially in determining specificity 
and sensitivity [55, 57].  A drawback to MLST is high-cost equipment needed 
along with the necessary expertise in running and evaluating the testing data.  
Additionally, MLST research has been focused on pathogenic Leptospira with 
limited knowledge of the biodiversity found in the environment [58].  An emerging 
molecular analysis is whole-genome sequencing (WGS) for both epidemiological 
and strain typing [58].  WGS utilizes MLST along with core genome and as this 
method is further developed it will lead to a more comprehensive characterization 
of Leptospira.  In 2018 the genus Leptospira was updated with the addition of 35 
new species and divided into three phylogenetic clusters correlating to their 
pathogenicity: saprophytic, intermediate and pathogenic [59].  In these three 
clades there are 13 pathogenic species, 11 intermediate species containing over 
260 serovars, whereas the saprophytic group contains 11 species and over 60 
serovars.  The use of WGS restructured the Leptospira genus in 2019 with the 
addition of 31 new species [58, 60].  Two major clusters of pathogenic species 
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were further divided into 2 subclusters called P1 and P2.  The P2 subcluster now 
contains the intermediate species and the saprophytes, which were further 
divided and named S1 and S2.       
Proper collection and storage of samples for successful isolation of DNA is 
crucial.  Whole blood or plasma are superior to serum for detection of leptospires 
by PCR. This is due to the organism ‘sticking’ to either/or white blood cells 
(WBC) and red blood cells (RBC) [47].  Only EDTA or sodium citrate should be 
used as an anti-coagulant as heparin will interfere with downstream PCR and 
sequencing.  Ideally, urine samples should not be collected until the second or 
third week after suspicion of a Leptospira infection (i.e. compatible signs and test 
results) are detected, when shedding in urine is most likely  [47].  Once collected, 
it must be kept on ice until it can either be refrigerated or frozen to decrease 
enzymatic breakdown. 
Additional molecular methods such as pulse-field gel electrophoresis 
(PFGE), randomly amplified polymorphic DNA, amplified fragment length 
polymorphism (RFLP), multi-locus variable number of tandem repeats analysis 
and multilocus sequence typing have shown promising results [15, 33].  The use 
of PFGE is considered the gold standard for the molecular identification of 
leptospires.  All these tests require very specific training, can be labor intensive, 
and are typically performed only in larger diagnostic or research laboratories.  
However, the use of molecular techniques in conjunction with MAT has become 





1.4 Environmental Effects on Incidence of Leptospirosis in Mammals 
Evidence is mounting that select zoonotic diseases might be exacerbated 
by climate change [61, 62].  Earth’s land and oceanic temperatures are 
increasing which has impact on the microbiome of ecosystems.  Microbes can 
adapt to higher temperatures.  Increasing environmental temperatures may 
select for heat tolerant microbes [61].  Climate change is thought to be a factor 
leading to increased spread of zoonotic infections.  Microbes adapt and migrate 
with humans and animals to new environments [63].  When people move within a 
country or migrate to a new one, they are carrying microbes along with them and 
are also exposed to ‘foreign’ microbes at the new location.  Examples of climate 
change include alterations in precipitation patterns, leading to increased  
wildfires, hurricanes and tornadoes [62].  Often, people are forced to relocate 
because of climate change.  For example, in the western US, wildfires and 
flooding in the southeast have forced people to move (Figure 1.1) [64-66].     
Figure 1.1: Population Movement Based on Climate Change Issues 
 




Globally, temperatures have increased 1.70F since 1890 [67].  Figure 1.2 
depicts the global rise in temperature.  The previous ten years have been the 
warmest recorded since 1884.   
 
Figure 1.2: Global Temperature Rise from 1880-2020 
 
Precipitation, on average, has increased globally over the past century.  
The total area of Arctic ice has decreased overall by ~13.4% since 2010, 
increasing ocean levels [67].  These environmental changes have promoted 
zoonotic infections to be endemic in locations previously not reported.  Further, 
microbes will adapt to higher temperatures and increased precipitation, 
encouraging mutations posing increased risk for humans [61, 63].  The increase 
in global temperatures over the last 30 years, has doubled the number of 
survival days in the environment for Vibrio spp. [68].  
 Environmental conditions (precipitation, temperature, soil pH, soil 
microorganisms, bodies of water, and wildlife) play a part in the survival of 
leptospires in the environment [17, 30, 32, 69, 70].  Increases in both 
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precipitation and temperature have been implicated in increased incidence of 
leptospirosis in both animals and humans [6, 15, 30].  In a 16 year retrospective 
study of weather data, precipitation was found to increase the incidence of 
leptospirosis in horses more so than temperature [30].  Both precipitation and 
temperature combined resulted in increased incidence above precipitation alone 
[30].  In the US, there has been increased rainfall and temperatures in the 
Northeast, along with major flooding events and heatwaves in the Midwest over 
the past 20 years.  The average annual precipitation worldwide has increased at 
a rate of 0.08 inches/decade since 1901 [71].  In the Bluegrass region of 
Kentucky, a record 76 inches of rain was recorded in 2018 [72].  It is well known 
that Leptospira flourish in temperate climates with moderate to increased rainfall 
[30].   
In a 2019 article from the Pasteur Institute, leptospirosis was the only 
bacterial disease predicted to have increased incidence/prevalence related to 
climate change across Europe [73].  This can be seen by increases in global 
flooding destroying crops and increasing rodent populations, leading to outbreaks 
of leptospirosis [74].      
 There has been insufficient research in the survival of leptospires in soil.  
Recent studies have shown soil may have a significant role in the persistence of 
leptospires in the environment [17, 32].  Leptospires can survive for long periods 
of time in moist soil with organic matter [75].  Research has demonstrated a 
higher incidence of leptospires in soil compared to adjacent reservoirs of fresh 
water [69, 75].  Various soil samples have a greater diversity and concentration 
 
 16 
of both non-pathogenic and pathogenic Leptospira compared to water [59, 60, 
76].  The complexity of soil and extensive growth period of Leptospira in vitro has 
made it difficult to culture the organism, but with the advent of multi-sequencing 
genomics additional information is being discovered [17].  Genomics has 
advanced knowledge regarding leptospires in the environment.  It is now 
believed leptospires are retained in the soil and with increased rainfall are 
flushed into adjacent waterways and standing water [17, 32, 77].   Soil nutrients 
also may influence the survival of leptospires in the soil.  One study 
demonstrated that soil with high levels of copper, iron and manganese had a 
higher concentration of Leptospira than in soil with lesser concentrations of these 
elements [78]. 
Seasonality helps to determine the species detected in the environment.  
In Chile, L. kirschneri was more common in the spring, whereas L. interrogans 
occurred more often in the winter [79].  Leptospiral species prevalence could be 
due to seasonality changes in wildlife populations.  A study in New Caledonia 
found species changes in the black rat, from L. interrogans in the winter season 
to L. borgpetersenii during the hot rainy season [80].  
  Biofilms in conjunction with climate change may also be important in the 
survival of Leptospira in the environment.  The first description of Leptospira 
biofilms was in 2008 [4].  In vitro experiments found saprophytic leptospires take 
5 days or less to form biofilms, compared to an average of 20 days for 
pathogens.  Additionally, saprophytic leptospires were able to form biofilms at 21, 
30 and 37OC whereas pathogenic occurred only at 30 and 37OC, in liquid culture.  
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The ability of leptospires to form biofilms in nature allows them to survive in a 
multitude of environments.  Studies have shown a communal relationship with 
other organisms in soil and aquatic biofilms [81-83].  Leptospires were once 
thought to exist in nature alone however biofilms allow them to exist in a 
protective environment for longer periods of time [4, 59].  The protection of 
biofilms increases the time for animals and humans to become exposed to 
leptospires.  Leptospira biofilms have also be shown to occur in vivo  [84, 85].  
Further investigations are needed to ascertain the importance of biofilms 
regarding the pathogenesis of leptospirosis. 
 
1.5 Epidemiology of Leptospirosis 
Leptospirosis is found in every continent, except for the earth’s polar 
regions [86].  Detecting and tracking outbreaks is difficult because of the 
complexity and cost of making a definitive diagnosis of leptospirosis. In addition, 
clinical presentations vary, physicians may lack suspicion and knowledge 
regarding the pathogenesis and epidemiology of the disease.     
In temperate climates, leptospirosis occurs more often between June and 
early fall.  In the United States and Canada, it occurs more frequently in late 
summer through January [6, 87, 88].  In the semitropical portions of the United 
States, an increase of canine leptospirosis if often seen more in late summer and 
early fall [6]. Outbreaks of leptospirosis increase in warmer temperatures 
following periods of heavy rainfall and when flooding occurs [11, 15, 89].  
Leptospires are unable to replicate outside the host, however they can live and 
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replicate in invertebrates and insects, though the importance of this as it relates 
to the transmission of leptospirosis is unknown [6, 90].  Leptospirosis is 
designated as a reportable disease by the European Union [91].  Because of its 
ubiquitous nature, surveillance for both human and animal cases of leptospirosis 
is recommended throughout the world. [20].   
There are two categories to describe hosts of leptospirosis, maintenance 
and accidental [6].  In animals, a maintenance host generally means that the 
infection is endemic and is transmitted from animal to animal through direct 
contact [11, 89].  Leptospires are usually acquired at a young age, with lifelong 
shedding of the organism in the urine common [6].  The degree of shedding 
tends to increase with age.  Rodents, and domestic animals such as dogs, cows 
and pigs, are considered as key maintenance animals.  Some serovars have 
more than one primary host.  However, serovars such as Icterohaemorrhagiae 
are primarily associated with rats and Hardjo with cattle [92]. 
 Accidental hosts, which includes humans,  are infected by indirect contact 
with the bacteria in water (either through drinking or recreational exposure), soil 
or through direct contact of urine or reproductive fluids, often during occupational 
exposure [6] [11, 21].  
There are various factors that influence the maintenance of leptospires in 
the environment and the spread of leptospirosis in both humans and animals. It is 
no surprise that a higher incidence is found in developing countries.  Factors 
such as age, socioeconomic status, access to clean water, crowding, medical 
care, prior health status, nutrition and lack of diagnostic tools, along with lack of 
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rapid and accurate laboratory identification all play a role in prevalence and 
spread of the disease [6].  Many physicians are not well-trained in zoonotic 
diseases such as leptospirosis and often will not consider leptospirosis in their 
differential diagnosis list [20].  The incidence of leptospirosis for animals and 
humans is higher in developing countries with an extensive agricultural base.  
Whereas in developed countries, agriculture may have a role, but to a lesser 
extent. 
  In 2008, an outbreak in Sri Lanka resulted in 3,825 cases (January-
August 2008) of leptospirosis in humans with 33 deaths reported in a three-week 
period [93].  In October 2009, an outbreak of leptospirosis occurred in the 
Philippines after heavy rains from a tropical storm [94].  There were over 2,000 
human cases with 167 deaths within a month after the flooding had occurred.  In 
Ireland there was an increase in human leptospirosis cases, 22 occurring in 2007 
and 30 cases in 2008 with 17 hospitalizations and one death [95, 96].  The cases 
in Ireland occurred primarily through agricultural exposure and participation in 
watersports.  In the previous 5 years there have been 96 postings on ProMed-
Mail regarding cases of leptospirosis throughout the world [97].  In 2014, 239 
active military members became ill after exposure to pond water on a marine 
base in Okinawa, Japan [98].  In September 2017 after Hurricane Maria in Puerto 
Rico, outbreaks occurred in both humans and domestic animals [99].  Increased 
cases in Puerto Rico are thought to be linked to lack of access to clean drinking 
water.  During the months of June-August 2018 an outbreak occurred in northern 
Israel [100].  Over 600 people were diagnosed with leptospirosis, and 146 
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hospitalized with a history of swimming in both natural springs and streams.  The 
global burden of leptospirosis cases in humans in 2015 is depicted in Figure 1.3. 
 
 
Figure 1.3: Human Global Burden of Leptospirosis 
(DALYs*/100,000/year) 
 
*Disability Adjusted Life Years 
[101] 
 
In developed countries, exposure can occur during recreational activities 
and in urban areas with high rodent populations [6, 21, 102].  Table 1.3 lists 
several human outbreaks of leptospirosis in the past two decades in the US.  
Urbanization can lead to an increased prevalence of leptospirosis.  In a 
retrospective study conducted in Indiana 1997-2002, increased prevalence of 
leptospirosis was detected in dogs in once rural areas which been had become 
urbanized over the past 10 years [92].  Outbreaks of leptospirosis occurred in 
Illinois in 1998 after a triathlon and again in 2005 in Florida.  The triathlon 
involved a trek through a marshy area [103].  In one case, an infant contracted 
the disease after nursing a mother who was infected with leptospirosis.  There 
have also been several cases of transplacental leptospirosis with subsequent 
abortion in humans [104, 105].   
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Table 1.3: Recent Outbreaks of Leptospirosis in Humans in US 




















Hawaii4 353 cases Multiple 
exposures 
2005 Florida5 14/31 
(45%) 
Triathlon 
   1[106]; 2[92]; 3[107]; 4[108]; 5[103] 
 
  Humans or animals that have been exposed or have recovered from 
leptospirosis develop an acquired immune response which can help protect 
against future infections of the same serovar.  Immunity generated by exposure 
to one serovar is generally not cross-protective for other serovars [6, 7].  
Recent studies have shown seroconversion in humans to Leptospira 
positive animals.  A study conducted in 2010 demonstrated seroconversion to 
leptospires by practicing equine veterinarians and horse farm workers located in 
Central Kentucky for the first time [30].  Veterinary students in Trinidad showed a 
higher seroconversion to Leptospira than non-veterinary students [109].  In New 
Zealand veterinarians attending a conference volunteered to be tested for 







1.6 Clinical Leptospirosis in Humans 
Leptospirosis in humans mimic flu or flu-like diseases such as dengue and 
malaria [15, 35, 111].   Presentation of the disease in humans range from 
asymptomatic to severe.  Typically, symptoms begin within a few days after 
exposure, but can take up to four weeks to occur [12, 14].  Fever tends to be 
biphasic and may last up to nine days, followed by several afebrile days before 
the fever reappears. Once the leptospires enter the body, they soon move into 
the blood stream and infect multiple organ systems such as liver, spleen, 
kidneys, central nervous system, genital tract and eyes, causing various lesions 
[14, 36]. These lesions are thought to be caused by leptospiral toxin(s) or toxic 
cellular components that damage the endothelium of small blood vessels, 
triggering localized ischemia in organs.  This leads to hepatocellular damage, 
renal tubular necrosis and myositis.  In severe cases hemorrhage can occur 
along with platelet insufficiency and jaundice. 
Leptospirosis manifests itself in two distinct phases.  The first phase 
involves fever, chills, vomiting and/or diarrhea, myalgia and headache.  A rash 
may occur on the skin and palate [14]. Chronic uveitis may also occur typically a 
year after the initial infection [112].  Symptoms usually abate within several days 
but may continue for 3 weeks or longer.  Relapses can occur and often lead to 
kidney and/or liver failure, myocarditis, mucosal hemorrhage or meningitis [6, 12, 
14].  The second phase is referred to as Weil’s disease named after Adolph Weil, 
a German physician who first described leptospirosis.  Mild to severe illnesses in 
humans are caused by serovars Hardjo, Grippotyphosa or Pomona. However, 
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serovars Copenhageni and Icterohaemorrhagiae are typically the ones that result 
in the most severe illness.  The severity of the disease depends on the organ 
systems infected.  The serovars that cause illness vary from country to country, 
making it difficult to develop a generic vaccine to protect humans from 
leptospirosis.  In addition, new serovars can emerge.  One study revealed the 
emergence of new serovars on the islands of American Samoa [113].  These 
serovars (Hebdomadis, LT 751, LT 1163) are suspected to have caused chronic 
leptospirosis with systemic illness.  Mortality can be as high as 25% in untreated 
cases within two weeks of symptoms.  However, deaths have been reported as 
early as five days subsequent to initial symptoms in severe cases [114].  
In 1994, leptospirosis was removed from the Center for Disease Control 
(CDC) list of notifiable disease in the United States since incidence in humans 
had been declining [115, 116].  Furthermore, testing for leptospirosis was not 
readily available by medical laboratories throughout the US.  As a result, many 
states were not reporting and likely underestimating prevalence.  In addition 
other emerging diseases required placement on the notifiable disease list, taking 
the place of leptospirosis [117].  In the late 1990s, outbreaks of recreational 
human leptospirosis in the US prompted the Council of State and Territorial 
Epidemiologists to reinstate leptospirosis as a notifiable disease in 2012 [20, 
108].  Leptospirosis was placed back on CDC list of notifiable diseases in 2013.  
Leptospirosis outbreaks are posted as part of the National Outbreak Reporting 
System on the CDC’s website [118].  Increased incidence of human leptospirosis 
outbreaks has been seen over the past several decades, mostly occurring at 
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recreational lakes [115, 119].  In the 1980s and 1990s outbreaks also occurred in 
poor metropolitan areas of Detroit and Baltimore [6, 115, 117, 119].   
Human leptospirosis is treated using antibiotics such as penicillin, 
erythromycin or doxycycline, and most effective when given early in the course of 
the disease [6, 12, 114, 120].  Even though the acute disease can be self-
limiting, 5-10% of cases lead to severe illness, thus most physicians initiate 
treatment with antibiotics to try and clear the infection.  Numerous studies have 
shown the duration of the disease is decreased when antibiotics are 
administered following the onset of symptoms [6, 114].  Managing symptoms 
through supportive care such as bed rest, analgesics for headaches and muscle 
pain, antipyretics for fever and intravenous fluids where indicated, will help in 





1.7 Animals-Epidemiology and Geographic Distribution of Leptospirosis 
 
 
Leptospiral infections in animals present as a peracute, acute, subacute, 
or chronic infections, with a range of signs from gastrointestinal, respiratory, 
ocular, reproductive, renal and hepatic [6].  The signs and duration vary 
dependent on species.   
 
1.7.1 Clinical Leptospirosis in Canines 
The classic presentation is vomiting, diarrhea, fever, jaundice, uremia 
secondary to renal failure, disseminated intravascular coagulation (DIC), 
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hemorrhage and death [6, 121].  The incidence of canine leptospirosis in the US 
has increased over the past 25 years [122].  Increased incidence has been 
reported in Ohio, Florida, Michigan, Texas, Illinois, New York, California, 
Massachusetts and most recently Utah in 2019.   In September 2019, Utah 
reported over 12 dogs diagnosed with leptospirosis [123].  A study published in 
2017 shows the number of positive canine MAT tests in the US between 2000-
2014 (Figure 1.4) [122].  Positive MAT tests increased from 8.7% to 12% from 
2002 through 2004.   
 
Figure 1.4: Results of Positive Canine MAT Tests by County in 
US Between 2000-2014 (Counties without indicated data had 
no MATs submitted to reference laboratories)* 
 
  *[122] 
   The increase in cases could potentially be due to decreased vaccination 
for leptospirosis in dogs [124].  In 2011 the American Veterinary Medical 
Association, (AVMA) reported <4% of dogs had been vaccinated against 
leptospirosis [122].  Conceivably, with the increased use of dog parks and 
daycare, this may increase the risk of exposure, especially when dogs are not 
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routinely being vaccinated.  The urbanization of rural areas increases contact of 
humans, dogs and other domestic animals to wildlife, many of which can shed 
leptospires into the environment throughout their lives [92].   
The combination of climate change, low vaccination rate, and urbanization 
of rural areas may be increasing the occurrence of leptospirosis in dogs.  
Asymptomatic chronic carriers may be shedding leptospires in their urine, 
contaminating the environment [125].  In canines, treatment is supportive care, 
along with antimicrobial therapy [121].  Penicillin, amoxicillin and doxycycline are 
the drugs of choice for treating leptospirosis in dogs.   
 
1.7.2 Clinical Leptospirosis in Felines 
Clinical leptospirosis occurs infrequently in cats.  One study showed 1/172 
(0.5%) urine samples positive by PCR [126].  Additional studies have shown a 
range of positivity by MAT from 0%-9.3% [127-131].  However, positive titers for 
serovars such as Canicola, Icterohaemorrhagiae, Bataviae, Javanica and 
Pomona have been seen clinically in cats throughout the world [6, 29, 126, 127, 
132, 133].  Identification of leptospires in cats is mainly from kidney and urine 
samples [6, 42].  Seroprevalence in cats has been reported as high as 18% in 
the British Isles, Australia 6% and in the US 5% [128, 133].   Shedding of 
pathogenic leptospires in feline urine also occurs in feral and wild cats, but the 
role in transmission to humans or other animals is unknown [126, 134].  
Transmission from other animals have been shown in two separate studies with 
the potential transmission of serovar Pomona from dairy cows to a cat [135, 136].  
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In one study the cat presented with hematuria, the cat’s urine was both culture 
and qPCR positive.  The MAT titer was 6400 for both Pomona and Autumnalis.  
Exposure to rodents is thought to result in increased titers to either serovars 
Copenhageni or Ballum [135].  Therefore, the increased titers to Pomona and 
Autumnalis were a result of exposure to domestic animals.  Previous work has 
also shown cats contract serovars Ballum and Copenhageni when exposed to 
rodents [128].  Research indicates that practicing veterinarians should always 
consider leptospirosis as a rule-out in cats with renal disease and/or access to 
the outdoors [135, 137, 138].  Cats have been shown to shed Leptospira in their 
urine but more research is needed to determine shedding frequency and duration 
[139].  Interestingly cats can have a negative MAT titer but still be shedding 
Leptospira in their urine [128].  Therefore, tests in addition to MAT such as PCR 
testing for urinary shedding need to be carried out to determine positivity in cats.  
In addition, cats infected by leptospires can present with no clinical signs.  [135, 
137].   This appears to be a global phenomenon which may also be due to under 
reporting of leptospirosis in cats [126, 137-139].    
 
1.7.3 Clinical Leptospirosis in Livestock 
 
1.7.3.1 Ruminants 
In 1935, bovine leptospirosis was first reported in Russia [140].  Clinical 
signs were decreased milk production and abortions.  Reports of bovine 
leptospirosis soon followed in Palestine.  Two different serotypes had been 
identified, in Europe L. bovis and in US, L pomona, both had also caused illness 
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in humans.  Blood in the milk of dairy cows was frequently seen in mild disease 
[140].  In the early 1950s it was believed leptospires shed in urine from infected 
animals was crucial to spreading the disease.  Research conducted  at the time 
indicated beef and dairy cattle can shed the bacterium for up to two years [141].  
Another study determined cattle can shed Leptospira in their urine for only 70 
days [142].  Recovery and shedding of Leptospira in another study was found to 
occur for up to 90 days [143].  The first documented case of bovine leptospirosis 
in the US was in 1947 by Baker and Little and subsequently identified in 1950 by 
Goehenour and Yager [143].  Up to 70% of US bovine herds were seropositive at 
this time.  The first vaccine was developed in 1953 by Charles York [143].  The 
introduction of a bacterin and subsequent vaccine in the 1950s was followed by a 
decline in the incidence of bovine leptospirosis [144, 145].    
Serovar Hardjo in bovine and sheep can be transmitted directly through 
sexual contact, urine exposure, infected placenta or uterine infection and do not 
seem to be impacted by levels of rainfall and is difficult to control by routine 
management practices [146].  In ruminants, incidental infections occur more 
often by indirect transmission by contaminated surfaces, feed and water [146].  
Most infections in ruminants tend to be subclinical.  However, exceptions to this 
occur in the very young presenting with meningitis, renal disease,  hematuria, 
jaundice, hemoglobinuria and death [146].  Older animals can also present with 
these signs, but occurrence is rare.  Pregnant or lactating females can present 
with agalactia or reproductive damage from either a host-maintained or incidental 
leptospiral infection in both bovine and sheep [146].   
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Clinical findings in cattle vary with the serovar causing the infection. 
Abortion caused by Pomona in cattle will occur 1-6 weeks after acute infection 
whereas serovar Hardjo abortion occurs 4-12 weeks after initial signs [146].  A 
chronic result of infection by serovar Harjo is infertility, however this can be 
controlled by vaccinating the herd [146].  In utero leptospiral infections can cause 
abortions, stillbirths, and weak offspring, mostly caused by serovars Pomona or 
Hardjo.   Abortion is frequently caused by serovar Pomona (up to 50%) 
compared to serovar Hardjo (3-10%) [146].  When abortions occur, the fetus and 
placenta typically contain a heavy load of leptospires resulting in risk of exposure 
to farm workers and veterinarians.  Shedding of Leptospira in the urine is 
common and can aid in transmission of the disease to other mammals and 
humans.  Exposure to Leptospira in humans and other mammals can occur after 
contact with stock ponds and slow-moving streams contaminated through urinary 
shedding of leptospires by cattle.   Economic losses due to reproductive failures 
on cattle and dairy farms, along with decreased milk production can be high [10].  
In dairy cows, quality and production of milk can be affected [147].  Financial loss 
due to human illness can also occur due to lost wages and medical costs.  
Finally, serovar Hardjo in both bovines and caprines has been shown to persist in 
the mammary glands [146].   
In sheep, leptospirosis is more common in countries with large ovine 
populations, such as New Zealand and Australia.  Although infections in other 
countries do occur.  Leptospiral abortions in sheep and goats generally occur late 
in gestation [146].  Abortion is mainly caused by serovar Hardjo, although 
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serovars Pomona, Bratislava, Grippotyphosa, Sejroe, Autumnalis and Ballum 
have also been implicated [146, 148].  Abortion, infertility, neonatal mortality and 
reduced milk production are common in small ruminants [148, 149].  Systemic 
infections pyrexia, anemia and hemorrhagic syndromes are seen, but rarely [148, 
149].  Sheep are considered carriers of serovar Hardjo [86, 148].  Leptospiral 
infections in sheep are still considered rare when compared to bovine and swine, 
however the seroprevalence appears to be increasing [148].  Ongoing farm 
management is critical in containment of leptospirosis in small ruminant herds 
[148].  Isolation of infected animals and timely vaccination are critical.  In 2011, 
80% of small ruminants were located in developing countries and 70% of these 
were residing in tropical environments [148].  Management is critical in these 
areas since leptospirosis is more common in tropics [6, 13, 15, 150].  Increased 
incidence is seen in the last several weeks of gestation or postpartum in sheep 
[146].  Occurrence of leptospirosis in goats ranges from 2.6% in Spain to 31% in 
Brazil [149].  Literature regarding leptospirosis in goats is limited compared to 
other ruminant species and swine.  This could be because losses through 
production and diseases in goats are not seen as a significant concern in 
developed countries compared to developing countries [86].    
Vaccines are available for bovines (worldwide) and small ruminants in 







Leptospirosis in swine is common.  The first reported isolation of 
Leptospira serovar Hardjo in swine was in 1983 [151].  Serovar Hardjo is typically 
not isolated from swine, however both serovars Bratislava and Pomona are 
common [9].  Seroprevalence is dependent on location.  Leptospires are 
commonly found in swine all over the world with symptoms ranging from sub-
clinical to abortion [152-154].   
Leptospirosis in swine occurs worldwide [86, 155].  Reproductive losses 
caused by serovars Canicola, Pomona, Icterohaemorrhagiae, Grippotyphosa, 
Bratislava and Tarassovi can cause significant losses through abortion [86].  In 
young animals, signs such as jaundice, renal failure, hematuria and hemorrhage 
from acute infection occur  and can be fatal [86].  Serovar Pomona is a common 
cause of infection in young pigs.  Leptospirosis has been detected in feral swine 
throughout the US, presenting a threat to other animals and humans [155].  
Serovar Bratislava was the prominent serovar detected in a nationwide study of 
feral swine [155].  In domestic swine serovar Bratislava is the major cause of 
reproductive failure in Europe and occurrences in the US are on the increase [86, 
156, 157].  The complete genome sequence for serovar Bratislava from a pig 
(strain PigK151) was published in 2015.  Until then, a complete genome 
sequence had only been completed on human Leptospira serovars Lai and 
Copenhageni [158].  A vaccine with serovars Bratislava, Canicola, 
Grippotyphosa, Pomona, Hardjo and Icterohaemorrhagiae is available 
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specifically for breeding swine [159].  A vaccine without serovar Bratislava is also 
available [160].   
The successful treatment of leptospirosis for cattle, sheep and swine 
involves the use of tetracycline, oxytetracycline, amoxicillin and enrofloxacin 
[147]. 
 
1.7.4 Sea Lions 
 The occurrence of leptospirosis is not limited to mammals on land. The 
first report of leptospirosis in sea lions was in 1970 off the coast of California 
[161].  Only adult males (2-8 years old) were involved with an overall mortality of 
40%.  An outbreak occurred the same year off the coast of Oregon, with 2% 
mortality [161].  MAT titers from sea lions beached in California in 1971, showed 
high titers to Pomona (100,000) and cross-reaction to Autumnalis (10,000).  
Since 1971, numerous outbreaks have occurred in both sea lions and otters [8, 
162-164].  An outbreak in 2004 along the coast from southern California to 
Washington showed high prevalence of serovar Pomona [163].  A high morbidity 
(65%) and mortality rate (73%) in the California coast sea lions was detected.  A 
majority of those infected were juveniles (71%) and 92% of infections were in 
males [163].  The 2004 outbreak occurred throughout the year, with the highest 
number of cases between July-December.  Surveillance of the California 
coastline continued through 2007.  No outbreaks occurred between 2005-2006, 
however another outbreak happened in 2007 [163].  Morbidity and mortality were 
63% and 74% respectively, and 58% were juveniles [8, 163].  Outbreaks in sea 
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lions off the coast of California have been on the increase with the second largest 
outbreak occurring in 2018, over 200 were diagnosed with 70% mortality [165].          
Clinical signs of illness in the sea lions include fever, emaciation, 
polydipsia, reluctance to use hind flippers, and dehydration [161, 163, 166].  High 
mortality occurs every 3-5 years as they migrate along the Pacific coast [8, 166].  
Leptospirosis in sea lions appears to be endemic with cyclic outbreaks caused by 
asymptomatic carriers shedding leptospires and exposing younger animals for 
long periods of time [166].  Asymptomatic carriers are more common among 
older adults and have been shown to shed leptospires post-infection for up to 
154 days [8].  The cyclic nature of outbreaks is believed to be due to the 
interaction of birth rates and herd immunity.  Where young animals are infected 
during outbreaks, many become carriers that spread leptospires to incoming 
young adults for years, and spread with the migration of males to Alaska and 
back [8].  In addition, there is possible involvement of other animals contributing 
to the infection in sea lions [163].  The difference in males vs females is likely 
due to yearly migration north of males, while females and pups stay by the 
rookeries in Southern California [163, 164].  This also poses a risk of 
transmission to humans and other animals coming in contact with sea lions.      
 
1.8 History of Leptospirosis in Horses  
 The first experimentally induced leptospirosis in horses occurred in 1930 
after exposure to Leptospira icterohaemorrhagiae [167].  In 1948, the first 
evidence of antibodies to Leptospira in horses (22/291, 7.5%) was reported [168, 
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169]. The first recorded isolation of Leptospira pomona by aerobic culture in 
horses in the United States (US) was achieved in 1952 [170].  In 1953 a horse 
was diagnosed with leptospirosis after becoming ill, with no other animals on the 
farm sick nor had increased titers [171].  The source of the Leptospira was never 
found.  Prior to 1952, the horse had not yet been considered to be susceptible to 
leptospirosis, and thus any possible systemic infections were never diagnosed.   
In addition, abortions in the horse caused by Leptospira were also not well 
defined. 
Prior to 1950, leptospirosis in horses was associated with uveitis, not 
clinical presentations.  In 1950s the only evidence linking recurrent uveitis to 
leptospirosis, was increased titers [172]. 
Since then, global studies have revealed increased seroprevalence of 
leptospires in the horse, including the US.   The presence of specific serovars 
varied depending on the location/country and percent positivity.  A study in New 
York showed 30% of horses tested were seropositive to L. pomona, 
icterohemorrhagieae, or Canicola [173].  Whereas a study in Illinois showed 
prevalence to serovars Pomona, Canicola and Grippotyphosa (19.5%, 9.5% and 
2.5% respectively) [174].  In 1957 several case studies of leptospirosis were 
reported in California.   Several mares aborted, and serological agglutination was 






1.8.1 Equine Leptospirosis 
 Horses are thought of as incidental hosts for most serovars of 
leptospirosis, except for L. interrogans serovar (sv) Bratislava [121].  L. 
interrogans (sv) Bratislava, has caused abortions in horses, especially in Ireland 
[86, 176, 177].    A 1998 serological study in New York revealed a high 
prevalence of both L. interrogans (sv) Autumnalis and L. interrogans (sv) 
Bratislava, with a smaller percent of five other serovars occurring in the equine 
population throughout the state [178, 179].  Serovar Bratislava was first isolated 
from a hedgehog in 1953. The hedgehog is considered the maintenance host for 
this serovar in Europe [180].  In swine, Bratislava causes abortion and neonatal 
death [181].  Swine are considered a maintenance host for this serovar in both 
Europe and the US.  Dogs are also a maintenance host for serovar Bratislava, as 
both clinical illness and abortion have been seen in that species [86].  Domestic 
and wild dogs may pose a risk for horse exposure [182].  Exposure and 
seroprevalence for Bratislava in humans has also occurred [183].   
Since the 1980s, horses in Europe have been considered maintenance 
hosts for serovar Bratislava, although clinical infections have occurred   
[177, 184].  However, the association of Bratislava with disease in horses is still 
not conclusive [86, 87, 157, 185, 186].  Serovar Bratislava has never been 
isolated aerobic culture from horses in the US due to the fastidious nature of this 
organism [9].  There is evidence that the strains detected by multiple-locus 
variable-number tandem repeat analysis (MLVA) testing and sequencing among 
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animals, are not the same (pigs, horses, cattle, sheep, dogs, hedgehogs and sea 
lions) [157, 187, 188].   
Transmission of serovar Bratislava in mammals can occur through 
exposure to infected urine, placenta, wildlife and possibly via breeding [9, 185, 
186].  The differences in clinical syndromes caused by serovar Bratislava in 
Europe and North America could be affected by equine genetics, strain 
differences and/or environment.  Clinically, Bratislava cases in Europe included 
abortion, equine recurrent uveitis (ERU), jaundice, fatigue and respiratory 
distress.  However, clinical cases related to serovar Bratislava have not been 
recognized in North America [177, 185].  Horses are genetically homogeneous.  
Thoroughbreds from Europe and North America do not cluster together due to 
differences in stallions used for breeding as seen in Figure 3.1 [189, 190].  Slight 
genetic diversity may contribute to differences seen between Europe and North 
America pertaining to serovar Bratislava.  Environmental pressure to strains of 
serovar Bratislava may also contribute to these differences.  Strains of serovar 
Bratislava circulating in Ireland and the European continent also differ [187].  In 
Europe, serovar Bratislava is considered both a non-pathogenic resident and a 
pathogen in the horse.  In the US it is only considered a non-pathogenic resident 
or commensal organism.  Further research is needed to better understand the 









Figure 1.5:  Principal Component Plot of Global Genetic   
Relatedness in Thoroughbred Horses*  
 
 *McGivney et al 2020 
   
In North America, transmission of Leptospira to horses is believed to be 
mainly through contact with wildlife; however, contact with contaminated feed, 
water and/or soil infected with Leptospira does occur.  Skunks are thought to be 
the maintenance host for serovar Kennewicki, Hardjo is maintained by cattle, and 
Grippotyphosa by raccoons [176].  Additional transmission may occur through 
semen and mare’s milk.  Male horses could be involved in the spread of 
leptospirosis.  Both swine and cattle have been shown to pass Leptospira 
through their semen [191, 192].  Stallions have also been shown to harbor 
leptospiral DNA [186, 193, 194].  Leptospira have been detected in the milk of 
female mammals during lactation in rats, bovine and humans [104, 195, 196].  
Thus, another potential point of transmission could be through the mares’ milk, 
though to date there has been no published reports of such transmission. 
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 In horses, leptospirosis has several clinical syndromes.  In pregnant 
mares, abortion, stillbirth or premature foaling is common. In yearlings recurrent 
uveitis (Moon Blindness) and renal failure are frequent [197].  Other rare 
systemic clinical manifestations seen in horses are fever, anorexia, lethargy, 
respiratory distress, encephalitis, jaundice and liver failure.  Several studies have 
reported increases in the seroprevalence within the past twenty years in horses 
[185, 198-200].  In Sweden, a study looking at 2000 horses over a period of a 
year found a substantial number were positive for both L. interrogans serovars 
Bratislava and Icterohaemorrhagiae using MAT (16.6% and 8.3% respectively), a 
majority of titers occurred at 1:100 [185].  A study from Brazil also showed a high 
seroprevalence of Icterohaemorrhagiae along with L. interrogans (sv) Castellonis 
and L. interrogans (sv)  Djasiman [201].  Both, the Swedish and Brazilian studies 
demonstrated higher titers in older animals vs. yearlings.  This has also been 
observed in other studies [200, 202].  A study conducted in 2011 by Carter et al 
showed seroprevalence in horses throughout the United States and one 
Canadian Province with a range from 10% to 30% depending on the region [203].  
These studies also showed a high percent of animals with low titers to numerous 
serovars, which indicates exposure, but not necessarily disease.  MAT cross 
reactivity is common and is caused by the persistence of IgM and IgG antibodies 
[15, 37].  Persistent titers can remain for years after infection and/or additional 
exposure without presence of infection.  Unless blood titers are checked 
repeatedly throughout the year, the chance of detecting a highly significant titer 
could be elusive.  A survey of veterinary diagnostic laboratories in the United 
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States was conducted to determine the number of cases, serovars and abortions 
seen in both horses and cattle [204].  Test results indicated a much higher 
detection rate in cattle compared to horses except for one laboratory.  In horses, 
penicillin plus dihydrostreptomycin has been used effectively to treat leptospirosis 
[176].     
  
1.8.2 Equine Recurrent Uveitis 
Chronic uveitis (aka moon blindness or equine recurrent uveitis) caused 
by leptospires is a common problem and is one of the leading causes of 
blindness in horses [2, 185, 198, 202, 205].  Uveitis is inflammation of the 
vascular tissue in the eye, specifically the iris, ciliary body (anterior uvea) and 
choroid (posterior uvea) [112, 206, 207].  These are part of the uveal tract (Figure 
1.6).  Between the peripheral vasculature and the inner structure of the eye, 
there are two barriers (blood/aqueous and blood/retinal barriers) to prevent cells 
and larger molecules from entering the eye.  The blood/aqueous barrier consists 
of the iris and ciliary body barrier and blood/retinal barrier comprises the choroid 
[112].  The barriers allow the eye to be immune privileged (limiting an immune 
response), until one or both of those barriers are disrupted.  Disruption of one or 
both barriers allow leakage through the vasculature causing an immune 
response, leading to uveitis.  The eye is also protected from an immune 
response through decreased antigen presenting cells and a lack of lymphatics 
[112].  Without these protections, a mounted immune response could lead to 
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irreversible damage.  The theory that ERU is caused by an immune mediated 
response, first appeared in the literature in the 1980s [208-210].            
Uveitis can be caused by trauma, infection (either local or systemic), 
neoplasia or can be idiopathic [206, 211].  Uveitis can either be acute with 
sudden onset, chronic (never healed) or recurrent, which is referred to as ERU.   
 
 Figure 1.6: Anatomy of the Equine Eye 
 
  [212] 
  
 There are three forms of ERU.  The first form comprises an intraocular 
inflammatory process which reoccurs months after the initial diagnosis of uveitis, 
and with each occurrence becomes more severe [112, 206].  This is considered 
the classic form of ERU.  The second form of ERU is called insidious and is 
typically seen in Appaloosas horses [206].  This includes a low-grade 
inflammatory process which persists with no outward signs, although damage to 
the eye continues.  The third type is posterior and is seen more in Warmblood 
horses.  Inflammation is mainly in the vitreous, retina and choroid [211].  ERU is 
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more common in the US (2-25%), and some European countries (8-10%) in the 
general equine population.  However, occurrence in Britain (0.3%) is much lower 
when compared to other countries [2, 206, 213].  Reasons for discrepancies 
could be due to the type of breeds and/or genetics of the horses in Britain 
compared to other countries.  Environmental factors may also contribute to the 
differences.  Numerous studies have shown a predilection of ERU to occur more 
frequently in Appaloosas and Warmblood horses compared to other breeds [2, 
214, 215].  In both Appaloosas and German Warmblood horses, genetic risk 
factors have shown to contribute to a higher percent of ERU.  Additionally, these 
two breeds show an association with the MHC-I haplotype ELA-A9 and ERU 
suggesting a genetic component [216-218].          
The contributing causal factors of ERU are elusive.  However, in the mid-
twentieth century a correlation between ERU and leptospirosis was proposed.  
There was no concrete evidence showing a relationship between the two and 
why, until recently [172, 219].   
The suspicion that ERU was related to Leptospira was first suggested in 
the 1940s and later substantiated in the 1950s [169, 170, 220].  In one study, 
horses with recurrent iridocyclitis (ERU) had 85% (223/263) agglutinating 
antibodies to Leptospira.  Initial reports indicated L. pomona as the principal 
cause of both leptospirosis and ERU.  However, serovars Canicola and 
Icterohaemorrhagiae have also been associated with both leptospiral infections 
and uveitis [173].      
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Currently, leptospirosis is considered the primary bacterial infection 
leading to ERU [112, 221].  Uveitis can occur early after a few months or years 
after leptospiral infection [220, 222, 223].  Serovar Pomona is still considered the 
most common cause of ERU.  Serovars Grippotyphosa and Bratislava have 
recently been implicated [224, 225].   
In 1985 antigenic correlations between the cornea and Leptospira were 
discovered [210].   In 2005, two novel lipoproteins were localized in pathogenic 
Leptospira interrogans, but not in saprophytic Leptospira.  Both reacted with the 
ocular components of horses, signifying a role in equine uveitis [205].  These two 
lipoproteins, referred to as leptospiral recurrent uveitis associated proteins A and 
B (LruA and LruB) were identified in the inner membrane of only pathogenic 
Leptospira.  Increased levels of both IgA and IgG to both LruA and LruB were 
detected in fluid from horses with uveitis but not in normal eyes (controls) [205].  
Furthering the belief that uveitis was triggered by an immune response, the study 
showed an antisera specific reaction by ocular components to both LruA and 
LruB.  Both LruA and LruB have also been found in humans with leptospiral 
induced uveitis [213, 226].  A study published in 2010 also demonstrated the 
relationship of Leptospira to ERU [224].  An additional novel protein was also 
discovered, leptospiral recurrent uveitis associated protein (LruC) and published 
in 2012.  LruC is also considered to be associated with ERU [227].   
Vimentin, a-crystallin B and b-crystallin B2 have been shown to be critical 
for preserving lens clarity.  LruA was found to be associated with both vimentin 
and a-crystallin B when they cross-reacted with LruA antiserum [224].  LruB 
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antiserum was found to cross-react with b-crystallin B2.  In one study, eye fluid 
was collected from ERU eyes which contained significantly higher levels of 
antibodies recognizing vimentin, a-crystallin B and b-crystallin B2, when 
compared to controls [224].  This study further demonstrates the immune 
relevant reactions occurring following a leptospiral infection and subsequent 
ERU. 
For a localized antibody reaction in the eye to Leptospira to be conclusive, 
there has to be 4x the MAT titer in the eye compared to MAT serum titers.  This 
is referred to as the Goldmann-Whitmer coefficient (C-value) [228].  A titer 4x 
higher in the eye fluid, implicates a leptospiral induced uveitis has occurred.  
Blindness may not occur for months or even years after infection with 
leptospirosis.  Treatment with either doxycycline or tetracycline for one month 
may minimize uveitis but rarely will prevent the progression to blindness [229].    
 In Kentucky, the occurrence of leptospirosis in horses has been well 
documented, especially in the past several decades, with over 25 articles 
compared to less than 20 in the remainder of the US during the same timeframe.  
The most common serovar found in Kentucky is Kennewicki (serogroup 
Pomona), however the occurrence of several other serovars is not uncommon 
[87, 230].  Interestingly, for the first time in 30 years, the University of Kentucky 
Veterinary Diagnostic Laboratory 2019-2020 did not diagnose any leptospiral 




came on the market in 2015 may have had a role in the decline of cases, 
especially in the Central Kentucky Bluegrass region.   
Prevention of leptospirosis is multi-faceted.  Prevention in animals 
includes wildlife control, avoiding feed contamination, clean water, vaccination, 
isolation of sick animals and proper farm management practices.  In humans, 
early identification and monitoring of outbreaks and occurrences, hygienic 
practices in the workplace, avoidance of wading or swimming in water 
contaminated by animal urine will also help decrease the occurrence of 
leptospirosis.  Improved awareness by physicians of the symptoms and risks 
especially in high-risk areas assist in diagnosis and prevention.  Combined, all 
can help facilitate the prevention of leptospirosis. 
The studies designed for this dissertation were to answer several different 
questions pertaining to equine leptospirosis.  To address the first question in 
Chapter Two, testing methods offered by laboratories of the American 
Association of Veterinary Laboratory Diagnosticians for leptospirosis were 
examined.  A survey was designed to understand if there is enough testing 
capacity offered and the types of testing offered by veterinary diagnostic 
laboratories in the United States for leptospirosis.  In Chapter Three the 
seroprevalence of leptospirosis in Central Kentucky was investigated in the 
general equine population submitted for necropsy regardless of reason for 
submission.  The aim of this study was to determine the percent positivity in 
kidneys, vitreous humor and urine by real-time PCR; seroprevalence of serovars 
Pomona, Grippotyphosa and Bratislava; and the effect of age and gender on 
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seropositivity.  Chapter Four investigated the effects of pregnancy and/or 
infection on the levels of heme oxygenase-1 (HO-1) in serum of horses.  The 
aims of the study were to determine if pregnancy and/or infection (specifically 
leptospirosis) upregulates HO-1 in the same manner seen in other mammals, 

















































  The Centers for Disease Control and Prevention defines a zoonosis as a 
disease spread between animals and people. Table 2.1 illustrates some recent 
outbreaks of zoonotic diseases in the world.  One of the most notable zoonotic 
disease pandemics in history, COVID-19, is occurring at the time of this writing 
and was declared a global health emergency in January 2020 by the World 
Health Organization (WHO).  Caused by Severe Acute Respiratory Syndrome 
coronavirus 2 (SARS-CoV-2), this agent has led to a global public health crisis, 
causing high morbidity and mortality in humans.  At least 6 of 10 infectious 
diseases in humans originate in animals and 3 out of 4 emerging diseases are 
zoonotic [61, 231].  As a result, zoonotic disease prevention and management is 
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Table 2.1: Zoonotic Outbreaks* 









Salmonella Mammals Turtles 
2006-












Lassa Fever Mastomys rodents 1969 Africa Yes 


























SARS CoV-2 Unknown Bats? 
2019 to 
present Worldwide Yes  
 *[232]  
 
 A One Health approach, with full integration of animal health, human 
health, and the environment is needed to aid in the prevention of future 
outbreaks and pandemics and the related economic losses.  In the case of food 
production animals, a One Health approach aids in the production of a 
wholesome and plentiful food supply and reduces economic losses related to 
morbidity and mortality [233].  Optimal animal health is realized through effective 
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vaccination programs for diseases such as brucellosis, leptospirosis, rabies and 
many other diseases.  Vaccination affords protection against leptospiral 
infections.  However, because of serovar diversity worldwide, a vaccine to 
protect against all pathogenic serovars in all species is currently not feasible.  
The large number of pathogenic Leptospira serovars (over 300) throughout the 
world, along with vaccine development and side effects, are reasons for the 
implausibility of one vaccine for a single species.    
Good communication and coordination among human health, animal 
health, and environmental health professionals’ disciplines can help prevent 
future outbreaks of serious diseases.  For example, a 2005 Q-fever outbreak in 
the Netherlands could have been largely avoided through better communication, 
decreasing economic losses and human illnesses [233].  Partnerships formed by 
members of the allied health professions have enabled strong surveillance for 
West Nile Virus, saving human and animal lives and conserving precious funds 
[233].  It is hoped that the One Health philosophy will continue to grow and thrive 
to serve public health, animal health, and environmental health.      
In the US prior to the 1990s, leptospirosis was sporadic in animals. 
However, in the past 30 years, the incidence of clinical leptospirosis has risen, 
especially in dogs [88, 122, 234, 235].  Since the 1950s, many peer-reviewed 
scientific articles have reported leptospiral seroprevalence in equine and bovine 




 There is a wide range of seroprevalence in horses based on location of 
premises.  A 2009 study conducted in Brazil showed a low seropositivity (8%) 
from 1200 equine serum samples [236].  A study in 2013-2014 conducted in 
Ethiopia found that the location and age of cart horses made a difference in 
seroprevalence [237].  Ethiopia has the largest equine population in Africa, 
estimated at 1.91 million and an even larger donkey population (6.75 million) 
[237].  Depending on the region in Ethiopia, 184/418 seropositive horses (titers≥
100) ranged from 39.8% to 62.1%.  In Europe, the seroprevalence has a broad 
range, from 1.5% in Italy to 72.2% in Ireland [238].  Another study published in 
2016 found a seroprevalence of over 29% of 747 serum samples from horses in 
Italy [239].  A study in Ireland found overall seroprevalence of 72.2% in horses 
with serovar Bratislava the highest (59.1%) [177].  A complete list of serovars 
detected in the above studies is listed in Table 2.2.  The differences in 
seroprevalence among these studies could be due to location of the horses not 
only between countries, but also within a country and sample size.  This also 
may be true for the differences in the US.  A study published in 2012 showed the 
highest seroprevalence in the Western and Southeastern sections of the US to 
serovar Bratislava [203].  Two recent studies showed increased seroprevalence 
to serogroups Australis and Grippotyphosa in Kansas and serovars Bratislava 














Table 2.2 Equine Leptospira Seroprevalence in Different Countries* 




range of Leptospira 
spp. 
Siqueira 
et al; 2019 
2009-
2010 
Brazil Equine C, B, H, P, 
He, Pa, V, 
Ca, 










Ethiopia Equine Br, D, To, 
Pom, M, 
G, Ar, Bu, 
K, Ca, Cy, 
J, 
B, Z, He, 
H, Au Ce 
I, 




serovar) to 34.5% 
(Bratislava-serovar) 
Tagliabue 
et al; 2016 
2010-
2011 




serovar) to 78.5% 
(Bratislava-serovar) 








serovar) to 59.1 
(Bratislava-serovar) 
* A=Autumnalis; Au=Australis; Ar=Arboreae; B=Bataviae; Br=Bratislava; 
Bu=Bulgarica; Ca=Canicola; Ce=Celledoni; C=Copenhageni; Cy=Cynopteri; 
D=Djasiman; G=Grippotyphosa; H=Hardjobovis; He=Hebdomadis; 
I=Icterohaemorrhagiae; J=Javanica; K=Kremastos; M-Medanensis; Pa=Pana; 
P=Pomona; Py=Pyrogenes; R=Robinsoni; Sh=Shermani; Sz=Szwajizak; 





 In many areas of the world, testing for Leptospira is not performed, 
negating surveillance in areas where leptospirosis may be emerging and/or 
prevalent.  Diagnostic monitoring for the presence of leptospirosis in animals is 
critical to limit the spread of the diseases to both animals and humans.  The aim 
of the survey done for this dissertation was to assess the availability of 
leptospirosis testing offered by member laboratories of the American Association 
of Veterinary Laboratory Diagnosticians (AAVLD), the extent they are utilized, 
and to better understand if there is enough testing capacity offered by these 
laboratories. 
    
 
2.2 Materials and Methods 
 
2.2.1 Survey 
A survey was sent to 60 AAVLD laboratory directors in early October 
2015.  The survey requested the laboratories to report all the leptospirosis test 
methods offered (e.g., MAT, PCR, FA), serovars measured, and the average 
number of both equine and bovine cases per year (e.g., abortions, uveitis, 
chronic renal or systemic leptospirosis) (Appendix 3).    
 
2.2.2 Statistics 
 Descriptive statistics (sample size, averages, percent) and graphs were 




Seventeen of the 60 AAVLD/NAHLN laboratories (28%) responded to the 
survey.  Only 13/17 (76.5%) of responding laboratories offered one or more tests 
for leptospirosis.  One laboratory had discontinued testing in the past year due to 
lack of submissions and interest.  Table 2.3 includes the laboratories and 
serovars offered by the responding laboratories in the study.  A current listing 
and map of all AAVLD accredited laboratories and leptospiral tests available are 
in Appendix 4 and 5 respectively.  Table 2.4 includes the number of laboratories 
testing for the following serovars by MAT:  Pomona, Hardjo, 
Icterohaemorrhagiae, Grippotyphosa, Canicola, Bratislava, Autumnalis, Sejroe 
and Copenhageni.  Responses from the 17 laboratories indicate 76.5% are 
testing for similar serovars.  The serovars commonly analyzed by MAT were 
Pomona, Hardjo, Icterohaemorrhagiae, Grippotyphosa, Canicola, and Bratislava.  
Serovar Bratislava was tested in 10/13 laboratories (76.9%).  One laboratory 
tested for Bratislava specifically in bovine samples only. 
To determine whether Leptospira was the cause of an abortion in either 
horses or cattle, 10/17 (58.8%) utilized PCR while 4/17 (23.5%) ran FA tests.  
Regarding the diagnosis of Equine Recurrent Uveitis, 7/17 (41.2%) used PCR 
and/or MAT for analysis.  Ten of the seventeen respondents (58.8%) do not test 
eye fluid for the presence of leptospires.    
A total of 10,376 bovine samples from 13 laboratories were submitted for 
Leptospira MAT testing.  The range of bovine cases submitted for testing was 10-
3774/year (Table 2.5 and Figure 2.1).  A total of 4415 equine samples were 
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tested, the lowest in one state was 1/year and highest was 2731/year.  The 
average number of abortions caused by Leptospira in bovine was 2.4/year and in 
equine 1/year (Figure 2.2). 
 Table 2.3: MAT Serovars Offered by Responding Laboratories 
Laboratory MAT Serovars Offered-Equine and/or Bovine 
1 Pomona, Hardjo, Icterohaemorrhagiae, Grippotyphosa, Canicola, Autumnalis, Bratislava 
2 Icterohaemorrhagiae, Hardjo, Pomona, Grippotyphosa, Canicola, Bratislava 
3 Pomona, Icterohaemorrhagiae, Canicola, Grippotyphosa, Hardjoprajitno, Bratislava, Sejroe 
4 Bratislava, Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae, Pomona 
5 Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae, Pomona, Bratislava 
6 Bratislava, Canicola, Pomona, Grippotyphosa, Icterohaemorrhagiae, Hardjo 
7 Autumnalis, Bratislava, Canicola, Grippotyphosa, Icterohaemorrhagiae, Hardjo, Pomona 
8 Not Offered 
9 Bratislava, Canicola, Grippotyphosa, Hardjo, Copenhageni, Pomona 
10 Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae, Pomona 
11 Grippotyphosa, Hardjo, Icterohaemorrhagiae, Pomona, Sejroe (Canicola and Bratislava also included for Bovine panel) 
12 Bratislava, Canicola, Grippotyphosa, Hardjo, Icterohaemorrhagiae, Pomona 
13 Canicola, Autumnalis, Bratislava, Hardjo, Icterohaemorrhagiae, Pomona, Grippotyphosa 
14 Not Offered 
15 Not Offered 
16 Discontinued 











Table 2.4: Laboratory Analysis of Serovars by MAT*   
Serovar Number of Laboratories Testing 
Pomona 13/17 (76.5%) 
Hardjo 13/17 (76.5%) 
Icterohaemorrhagiae 13/17 (76.5%) 
Grippotyphosa 13/17 (76.5%) 
Canicola 13/17 (76.5%) 
Bratislava 13/17 (76.5%) 
Autumnalis 3/17 (17.7%) 
Sejroe 2/17 (11.8%) 
Copenhageni 1/17 (5.9%) 
*Microagglutination Test 
 PCR targeting pathogenic Leptospira was the principal test used to 
determine leptospiral abortions.  Of those labs responding to the survey, 25% of 
laboratories do not test for leptospirosis and 62% did not test eye fluid by PCR.   














1 Yes 4259 3211 1048 
2 Yes 1346 1165 181 
3 Yes 3992 3774 218 
4 Yes 271 235 36 
5 Yes 160 150 10 
6 Yes 260 250 10 
7 Yes 110 92 18 
8 Yes 24 10 14 
9 Yes 583 505 78 
10 Yes 123 76 47 
11 Yes 689 688 1 
12 Yes 85 62 23 
13 (17) Yes 2889 158 2731 
14 (8) No    
15 (14) No    
16 (15) No    


































































 Only 28% of AAVLD accredited laboratories responded to the survey.  The 
low number of respondents makes it difficult to determine the extent of leptospiral 
testing throughout the US.   A high percent of the responding laboratories tested 
for serovar Bratislava.  Previous US studies have shown a high local 
seroprevalence for serovar Bratislava in horses [199, 203].  One study showed a 
seroprevalence of 30.5% for titers≥100 where another study showed 31.6% with 
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necessarily translate to either clinical disease or abortion in horses, Bratislava is 
rarely reported as a pathogenic serovar [86].  However, it has been identified by 
MAT in horses with clinical infections and MAT and culture in aborted fetuses 
[86, 184].  Bovine seroprevalence of serovar Bratislava is infrequently reported 
and ranges from <1% to ~23% [240-243].  There are few reports in the US of 
seroprevalence to Bratislava in cattle [243, 244].   However, abortions in 
seropositive bovines in Spain and Brazil have occurred [240, 242, 245].   A 1997 
study in Spain found 25.4% of cattle tested had a seroprevalence to Bratislava, 
with 9.7% aborting from 32 farms [240].  The study in Brazil found 15.74% 
seroprevalence to Bratislava in cattle from 15 farms [242].         
Four of the laboratories responding to the survey did not offer leptospirosis 
testing.  Presently, three laboratories are now offering MAT and PCR testing.  
The decision to begin offering leptospirosis testing at a veterinary diagnostic 
laboratory may be driven by evidence of increased leptospiral prevalence in the 
US and across the globe.  From January 2014 through October 2020, there were 
114 ProMed-mail reports of leptospirosis, 50 of which were animal outbreaks 
(https://promedmail.org/promed-posts/).  During this same timeframe, 20 reports 
of leptospirosis outbreaks in animals occurred in the US.  Between January 
2010-January 2015 there were only 6 reports in ProMed-mail of leptospirosis in 
animals in the US while the number of reports in the world increased by 33.3% 
and in the US 70%.  There appears to be an increase in reporting of animal 
leptospirosis in the United States and globally.  However, this may not represent 
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an increase in the incidence of clinical human or animal leptospirosis 
geographically. 
A high percent (77%) of laboratories that responded to the survey offer 
testing for Leptospira by PCR.  A small percent of laboratories tested eye fluid for 
Leptospira, therefore many cases of Equine Recurrent Uveitis may remain 
undiagnosed.  Most diagnostic testing for uveitis is likely done pre-mortem at 
veterinary clinics and hospitals, rather than on postmortem examinations 
(personal communication-Dr. Craig Carter, UKVDL). 
Samples submitted to veterinary diagnostic laboratories are not random 
and do not reflect a true incidence of a disease confirmed in specimens sent from 
the field.  Practicing veterinarians submit specimens to veterinary diagnostic 
laboratories and request testing for leptospirosis because of clinical suspicion as 
a possible cause of morbidity or morbidity in an animal or group of animals.  
Furthermore, the risk of exposure to Leptospira by veterinarians and animal 
owners may not be considered and may be overlooked. Considering the low 
numbers of leptospiral testing in Figures 4 and 5, it appears laboratories that do 
offer testing services for leptospirosis are being underutilized. In addition, 
veterinarians and animal owners may decide not to request a necropsy on 
animals dying on the farm for economic reasons or lack of curiosity.   
There are 60 AAVLD laboratories in various states throughout the nation, 
with some states operating multiple laboratories).  Every state except Idaho, 
Nevada, Alaska, Rhode Island, Massachusetts and Maine have an AAVLD 
laboratory.  Two states refer leptospiral testing out of state.  Seven states (14%) 
 
 59 
do not run MAT titer.  Since 12% of the states do not test for leptospirosis there is 
a likelihood that some clinical cases are not detected.  Current information 
reported from ProMED-mail and journal articles, indicates cases of leptospirosis 
have increased over the past ten years in both humans and animals [73, 150, 
246].   
It is currently accepted that climate change can increase the risk of future 
pandemics [63, 64].  Climate change has a role in emerging a re-emerging 
zoonotic pathogens which can lead to high morbidity and mortality in both 
animals and humans.  This is also true for leptospirosis as new serovars are 
emerging and infections with increased incidence in both animals and humans 
[234, 246].  There is a critical need for more veterinary diagnostic laboratories to 
offer high quality and timely testing for leptospirosis throughout the US.  When 
animals present with clinical signs of leptospirosis, it is important that the disease 
be ruled-in or ruled-out in a laboratory, with follow-up to be sure that humans 
exposed to the animal(s) are not also infected.  A follow-up study is 
recommended to confirm the total availability of leptospirosis testing in the US, 
including commercial laboratories, to assure the timely and accurate identification 
of Leptospira-related disease in both animals and humans.   
This study and other recent studies suggest a lack of reporting positive 
titers and/or diagnoses for clinical leptospirosis around the US.  This is likely due 
to lack of awareness of those laboratories that offer testing or the lack of 
availability of high-quality testing offered by diagnostic laboratories.  This can 
also be explained by lack of clinical suspicion of leptospirosis by producers, 
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practicing veterinarians, and diagnostic laboratory staff [29, 199, 244, 247].  
Finally, both veterinary and human laboratories should work closely to aggregate 
data on confirmed cases of leptospirosis to provide much needed medical 
situational awareness of this widespread disease which can cause severe illness 
and can be fatal [248].  To be sure, increased testing and diagnosis of 
leptospirosis in clinical veterinary medicine would likely translate to improved 





















Assessment of the Carrier State of Leptospira in 500 Juvenile and Adult 
Horses in the Bluegrass Region of Kentucky 
3.1 Introduction 
Leptospirosis has been identified on every continent except Antarctica 
[14].  Leptospirosis can affect mammals, insects and birds [6, 26].  Leptospirosis 
in livestock is common and can be linked to leptospirosis in horses.  Horses 
grazing pastures once occupied by livestock can pose a risk of exposure to 
Leptospira.  Serovar Hardjo is the primary serovar in both bovine and ovine in the 
US but has rarely been a problem in horses.  However, transmission of other 
serovars such as Bratislava can occur [249-251].      
 In Central Kentucky seroprevalence of Bratislava has been detected 
since the early 1990s [252, 253].  Serovars Bratislava and Grippotyphosa have 
been shown to cause abortion, but serogroup Pomona serovar Kennewicki is 
currently the predominant agent causing abortion in Kentucky [87, 253].  In 
Kentucky, serovar Bratislava is not included in the panels that are routinely 
requested by clients at the University of Kentucky Veterinary Diagnostic 
Laboratory (UKVDL) (personal communication-Dr. Craig Carter, UKVDL).   
One of the objectives of this study was to determine the seroprevalence of 
Bratislava in the general equine population.  Leptospirosis serology testing in 
Central Kentucky is run mainly on pregnant mares to monitor titer levels in their 
herds.  In Central Kentucky many farms begin MAT surveillance in October, 
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every two to four weeks through March until all mares foal (personal 
communication-Dr. Craig Carter, UKVDL).  Many equine veterinarians practicing 
in the Bluegrass Region of Kentucky use these titers to decide whether to 
provide prophylactic antibiotic treatment for mares to prevent abortion (personal 
communication-Dr. Stuart Brown, formerly of Hagyard Equine Medical Institute).   
Unless non-pregnant or male horses are sick, monitoring MAT titers are not 
routinely done.  Therefore, it is essential to determine the prevalence of serovar 
Bratislava to help to understand the role is may play regarding clinical disease in 
horses.  Because of the widespread seroprevalence of serovar Bratislava, it is 
important to determine the risk of exposure and potential of illness in mammals, 
including humans.           
More than 90 peer-reviewed articles have been published in the scientific 
literature over the past 10 years investigating leptospiral seroprevalence in 
horses.  To date there have been no studies published evaluating the 
postmortem Leptospira carrier state in horses.  Previous papers have focused on 
necropsy studies in aborted fetuses but not in juvenile and/or adult horses.  
Papers published in the past 40 years studying the causes of abortion vary 
depending on the locale.  Over 45 of the previous studies were undertaken in 
Kentucky and the British Isles.  Donahue et al (1991) published the first extensive 
article  on equine leptospirosis in Kentucky from a diagnostic laboratory 
perspective [252].  The study found 15/584 (2.5%) equine abortions/stillbirths 
over a one-year period were due to leptospirosis.  A paper in 1993 investigated 
two foaling seasons (1988 and 1989) in Kentucky [254].  Over 1200 aborted 
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fetuses, placentas and stillborn foals were examined to determine the etiology 
ranging from infectious disease, twinning and/or dystocia.  More than 40% were 
aborted after 300 days.  Abortions in mares with placentitis occurred on average, 
at day 276 [254].  Out of the number of abortions due to placentitis, 37 of 236 
(15.67%) were caused specifically by Leptospira  [255].  This was the first 
evidence of Leptospira spp. causing an increased number of abortions in 
Kentucky.  Another study examined fetuses, stillborn foals and placentas over a 
five year period [253].  A total of 71/2945 (2.4%) abortions caused by Leptospira 
were identified.  Serovar Pomona was detected more often 40/47 (85.1%) in 
fetuses.  Serovars Bratislava and Grippotyphosa were detected in 2 and 4 
aborted fetuses respectively.  
 The primary aim of this study is to determine the carrier state of Leptospira 
in horses submitted to the University of Kentucky Veterinary Diagnostic 
Laboratory for necropsy.  Another aim of this study was to ascertain the 
prevalence of leptospires in heart blood, kidney, vitreous humor and urine by 
both MAT and qPCR.   An additional aim was to determine if age, gender and 
reason for submission has a role in seroprevalence.   
 
3.2  Materials and Methods 
3.2.1 Study Design 
 Kidney, vitreous humor, heart blood and urine (when available) samples 
were collected from 500 horses (6 months or older) brought to the UKVDL for 
necropsy. Horses were enrolled within 24 hours after either euthanasia or death.  
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Study candidates were not excluded based on sex, status of pregnancy, age or 
breed.  Clinical, diagnostic and vaccination history for each horse was captured 
from the accession form and final diagnostic reports when available.  Necropsies 
were performed by board certified veterinary pathologists.  
 
 
3.2.2 Sample Collection and Processing 
 
3.2.2.1 Heart Blood 
Heart blood was collected from either the left or right ventricle utilizing a 
16-gauge needle, placed in a sterile container, centrifuged and serum was 
removed.  Serum was stored at 4C prior to analysis. Leptospiral antibody titers 
for serovars Pomona, Grippotyphosa and Bratislava were measured by MAT.  
MAT was performed in accordance with the methodology of the National 
Veterinary Services Laboratories (Ames, IA) and the OIE (World Organization for 
Animal Health, 6th edition) Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals Procedure.  The reference antigens were propagated in 
polysorbate-80 bovine albumin media for 4-8 days and diluted to working 
strength on the day of the test.   Serum was screened at a 1:50 dilution (in 
phosphate buffered saline) in a volume of 50µl in wells of a 96-well flat bottom 
plate containing 50µl of diluted antigen.  The final serum dilution was therefore 
1:100.   The plate was incubated at room temperature for 1½ hours.  After 
incubation the plates were examined for agglutination using dark-field 
microscopy.  A reaction was deemed positive when 50% of the antigen was 
agglutinated.  Control sera from horses with known titers were run concurrently 
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on each day of testing.  Sera that demonstrated at least 50% agglutination at the 
screening dilution of 1:100 was serially diluted with their respective antigen to 
determine an endpoint titer. 
 
3.2.2.2 Kidneys 
A square 2.5 cm x 1 cm section was removed from the caudal and cranial 
cortex regions of both kidneys, further sectioned, placed in a sterile container and 
frozen at -80C until analyzed.  qPCR for L. interrogans was performed utilizing a 
validated method at UKVDL on the ABI 7500 Fast instrument (Life 
Technologies/Thermo Fisher Scientific, Carlsbad, CA) (Erol et al 2014).  See 
DNA/PCR section below.  Gross and histopathological studies were performed 
on all kidneys as part of the routine necropsy.   
 
3.2.2.3 Vitreous Humor 
Vitreous humor samples were harvested from both eyes by inserting an 18-
gauge needle 1 cm caudal to the limbus and aspirating 2 ml from the central 
vitreal body.  Samples were stored at 4C prior to analysis.  MAT was performed 
as stated in Heart Blood section.  Following MAT analysis, remaining vitreous 
sample was stored at -20C pending further evaluation.  Real-time PCR for L. 




 Urine samples were extracted from the bladder when present (postmortem 
changes often fully express all urine from the bladder).  Cystocentesis was 
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performed using a 14g needle, removing up to 10ml when possible, of urine 
(when present) was removed placed in a sterile container and frozen at -80C 
until analyzed.  Urine samples were processed by two methods [47].  For method 
one, urine was thawed, vortexed with 200ul removed and placed in a sterile 
container for further DNA extraction. For method two, a second sample (1ml) was 
placed in a separate sterile microcentrifuge tube, centrifuged at 12,000g for 10 
minutes at 4C.  Supernatant was removed and the pellet was reconstituted with 
200µl phosphate buffered saline (PBS).  DNA was extracted from both methods 
at the same time.       
 
3.2.3 DNA Extraction/PCR Analysis: Kidney, Vitreous Humor and Urine 
Samples 
  DNA extraction from all samples was performed using Qiagen DNeasy 
Blood and Tissue Kit (Carlsbad, CA) following the manufacturer’s protocol.  
Briefly a small section of kidney (~25mg) was removed placed in a MagNa Lyser 
Green Bead Tube (Roche Life Science, Indianapolis, IN) with ATL Buffer and 
proteinase K solution (Qiagen) and homogenized for 40 seconds using a Roche 
MagNA Lyser Instrument.  Phosphate buffered saline (PBS) and a sample from a 
Leptospira interrogans culture was used as negative and positive controls 
respectively.  Both positive and negative controls were processed with each 
group of samples.  Samples/controls were incubated at 56C for one hour, 
continuously mixed on a rotating platform and then centrifuged for 5 minutes at 
room temperature, 200ul of supernatant was removed and processed using 
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QIAcube Nucleic Acid Purification Instrumentation (Qiagen) according to 
manufacturer’s protocol.  DNA extracted samples were stored at -20C until 
analyzed by qPCR.  DNA processing of both vitreous humor and urine samples 
were processed exactly as kidney samples, using 200ul from each sample.   
 Real-time PCR was carried out using primers and protocol from an 
established procedure [47, 256].  Primers used targeted the LipL32 gene found 
only in pathogenic Leptospira.  Briefly 2.5µl of DNA sample was added to 22.5µl 
of QuantiFast Pathogen PCR +IC (internal control) Kit (Carlsbad, CA) and 
0.4µmol/l each of forward (LipL32-45F [CCCGCGTCCGATTAG]) and reverse 
(LIPL32-286R [GAACTCCCATTTCAGCGATT]) primers and probe LipL32-189P 
(6-FAM  AAAGCCAGGACAAGCGCCG-BHQ1).  A negative (sterile water) and 
positive control (Leptospira interrogans DNA) were included for amplification.  
The ABI 7500 Fast qPCR instrumentation (Applied Biosystems-Thermo Fisher 
Scientific, Foster City, CA) was used for amplification.  The amplification cycle 
was one cycle at 95C (5 minutes), 45 cycles of denaturing at 95C (15 seconds), 
extension-detection (30 seconds) at 58C.  A Ct 30±3 was considered positive for 
the internal control, following manufacturers guidelines.  Samples were 
considered positive with Ct<45.               
3.2.4 Animal and Weather Data Collection 
The following data elements were collected from the necropsy forms 
submitted for each animal if filled out by the submitter, including breed, age, sex, 
weight, necropsy results, county/state living at time of death, date of death.   
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Weather data was obtained from Midwestern Regional Climate Center 
(https://mrcc.illinois.edu) for foaling seasons from June 2015 through May 2019 
for the Central Bluegrass region of Kentucky.  The Central Bluegrass region for 
this study, included the counties of Fayette, Bourbon, Woodford and Scott.  
Average monthly temperature and precipitation were acquired. 
 
3.2.5 Statistical Analysis 
 
The association between sex, age, breed, MAT, renal lesions (with or 
without the presence of Leptospira), and PCR was calculated using multiple 
linear regression.  Distribution Analysis was performed on study population by 
gender and population by breed.  Contingency Analysis and analysis by Fisher’s 
Exact Test were used to analyze study population by age, combined results by 
gender by titer and age brackets, and MAT heart blood results by gender.  One-
way analysis was used to determine breed differences by gender and age.  
Differences between gender of MAT titers≥1600 was analyzed using fit least 
squares of titer bracket by sex, age bracket and serovar.  Differences within 
females and pregnancy was determined by Contingency Analysis and further 
analyzed by Bowker’s Test and Cochran Armitage Trend Test.  All data was 
analyzed using JMP 13.2 for MAC (SAS Institute Inc. Cary, NC).  P-values ≤0.05 
were considered statistically significant.   
 
3.3 Results 
 Stratification by gender, breed and age are found in Tables 3.1, 3.2 and 
3.3 respectively.  Representative breeds submitted in the study can be found in 
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Figure 3.1.  There was no statistical difference in the study population based on 
gender.  There were 29 (10.5%) females pregnant or had aborted at the time of 
death.     
There were significantly more Thoroughbreds submitted compared to 
other breeds which was anticipated.  According to the 2012 census of horses in 
Kentucky (Table 3.4), the number of Thoroughbreds in the state and in the 
Central Kentucky region was much higher (68.1%) when compared to other 
breeds [257].   
 
Table 3.1: Study Population by Gender 
Gender Number Pregnant 
Female 277 (55.4%) 29 (10.5%) 
Male 208 (41.6%) 
 




Three age brackets were established as follows: bracket 1≤ 1 year; 
bracket 2 is 2 to 12 years; bracket 3≥13 years.  Age brackets were chosen to 
include foals and yearlings together, the additional two brackets obtained by 
averaging the age spread of the horses submitted.  Age bracket two had the 
highest percent of submissions followed by brackets three and one (46.8%, 












Table 3.2: Study Population by Breed 
Breed Number 
Thoroughbred 353 (70.6%) 
Saddlebred 25 (5%) 
Quarter Horse 25 (5%) 
Standardbred 12 (2.4%) 
Other 31 (6.2%) 






           Table 3.3:  Study Population by Age Stratification 
Age Age Bracket 
Total 
Number Female Male 
≤ 𝟏𝟏 year 1 76 (15.2%) 25 (5.0%) 51+ (10.2) 
2-12 years 2 231 (46.2%) 123 (24.6%) 108 (21.6%) 
≥13 years 3 109 (21.8%) 70++ (14%) 39 (7.8%) 
Unknown   59 10 
 + p<0.0001 significantly more younger males 








     Table 3.4:  2012 Equine Survey-Central Kentucky Counties* 
      *2012 Kentucky Equine Survey (Thoroughbred state total=54,000) 







TB SB QH SDB Other 
Fayette 24,600 17,510 1240 960 400 1090 
Bourbon 13,000 9330 980 380 580 360 
Scott 7,000 3170  690 330 680 
Woodford 11,900 8440 670 570 670 310 
Total 44,800 38450 2890 2600 1980 2440 
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The groupings for breed and sex are listed in Table 3.5.  Standardbreds 
were under-represented compared to Saddlebreds, Quarter horses and 
Thoroughbreds.  Therefore, they were combined with other known breeds which 
were present in very low numbers and unidentified breeds, all were placed into 
one group labeled Other.  The mean age for both Thoroughbred (p<0.0001) and 
quarter horses (p<0.417) was significantly higher in females than their respective 
males.  The mean age of thoroughbred males was significantly younger 
(p<0.0001) when compared within to all other groups.         
 
      Table 3.5: Breed Statistics by Gender and Age 







Thoroughbred 353 (70.6%) 7.4 177 9.6
+ 125 4.3++++ 51 
Saddlebred 25 (5%) 9 11 7.3 11 111.4 3 
Quarter Horse 25 (5%) 10.2 6 14.8
++ 17 9.1 2 
Other 97 (19.4%) 11.8 24 11 45 12.7 28 
     *Fe (female), M (male) 
     +p<0.0001 
     ++p<0.0417 
     +++p<0.0001 within 
 
 
 There was a significant difference (p<0.001) in the number of older 
animals (≥13 years) with titers when compared to younger animals (Table 3.6).  
Older animals with titers also had significantly higher titers (p<0.001) when 





females with titers (p<0.0001) compared to males (Table 3.7).  Females 
additionally had significantly higher titers (p<0.001) compared to males.   
 
                     Table 3.6: Combined Female and Male Titer Results by Age  
Age Negative Titer=100 Titer≥ 𝟐𝟐𝟖𝟖𝟖𝟖 
≤ 𝟏𝟏 year 67 5 9 
2-12 years 163 20 49* 
≥13 years 54 11 44** 
                      Both * and **p<0.0001 to age≤ 1 year 
 
     
  
      
       
   Table 3.7: Gender by Age and Titer Bracket  
Age Bracket  Titer Bracket Female Male 
1 0 19 (6.9%) 
44 
(21.2%) 
1 1 1 (0.4%) 3 (1.4%) 
1 2 5 (1.8%) 4 (1.9%) 
2 0 77 (27.8%) 
84 
(40.4%) 
2 1 8 (2.9%) 12 (5.8%) 
2 2 38* (13.7%) 
11 
(5.3%)   
3 0 31 (11.2%) 
23 
(11.1%) 
3 1 5 (1.8%) 6 (2.9%) 
3 2 34* (12.3%) 
10 
(4.8%) 
Total Number with titer 91** 46 
                 *p<0.0005 
  **p<0.0001 





3.3.1 MAT Heart Blood  
 
Serovar results for heart blood and results by gender can be found in 
Tables 3.8 and 3.9 respectively.  There was a significantly higher number of 
horses (p<0.0001) with titers to serovar Bratislava compared to Pomona and 
Grippotyphosa.  Females had significantly higher number of titers to Bratislava 
(p<0.0001) compared to males, and within females (p<0.0001).  Females also 
had a significantly higher number of titers ≥200 compared to males (p<0.0001).  
Results within males revealed significantly more males with serovar Bratislava 
compared to both Pomona and Grippotyphosa (p<0.0001).  Titers ≥100 
seroprevalence for Bratislava increased to 25.6%.  Both serovars Pomona and 
Grippotyphosa only increased slightly to 3% and 5% respectively comparing 
titers ≥100 to titers ≥200.  
 
  Table 3.8: Serovar-Prevalence in Heart Blood≥200 





Pomona 14 (2.8%)  22 (4.5%) 8 (1.6%) 
Grippotyphosa 21 (4.2%)  12 (2.4%) 2 (0.4%) 
Bratislava 90 (18.1%) **  17 (3.5%) 9 (1.8%) 
             *3 titers were not analyzed 












Bracket Female Male 
Pomona 15 1 





  Negative 162 160 
Titer=100 19 21 
Titer≥200 96*** 26 
      *p<0.0001      
                            **p<0.0001 
                            ***p<0.0001 
 
 
 Both sex and age had significant effects on serovar (Tables 3.10-3.12).  
Older animals had significantly greater titers (p<0.0001) compared to younger 
animals regardless of sex.  Females were significantly (p<0.0002) more likely to 
have a titer regardless of serovar compared to males.   
 
        Table 3.10: Combined Female and Male Positive Serovars by Age 
Age  Bratislava Grippotyphosa Pomona Negative 
≤ 𝟏𝟏 year 9 5 0 56 
2-12 years 49* 13 7 164 
≥13 years 46** 2 8 53 
        *p<0.0001 







Table 3.11: Serovar Results for Female by Age  









≤ 𝟏𝟏 year 25 2 (0.9%) 4 (1.8%) 0 19 (8.7%) 
2-12 years 123 30 (13.8%)* 9 (4.1%) 7 (3.2%) 
77 
(35.3%) 


















≤ 𝟏𝟏 year 51 6 1 0 44 
2-12 years 107 19* 4 0 84 
≥13 years 39 15* 0 1 23 
*p<0.01 
 
There were a significantly higher number of Thoroughbreds with titers to 
Bratislava compared to all other breeds (p>0.0001) (Table 3.13).  Females of 
both Thoroughbreds and horses in Other breed category had a significantly 











                Table 3.13: Serovar Bratislava Results by Sex and Breed 












































             *485 in each group, 15 animals’ unknown sex not included 
           **within sex 
           *** within total of breed+sex 
           ****within total of breed  
           ^p<0.0001 
 
The prevalence of titers ≥1600 are listed in Table 3.14.  Serovar 
Bratislava occurred more often regardless of gender.  Females had a significantly 












 Table 3.14: Serovar Titers ≥1600 
Serovar Total* Female Male 
Bratislava 18 (58.1%) 12* (38.7%) 
5  
(16.1%) 
Pomona 5  (16.1%) 
5  
(16.1%)  





Average Age  15.1 years 12.6 years 






 There were 29/277 (10.5%) females presented as, in-foal or complications 
from abortion for necropsy.  There was no significant difference between age of 
non-pregnant (NP) and pregnant mares (P) (9.8 and 12.1 years respectively).  
The titer bracket distribution of NP compared to P-mares are in Figures 3.2 and 
3.3 respectively.  A larger percent of NP-mares (61%) were negative (bracket 
zero) compared to 34% of P-mares.  There was no difference between NP and 
P-mares in titer bracket one (titers=100) with 6% and 10% respectively.  Titer 
bracket two (titer≥200) comprised 32% NP and 55% of P-mares.  P-mares had 
significantly higher titers compared to NP-mares (p<0.0318) (Figure 3.4).  Both 
NP and P-mares had a significantly higher number of positive titers to serovar 
Bratislava (p<0.0079) compared to the other serovars.  Non-pregnant mares with 
titers ≥1600 regardless of serovar verged on significance (p<0.067) compared to 
P mares (Figure 3.5).   The number of non-pregnant and pregnant mares with 
titers ≥1600 was low (18 and 5 respectively).  A greater number of samples is 





























Figure 3.4: Analysis of Titer Brackets by Pregnancy 
                 
 





Figure 3.5:  Female Serovar Titers ≥1600 by Pregnancy 
 



































Serovars and titers detected in vitreous samples and corresponding heart 
blood titers are listed in Table 3.15.  There were 4 vitreous samples with titers 
≥100.  Three out of four had titers to Bratislava in both the heart and vitreous 
samples.  Only one vitreous sample had a titer to Pomona, the heart sample was 
negative.    
 
Table 3.15: Vitreous Humor and Heart Blood Titers  
Serovar 
Vitreous Heart 
N Titer Titer 
Bratislava 1 6400 6400 
  1 200 12,800 
  1 100 1600 
Pomona 1 100 0 
 
 
3.3.4 Real-Time PCR Testing 
 
There were 496 kidney samples tested by qPCR, one sample was 
positive.  A total of 73 urine samples were tested, all were negative.  Only 3/455 
vitreous samples were positive by qPCR, none had elevated titers. 
 
3.3.5 Precipitation and Temperature 
 No differences were seen with time of year, titers and increases in 





 The objective of this study was to determine the seroprevalence of 
Leptospira in the general population of horses submitted to the VDL for necropsy 
regardless of sex, age, breed or pregnancy status.  The VDL receives serum 
samples from farms beginning in October through March to monitor leptospiral 
titers in pregnant mares.  Titer evaluations are performed to detect rising titers, 
which could lead to abortion and assisting in the decision whether or not to 
employ a prophylactic antibiotic treatment.  Titers are rarely evaluated on non-
pregnant mares or male horses.  Leptospiral titers may be analyzed on other 
horses if uveitis, ERU, renal disease or septicemia are occurring (personal 
communication-Dr. Craig Carter, UKVDL).    
 The current study found no significant differences between the number of 
female and male submissions to the VDL.  Looking at equine submissions 
between 2010-2020 to the VDL, other years have shown the same pattern 
(Appendix 4).  The number of Thoroughbreds was significantly higher when 
compared to all other breeds (known and unknown) combined.  This was a 
predictable outcome for the Central Kentucky region.  The number of 
Thoroughbreds submitted mirrors a survey of the equine industry which showed 
approximately 68% of horses in Central Kentucky area are Thoroughbreds [257].   
 The majority of horses were in three breed groups (70.6% Thoroughbred, 
5% Saddlebred, 5% Quarter horses).  The mean age of male to female 
Thoroughbreds was significantly lower.  Examining age brackets between 
gender, there was a significantly higher number of males ≤ 1 year compared to 
 
 83 
females and higher number of females 13 years compared to males.  Regarding 
breed submissions, males had a significantly higher number of young 
Thoroughbreds submitted for fractures, compared to any other breed.  Males 
also had a significantly higher number of fractures compared to females.  Males 
in this study consisted of 24% of total submissions in age brackets 1 and 2.  A 
significantly higher number of males were submitted for fractures and Wobbler 
Syndrome.  One reason for increased number of young males with fractures 
might be an escalation in aggressiveness leading to accidents in paddock areas 
(personal communication-Dr. Jennifer Janes, UKVDL).  Wobbler Syndrome has 
been shown to be significantly higher in males compared to females [258].  
 The number of titers ≥ 200 were seen in older horses.  Published 
research shows as a horse ages, titers appear to become established and 
environmental exposure to Leptospira over many years increases this risk [41, 
237].  Healthy horses as they age (>7 years) have been shown to have increased 
titers compared to younger horses (<3 years) [185, 202, 259].  One study 
showed an increase in seroprevalence by 10% for every year a horse ages [202].    
Combining females and males there were no significant difference 
between the number of horses with titers in age brackets 2 and 3.  However, 
when separating the genders, significant differences can be seen.  There was a 
significantly higher number of females with titers compared to males.  Previous 
research has shown this, and could be due to females pastured together more 
often than males [260].  This allows females to have increased exposure to 
wildlife and each other, potentially increasing exposure to Leptospira.  Females 
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had significantly higher titers compared to males.  A reason behind a higher 
number of females with increased titers is age stratification.  Males had a 
significantly higher number in age bracket 1 compared to females.  Horses in age 
bracket 1 had either no titer or very low titers.  Females had a significantly higher 
number in age bracket 3 compared to males.   
 Differences between gender are observed in serovar prevalence.  There 
were significantly more horses with titers to serovar Bratislava compared to both 
Pomona and Grippotyphosa.  These results are similar to previous studies in 
both North America and Europe.  As early as 1981 serovar Bratislava was found 
to be the most prevalent serovar (31.7%) in a random group of horses for export 
from England [261].  Others in Canada, US and Europe have also found this 
serovar to be more prevalent [177, 259, 262].  The horse is thought to be the 
maintenance host for serovar Bratislava, although subclinical infections are 
thought to be prominent [86, 186].  Clinical infections caused by serovar 
Bratislava have occurred [177].  A study in Croatia found over 28% of serum 
samples from horses had titers to serovar Bratislava [263].  Recently a study 
published in 2018 showed over 47% of horses in the Midwest (specifically 
Kansas, Missouri, and Nebraska) had titers of ≥ 100 to serovar Bratislava [199].   
 A significantly higher number of females had titers to Bratislava compared 
to males, and within females.  Females also had a significantly higher number of 
titers ≥200 compared to males to serovar Bratislava.  Considering gender and 
age there was a significant effect on serovar.  Females were significantly more 
likely to have a titer to all three serovars.  Once again, this phenomenon may be 
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due to the way females are grouped together.   Males are typically either alone or 
grouped in very small numbers.   
 The high incidence of serovar Bratislava in this study has been previously 
documented in Kentucky.  On one Kentucky horse farm, a 53% seroprevalence 
of Bratislava was observed [264].  In another study, horses from three Central 
Kentucky farms had a 33% seroprevalence to Bratislava [230].  A study 
conducted in 2011 analyzed 50 serum samples for leptospiral titers submitted to 
the VDL for reasons other than leptospirosis [203].  These samples were part of 
a larger study evaluating the prevalence of equine leptospirosis in the US and 
one province of Canada.   The study demonstrated 38/39 (97.4%) of samples in 
Kentucky with a titer ≥100 to Bratislava, with only one sample having a titer with 
Grippotyphosa.  The study separated out geldings from stallions, which 
demonstrated 75% of stallions had negative titers compared to 87.5% geldings 
with a titer ≥100.  There were no significant differences between gender 
regardless of separating out geldings from stallions or grouping them together.  
There was no difference between gender and serovar prevalence.  The 
outcomes between the 2011 and this study may be due to the differences in 
breeds represented.  The present study had significantly more Thoroughbreds 
(70.6%) compared to only 8.5% in the 2011 study.  Both studies had no 
significant differences in the number of females vs males.  Another difference 
was the time of year the samples were taken.  All samples in 2011 were collected 
in April compared to samples taken throughout the year in the current study.  
Typically, in the Central Kentucky area the highest number or horses with titers 
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occurs between the months of October and March [30, 87, 254].  When looking 
at age in the 2011 study (not age bracket) females (mean=12.4) are significantly 
older compared to all males (p=0.0155) (mean=8.9).   
 The current study had significantly more female Thoroughbreds with a 
seroprevalence to Bratislava compared to males and all other breeds.  Also, 
females in the Other category had a significantly higher seroprevalence to 
Bratislava compared to males.  A study published in 2009 showed similar results 
[185].  However, in the 2009 study, geldings and stallions were analyzed 
separately.  If they had grouped all males, it appears there would have not been 
a difference.  The suggestion was mares spend more time out in the field 
together compared to males (especially stallions) therefore exposing them to 
increased risk of exposure to Leptospira.   
Racoons have long been associated with the spread of Leptospira  [265, 
266].  Racoons in the state of Kentucky are legally hunted for their pelts.  
However, over the past several decades hunting racoons has decreased 
dramatically due to the value of the pelt plummeting (personal communication-Dr. 
Matthew Springer, University of Kentucky).  The number of raccoons in the state 
have increased dramatically directly related to decreased hunting.  Several 
studies have shown raccoons have a high percent of seroprevalence to serovar 
Bratislava.  A study in Indiana found over 38% seroprevalence to serovar 
Bratislava in raccoons [266].   A second study in Illinois found over 28% 
seroprevalence to serovar Bratislava in raccoons [29].  One can speculate this 
may contribute to the increased occurrence of leptospiral titers and possibly 
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clinical leptospirosis not only in horses but other mammals.  A study conducted in 
Kentucky isolated Leptospira interrogans serovar Pomona type Kennewicki in 
4/14 raccoons [267].   
 Leptospirosis in horses is endemic in Kentucky.   Veterinarians practicing 
in Kentucky consider titers ≥1600 indicative of a possible infection or a major 
exposure.  In this study, females had a significantly higher number of titers 
≥1600 and neither age nor serovar had a significant impact on the level of titers.  
Pregnant mares had significantly higher titers (not titer brackets) after taking into 
consideration unequal variances.  There were no other significant differences 
within the female group.  Mares are immune compromised in the last trimester of 
pregnancy, therefore titers may increase during this time period, after multiple 
exposures to Leptospira environmentally and/or by direct contact with other 
animals.  Stress caused by increased leptospiral titers and transplacental 
infection may increase chances for abortion [86].  
 Only 4 horses had positive titers in the vitreous, none considered to have 
an active infection according to the Goldmann-Whitmer coefficient.  The low 
number of vitreous samples with a titer is not surprising since none of these 
animals were euthanized because of blindness or ERU.  However, there were 14 
vitreous samples with a green fluorescent color indicating they had recently had 
an ophthalmological exam.  All fourteen horses had negative titers in both their 
heart and vitreous samples.  A high percent of horses in this study were 
Thoroughbreds.  Although they can present with ERU, they have not been found 
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to have a genetic link like Appaloosas [214, 216].  Also, a lower percent of 
Thoroughbreds present with ERU compared to other breeds [214, 217].   
 Urine samples were collected from 16% of animals, all were negative by 
PCR.  Identification of leptospires through culture or PCR from urine samples is 
difficult because of the sensitivity of the organism to pH and enzymatic 
breakdown in the urine.  Additionally, all samples were taken from deceased 
horses resulting in a collection of urine which might reduce detection by PCR.  
Studies have shown positive results for Leptospira by PCR in urine upon 
collection from live horses especially after abortions caused by leptospirosis  
[167, 268, 269].   
 There are a number of limitations to this study.  Samples were taken at the 
time of death.  In addition, there were no paired serum sample collections to 
determine whether horses with titers ≥1600 might indicate a current recent 
leptospiral infection (fourfold rise in titer).  Multiple serum titers are critical in 
determining leptospirosis and its course.  Only 73/500 (14.6%) urine samples 
were analyzed, all negative by PCR.  The low number along with only one 
sample from each horse makes it difficult to draw conclusions about shedding of 
leptospires in the horse.  A small section of kidney was taken for analysis.  Lack 
of isolation from the kidney could have been due to missing potential tubule(s) 
containing the organism from the section taken at necropsy and subsequent DNA 





Horses submitted for necropsy between May 2016 to January 2019 have 
evidence of exposure to Leptospira (elevated MAT titers) regardless of the 
reason for submission.  There was a higher seroprevalence of serovar Bratislava 
compared to both Pomona and Grippotyphosa.  This has been seen previously in 
Kentucky [203, 230].  Further research is needed to determine the strains of 
Bratislava in the US and their differences, if any, to Europe.  Females compared 
to males appear to have an increased risk of having significantly higher MAT 
titers.  This may be due to housing of mares together compared to males which 
tend to be either alone or in smaller numbers.  This could also be specific to 
Central Kentucky.  Further research is needed to ascertain whether this is 
occurring only in this region or is common throughout the US and/or globally.  
Older horses are more likely to have a titer for Leptospira and also have higher 
titers.  This has been documented in multiple papers [41, 185, 202, 237, 259].  
PCR results were negative for pathogenic Leptospira in urine, with a low number 
of positive kidney and vitreous samples.  This suggests that the risk of leptospiral 
shedding of the organism in urine by horses in Central Kentucky is minor and 
possibly indicates that horses clear leptospiral infections quickly.  Results also 
suggest the risk of humans/animals acquiring a leptospiral infection from horses 
without an active infection is low.  However, only one sample was 
analyzed/animal with no previous or follow up samples for comparison in order to 
determine the occurrence of an active infection. Therefore, further research is 




   Chapter Four 
 




Heme oxygenase (HO) is an enzyme with three known mammalian 
isoforms: HO-1, HO-2 and HO-3 [270-273].  HO-1 is found throughout the body 
but is highly expressed in the liver, spleen and places with high red blood cell 
(RBC) turnover [270, 274].  HO-1 concentrations are very low or undetectable 
under normal conditions, but highly inducible under inflammatory conditions and 
stress.   HO-2 is expressed constitutively in mammals [272, 274].  HO-2 is highly 
expressed in many tissues such as kidney, liver, testes, spleen, and the nervous 
and cardiovascular systems [274, 275].  HO-2 is thought to be neuroprotective in 
the brain and play an important role in male reproduction [275].  HO-2 is also 
thought to be involved in the maintenance of basal heme metabolism.  Unlike 
HO-1, information about HO-2 is limited due to the lack of selective chemical 
probes to study the enzyme [275].  HO-3 is thought to be a pseudogene derived 
from HO-2 transcripts and has only been identified in rat brain [273].  The 
function of HO-3 is still unknown.          
HO-1 deficiency in humans was first noted in a young boy with a multitude 
of developmental disturbances, including hemolytic anemia, low bilirubin, 
abnormal coagulation, intravascular hemolysis, severe growth impedance along 
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with many other maladies all traced back to HO-1 deficiency  [276].    A HO-1 
deficiency in mice was associated with a number of problems including abortion, 
increased inflammatory responses, lymphadenopathy and splenomegaly [277].  
Deficiency in HO-1 in mammals leads to the inability to respond to inflammatory 
processes.  The body’s failure to respond with a proper immune response can 
lead to an exaggerated inflammatory response [277].  In cases of organ 
transplantation, it will lead to rejection.  The importance of HO-1 in both adaptive 
and general oxidative stress in mammalian cells was confirmed in the mid-1980s 
[278] 
 The increasing interest and importance of HO-1 can be appreciated by 
the number of articles published over the past 30 years.  In 1992 there were 8 
articles published (PubMed), since 1993 there have been well over 10,000. 
 
4.2 Heme Oxygenase-1 
HO-1 is upregulated by numerous chemicals, inflammatory cytokines and 
is found in various tissues, bone marrow and cells [279-281].  It has been 
detected in various mammals including humans, rats, mice, swine, sheep and 
bovine  [282-288].  HO-1 is an enzyme involved in the biosynthesis of heme and 
is the first and rate-limiting step of the oxidative degradation of heme.  The by-
products of the reaction produce carbon monoxide (CO), free iron and heme 
precursor biliverdin (BV), which subsequently is converted to bilirubin (BR) [278, 
279, 289].  HO-1 and HO-2 can degrade heme into its by-products, however only 
HO-1 can be induced by a large number of chemicals and drugs, such as metals, 
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eicosanoids, aspirin, statins and niacin [290].  The by-products of HO-1 are anti-
inflammatory, reducing organ injury.  Additionally, they assist in maintaining 
heme at normal levels [291].  HO-1 is involved in vascular tone, anti-inflammatory 
processes, anti-apoptotic responses, responding to and reducing oxidative stress 
leading to decreased tissue damage in numerous organ systems [288].   
 
4.3 Hemoglobin 
 Hemoglobin (Hb) is a protein found in red blood cells [292].  In humans 
approximately 1% of Hb is degraded daily.  The main function of Hb is the 
storage and transport of oxygen [293, 294].   
There are differences in equine Hb as compared to humans and 
ruminants.  Horse Hb has a lower binding affinity to oxygen than humans, but 
higher than ruminants [295, 296].  Oxygen affinity is important for the quick 
release and delivery of oxygen to tissues and is pH dependent [293, 296].   
 
 
4.4 Equine Red Blood Cells 
 The average life span of RBCs in the horse is 140-150 days compared to 
120 days in humans [292, 297].  Red blood cells have many roles, the main one 
is carrying O2 from the lungs throughout the body to tissues, organs, muscles 
and to carry CO2 back to the lungs for exhalation.  RBCs in humans and horses 
both release and rapidly uptake amino acids, which represent 15-17% of their 
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total content [297].  This indicates another role for RBCs, transporting amino 
acids throughout the body. 
Equine RBCs vary among breeds [298].  There are key differences in 
RBCs between hot-blooded and cold-blooded breeds.  Hot-blooded horses 
include Arabian, Standardbred, Quarter horses, Thoroughbreds and Appaloosas 
[298].  Cold-blooded breeds include ponies, hackneys, draft horses and donkeys.  
Table 4.1 shows RBC differences in hot- and cold-blooded equine breeds and 
humans. 
 
Table 4.1: RBC Differences Between Hot- and Cold-Blooded Horses 




Female        Male 
RBC X1012/L 8.2-12.2 5.5-9.5 4.2-5.4 4.6-6.2 
Hemoglobin g/L 130-170 80-140 115-160 140-180 
PCV percent 32-48 24-44   
MCV fL 36-50 40-48 80-95 80-95 
MCH pg 13-19 12-17   
MCHC g/L 330-390 320-380 300-340 300-340 
Diameter µm 5.7 5.7 6.2-8.2 6.2-8.2 
 PCV=packed cell volume 
MCV=mean corpuscular volume 
MCH=mean corpuscular hemoglobin 
MCHC=mean corpuscular hemoglobin concentration 
 
 RBCs in the horse are unique in forming a rouleaux configuration [298].  
The RBCs aggregate together linearly, with the number of rouleaux formations 
attributed to the number of RBCs in circulation.  Figure 4.1 shows RBC rouleaux 
formation in horses.  Normally, RBCs have a strong negative charge and repel 
each other [298].  However, in horses the charge is weak, causing them to stack 
together into the rouleaux formation and have the propensity to aggregate in 
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anticoagulated blood samples.  Increased rouleaux formation can be seen in 




   Figure 4.1:  Rouleaux Formation in Equine RBC* 
 
   *[298] 
  
 
4.5 HO-1: Physiology and Immune Response 
   HO-1 is crucial for an oxidative stress response in humans [278].  HO-1 
can act as an agonist or antagonist depending on conditions and upregulation 
upon stimulation [278].  Stimulation can be an inflammatory process or trauma 
(protective).  One indicator of HO-1 trauma is bruising of the skin.  When trauma 
occurs blood capillaries break releasing RBCs [278].  The RBCs will lyse, a 
red/brown color on the skin occurs caused by hemoglobin/met-hemoglobin.  The 
yellow/green color is then generated by the release of biliverdin.   
During oxidative stress HO removes free heme decreasing the over 
production of reactive oxygen species (ROS) [299].   If left unchecked, free heme 
will undergo autooxidation to produce superoxide and hydrogen peroxide with 
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further development to ROS.  HO-1 is well known to demonstrate cytoprotective 
effects upon stress related conditions [277, 278, 300].  When oxidative injury 
occurs, be it from infection, cardiovascular event, trauma, inflammation or organ 
transplants, HO-1 is modulated.  HO-1 breaks down heme releasing CO and 
biliverdin, which execute their own antioxidant/anti-inflammatory properties 
concurrently with HO-1 downregulating pro-inflammatory cytokines [277, 301, 
302].   
Both tissue and cell damage/injury occur through lipid peroxidation and 
free radical formation if heme is left unchecked by HO [291, 303].  HO-1 
metabolizes high amounts of heme, elevating  by-products and leading to tissue 
damage [303].  Major damage can occur in the kidney by heme overload.  The 
heme proteins can form a precipitant in the renal tubules, compromising the 
filtration system of the kidneys and potentially leading to renal failure [303].   
A number of transcription factors control HO-1 including nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-kB), c-Jun NH2-terminal 
protein kinase (JNK) and activator protein 1 (AP-1) (Appendix 6) [303].  These 
transcription factors can be activated by iron, heme and free radicals.  Free iron 
in the ferrous form is a strong pro-oxidant and one of the breakdown products of 
heme.  The ferrous form is used in a number of processes to facilitate free radical 
formation, and in the Fenton reaction [303].  The Fenton reaction drives the 
production of free radicals.  Fenton reaction can also stimulate the production of 
ferritin which acts as an antioxidant by binding to iron and releasing it in a precise 
manner [304].  Ferritin is an iron storage protein found in many cells and tissues 
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in mammals, and in bacteria [304, 305].  Ferritin also has cytoprotective 
properties [299].  The amount of ferrous iron produced is dependent on the 
amount and availability of heme and induction of apoferritin [303, 306].  
Apoferritin is a protein when bound to iron, forms ferritin.  HO-1 control of heme 
prevents program cell death of parenchyma cells by co-expression of ferritin H 
chain (FTH) [304].  FTH controls the pro-oxidant effect of Fe after its’ release 
from the protoporphyrin IX ring of heme.  Transcription factor JNK is continually 
activated by the intracellular accumulation of free radicals; however FTH controls 
JNK activation and in a feedback mechanism JNK activation inhibits FTH, 
controlling the cellular overload of Fe [304].  All of this centers on availability and 
regulation of HO-1.     
HO-1, like nitric oxide, can be detrimental by unchecked degradation of 
heme and accumulation of its by-products [291].  HO-1 can downregulate nitric 
oxide synthase (NOS), and NOS can up and down regulate HO through multiple 
pathways including NF-kB [291, 307].  Dysregulation of either HO or NOS can 
lead to detrimental effects such as tissue and vascular damage.           
Interleukin-10 (IL-10) is a cytokine that influences multiple cell types with a 
wide range of effects [301, 308].  Notably IL-10 has the ability to inhibit pro-
inflammatory cytokines such as interleukin-1 beta (IL-1β), interleukin-6 (IL-6), 
interleukin-8 (IL-8) and tumor necrosis factor alpha (TNFα).  IL-10 has also been 
shown to induce HO-1, and there appears to be a synergistic effect between IL-
10 and HO-1 [302].  When HO-1 is restricted, the inhibitory effect of IL-10 on pro-
inflammatory cytokines is reduced.  HO-1 can be induced by TNFα, IL-1β, IL-6, 
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IL-8 and IL-10 [271].  HO-1 along with its by-products has also been shown to be 
important in not only the maintenance of pregnancy in humans, but also in 
protection against eclampsia and uterine contractility [274, 302].  IL-10 is also 




 HO-1 has been well documented regarding the vasculature of the uterus 
in humans, mice and rats [271, 281, 284, 309].  HO-1 supports and stabilizes the 
implantation of the embryo at conception and has a protective effect throughout 
pregnancy [281, 285, 309, 310].  HO-1 protects the placenta in immune 
tolerance/suppression between the fetus and mother, decreasing oxidative stress 
during pregnancy [311].      
 HO is found in the basal plate, chorionic villi, fetal membranes and the 
chorionic plate during pregnancy in humans [282, 288].  HO-1 has also been 
identified in human vascular endothelium, syncytiotrophoblast and 
cytotrophoblast cells.  The regulation of HO in the placenta is partly dependent 
on localized amounts of glucose and oxygen [312].  An in vitro study showed 
increases in HO-1 after cells were deprived of glucose and oxygen for 24 hours, 
and subsequently exposed to low concentrations of both [312].  The blood 
vessels in the placenta are not innervated, consequently vascular tone is 
controlled by localized soluble factors such as CO [312].  The placenta can 
overcome low oxygen by undertaking anaerobic glycolysis, however this will 
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increase oxidative stress.   In order to maintain homeostasis, levels of HO will 
increase to protect the placenta from by-products of anaerobic glycolysis [312].  
Preeclampsia (PE) can also cause complications in blood flow to the uterus and 
placenta, causing a deficiency in both glucose and oxygen, thereby increasing 
oxidative stress [312].  
 HO-1 and breakdown products of heme, namely CO and biliverdin, are 
important for maintenance throughout pregnancy [311].  There is an increased 
concentration gradient between the maternal and fetal circulation of biliverdin and 
bilirubin further indicating a role of HO [313].  Biliverdin cannot cross the 
placental barrier like bilirubin, however both the placenta and uterus (pregnant) 
can reduce biliverdin to bilirubin for transfer [313].  Once transfer occurs, bilirubin 
can serve as an antioxidant.  During pregnancy there is increased oxidative 
stress with trophoblast cells in contact with the maternal vascular system [285].  
The trophoblast cells carry oxygen and have the ability to cross the placenta 
barrier to the growing fetus [314].  Low levels of HO can lead to increased levels 
of heme at the fetal-maternal interface increasing an inflammatory response.   
The occurrence of fatty acids (FA), specifically polyunsaturated FA, have 
been found in the plasma of human umbilical cord, increasing chances of 
oxidation and fetal injury [288].  The amount of FA in fetal circulation is lower 
when compared to an adult.  The polyunsaturated FAs are susceptible to 
oxidation placing the fetus at increased risk of oxidative damage [288].      
 Both nitric oxide (NO) and HO have been found in humans, rats and mice 
at implantation, and are essential in trophoblast attachment and maintenance 
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[281, 288].  Increased oxidative stress in the fetus initiates an increase in both 
iNOS and HO-1 [315].   
HO-1 is a stress response protein upregulated at pregnancy [282].  The 
critical period in pregnancy is the implantation of the trophoblast cells into the 
uterine wall.  The uterine wall is extremely hypoxic with 1-2% oxygen, little 
vasculature, and an increased immune response during pregnancy [282].  In 
humans HO-1 and exhaled CO levels are lower in the placenta of women with 
PE compared to normal pregnancies [311, 316].     
  Several studies have shown a decrease in HO and spontaneous 
abortions in humans [314, 317].  Levels of HO-1 and HO-2 were decreased in 
trophoblasts from aborted fetuses compared to trophoblasts from terminated 
normal pregnancies.  In a case study of 3 deleterious pregnancy outcomes, a 
homozygous deletion was found in the HMOX1 gene (HO-1) leading to a 
frameshift and a premature termination codon [318].  This mutation was carried 
by both parents and to abortion and/or termination of each pregnancy.  
 
4.6.2 Mice/Rats 
Studies in mice have demonstrated the importance of HO-1 in maintaining 
pregnancy from early development through birth [319, 320].  In these models, as 
HO-1 decreased circulating levels of t-helper cell-1 (TH-1), while pro-
inflammatory IL-1β, TNFα and IFNg, increased [283].  In mouse models of 
abortion, levels of HO-1 in the placenta have been shown to decrease along with 
circulating IL-10 [310, 321, 322].  Supplementing abortion prone mice with HO-1 
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adenoviral vector has been shown to decrease levels of pro-inflammatory 
cytokines [281, 313, 322].  In both mice and rats a Th1 response triggers an 
elevation of IL-2, TNFα and IFNg  cytokines, and the loss of the fetus may occur 
[283, 323].  When a Th2 response occurs, increases in IL-4 and IL-10 have been 
shown to protect and maintain the pregnancy through birth.  In HO-1 knockout 
mice abortion will occur even if Th2 cytokines have been upregulated [283].  HO-
1 and its by-products are essential for maintaining pregnancy, protecting against 
eclampsia and uterine contractility in humans and other mammals [281, 313].   
HO-1 has also been shown to play an important role in bacterial infections that 
cause abortion, such as Listeria monocytogenes [324].   
The equine immune response during pregnancy has been well 
documented [325-327].  The importance of HO-1 in the horse is yet to be 
determined.  Preliminary data (presented below) shows an increased level of 
both HO-1 and IL-10 in pregnant mares, and mares with increased MAT titers to 
Leptospira.  The studies below were undertaken to determine the normal serum 
levels of HO-1 in the horse.  By establishing the basal levels of HO-1 we hope to 
determine changes, if any, when horses become ill or pregnant, to avert potential 













4.7 Materials and Methods 
 
 
4.7.1 Pilot Study 
 
 In 2015 there were no published papers referencing serum HO-1 levels in 
horses.  Therefore, a preliminary study was undertaken to determine if HO-1 
could be measured.  The literature indicates HO-1 is upregulated in pregnancy 
and/or infections in humans, rats and mice.  The farm chosen for the study 
recently had cases of leptospirosis confirmed by University of Kentucky 
Veterinary Diagnostic Laboratory in pregnant mares.   
 
4.7.1.1 Study Design 
 
Blood samples were collected from 9 mares by the resident veterinarian 
on one farm for four consecutive weeks during 2015.  The first blood samples 
taken were 20-40 days after 6 mares were bred.  Three mares included in the 
study were not pregnant and had been bred 3 months before the study but came 
up empty at day 28 post breeding (30+days prior to first sample).  Samples were 
submitted to the VDL and analyzed for leptospirosis by microagglutination test 
(MAT), centrifuged and serum was removed.  Serum was stored at 4C prior to 
MAT analysis.  Samples were stored at -20C after MAT analysis.  One additional 
sample was taken 294 days from day one.  MAT was performed in accordance 
with the methodology of the National Veterinary Services Laboratories (Ames, IA) 
and the OIE (World Organization for Animal Health, 6th edition) Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals Procedure.  The reference 
antigens were propagated in polysorbate-80 bovine albumin media for 4-8 days 
 
 102 
and diluted to working strength on the day of the test.   Serum was screened at a 
1:50 dilution (in phosphate buffered saline) in a volume of 50µl in wells of a 96-
well flat bottom plate containing 50µl of diluted antigen.  The final serum dilution 
was therefore 1:100.  The plate was incubated at room temperature for 1½ 
hours.  After incubation the plates were examined for agglutination using dark-
field microscopy.  A reaction was deemed positive when 50% of the antigen was 
agglutinated.  Control sera from horses with known titers were run concurrently 
on each day of testing.  Sera that demonstrated at least 50% agglutination at the 
screening dilution of 1:100 was serially diluted with their respective antigen to 
determine an endpoint titer.  Leptospira reference serovars used included 
Canicola, strain Hond Utretcht IV; Copenhageni (Icterohemorragica reference) 
strain M-20; Grippotyphosa, strain Andaman; Hardjo, strain Hardjoprajtino; and 
Pomona, strain Pomona.   
Serum samples were also analyzed by Enzyme-Linked Immunosorbent 
Assay (ELISA) for the following: Equine IL-10, Catalog#GR106003 (Genorise 
Scientific Inc., Glen Mills, PA; https://www.genorise.com) and Equine HO-1, 
Catalog#MBS019561 (MyBioSource, San Diego, CA; 
https://www.mybiosource.com).  ELISA tests were carried out following 
manufacturer’s instructions; both standards and samples were run in duplicate.  
The sensitivity of the IL-10 assay is 2pg/ml with a detection range of 6-
2000pg/ml.  The intra and inter-assay coefficient of variation is 5% and 8% 
respectively.  The sensitivity of the HO-1 ELISA kit is 0.1ng/ml and range of 
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detection is 0.625-20ng/ml.  Both the intra- and inter-assay coefficient of variation 
is less than 15% for HO-1 assay.   
 
4.7.1.2 Statistics 
Statistical analysis was carried out using student’s t-test and least squares 
fit (JMP v12, SAS, Cary, NC).  Confidence levels were set at 95%.  
 
Funding: This study was supported by a grant from the Southeast Center for 




 MAT, IL-10 and HO-1 data are listed in Tables 4.2 and 4.3 respectively.  
The primary serovar identified was Pomona.  There was a significant difference 
in HO-1 (p<0.002) levels in Leptospira positive compared to negative mares and 
pregnancy alone showed a significant difference in HO-1(p<0.02), but not in IL-











   Table 4.2: MAT Pilot Study Results 












Negative 102,400 51,200 51,200 1600 
Mare 
2P 
Negative 102,400 102,400 102,400 1600 
Mare 
3P 
Negative NA 204,800 NT 1600 
Mare 
4P 
Negative 51,200 51,200 51,200 1600 
Mare 5 Negative 12,800 51,200 12,800 100 
Mare 6 100 100 100 NT ND 
Mare 7 1660 3200 1600 NT ND 
Mare 
8P 
400 400 800 NT ND 
Mare 
9P 
100 100 100 NT ND 
   P=Pregnant; NT=not tested; ND=Non-detectable 
   *Day 21 for mares 1-5 and Day 14 for mares 6-9 
 
  Table 4.3: IL-10 and HO-1 Pilot Study  
 
Animal 












1P 9.6 3.9 11.9 2.3 15.3 3 11.9 3.2 16.9 1.3 
Mare 
2P 0.66 4.4 0.98 4.3 2.9 5 3.7 3.9 4 1.7 
Mare 
3P 9.4 4.5 10.6 3.6 10.6 4.2 10.9 3.9 5.1 BDL 
Mare 
4P 4.2 3.6 3 3 4.4 3.5 3 BDL 0.91 BDL 
Mare 5  2.5 0.86 6.4 5.2 1 1.2 3.4 1.3 2.1 1.4 
Mare 6 8 1.1 9.6 1.4 10.3 1.4 NT NT 14.4 BDL 
Mare 7 BDL 2 4.1 1 BDL BDL NT NT 2.2 BDL 
Mare 
8P BDL 3.4 3.3 1.4 3.3 0.66 
NT NT 2.6 2.4 
Mare 
9P BDL 2.6 3.5 1.8 5.2 1.5 
NT NT 2 0.91 
                BDL=below detectable limit; P=pregnant; NT=not tested 
              *Day 21 for mares 1-5 and Day 14 for mares 6-9 




Figure 4.2: Pilot Study Levels of IL-10 and HO-1 Levels in  Leptospira 
Positive and Negative Mares 
 
    IL-10 and HO-1 reported in pg/ml 
    *p<0.002; **p<0.009; ***p<0.04; +p<0.04 
 
There was no significant difference in either IL-10 or HO-1 levels in barren 
mares regardless of Leptospira state.  When comparing HO-1 levels in pregnant 
mares over time, there was a significant difference between day 1 and 7 
(p<0.03), and day 1 and 28 (p<0.04).  Additionally, HO-1 at day 294 in the 
pregnant mare group was significantly different in all the days (day 1 p<0.0002; 
day 7 p<0.002; day 14 p<0.01) except for days 28 and 294.  There is a significant 
correlation on both day 1 (p<0.003) and day 21 (p<0.02) in pregnant horses, as 
MAT levels increased so did HO-1 levels, when compared to non-pregnant 
mares.  There were no significant correlations detected for IL-10 to MAT levels in 
either group.  
 This is the first study to show a response to HO-1 in both pregnant/non-















































































































protein in either pregnancy or infection in horses is yet to be determined.  
However, this pilot study has shown HO-1 could be detected and differences do 
appear to occur with pregnancy and leptospiral infection.  This study laid the 
foundation for the larger study which follows. 
 
4.9 Determination of HO-1 Levels in Horses Located in Central Kentucky 
4.9.1 Materials and Methods 
4.9.1.1 Study Design 
The pilot study showed HO-1 could be measured in equine serum, this larger 
study was undertaken to identify the following: 
1. Determine HO-1 levels in healthy non-pregnant mares in Central Kentucky 
2. Determine HO-1 levels in mares in three groups: 
 
4.9.1.2 Animals 
4.9.1.2.1 Group One 
The following samples were submitted to the University of Kentucky 
Veterinary Diagnostic Laboratory (VDL) for leptospiral screening titers.  All serum 
samples were fresh and from pregnant mares except for two samples from foals.   
1. MAT titers of ≥25,600 to either serovar Pomona or Grippotyphosa:  
64 mares fit this requirement and 1 sample from each mare was 
analyzed except for the following:  
 
a. 9 mares had two samples within one month, both analyzed 
b. 2 samples were foals 
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4.9.1.1.2 Group Two 
Serum samples for Group Two were provided by Dr. Barry Ball, University 
of Kentucky, Professor of Veterinary Science.  All serum samples in Group Two 
had been frozen at -20oC. 
4.9.1.2.2.1 Control:  51 healthy mares not pregnant, located on the 
University of Kentucky’s Research Farm were designated as the 
control group.  One sample from each mare was analyzed.  Sample 
times varied from February 2013 to February 2018, with the majority of 
samples collected between the months of May-July. 
 
4.9.1.2.2.2 Field: 44 pregnant mares were included in this group.  
These samples were collected from horses located on farms in Central 
Kentucky.  Samples analyzed were collected from 7 months of 
pregnancy till foaling or abortion.  Twenty pregnant mares were 
separated into two groups of 10, designated as field with and without 
supplement (Table 4.4).  The supplement given was Altrenogest, a 
synthetic progestin.  The remaining 24 pregnant mares had a number 
of different conditions listed in Table 4.5.  One sample from each mare 
in this group were analyzed at the following time points of pregnancy:   
c. 7 months  
d. 9 months 






        Table 4.4:  Field Samples 
Group Number of Mares 
Field  
No Supplement 10 
Supplement  10 










        Table 4.5:  Field Samples-Case 
Diagnosis Number of Cases 
Umbilical torsion 1 
Placentitis 2 
Bacterial Placentitis 2 
Nocardioform Placentitis 2 
Mild acute placentitis 1 
Mild focal placentitis 2 
Inconclusive  1 
Viral Placentitis-EHV-1 1 





Chronic focal bacterial 
placentitis-Nocardioform 1 
Placenta previa-foal 
dead separation 1 
Focal, chronic placentitis 1 
Bacterial and mycotic 
yeast placentitis 1 
Minimal focal suppurative 
placentitis 1 
Focal severe bacterial 
placentitis 1 






4.9.1.2.2.3 Pregnant mares over time:  18 healthy mares located on 
the University of Kentucky’s Research Farm, were included in this 
group.  All mares carried to full term.  One serum sample from each 
mare at the following time points of pregnancy was analyzed: 
 
f. Initial sample day 15 -April 2012 
g. 75 days-June 2012 
h. 250 days-November 2012 
i. 310 days-January 2013 
j. 325 days-January 2013 
k. 340 days-January 2013 
 
4.9.1.2.3 Group Three 
1. A group of pregnant mares that had aborted due to leptospirosis were 
also analyzed.   Leptospiral Positive Mares who aborted:  34 mares 
had aborted because of confirmed leptospiral infection (samples 
provided by Dr. John Timoney, Professor University of Kentucky 




4.9.2 Serum Sample Processing 
4.9.2.1 MAT Analysis 
Fresh blood samples for MAT were submitted to the University of 
Kentucky’s Veterinary Diagnostic Laboratory (Group One), centrifuged and 
serum was removed.  Serum was stored at 4C prior to MAT analysis.  Samples 
were stored at -20OC after MAT analysis.  Serum samples were analyzed for 
leptospirosis using MAT.  MAT was performed in accordance with the 
methodology of the National Veterinary Services Laboratories (Ames, IA) and the 
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OIE (World Organization for Animal Health, 6th edition) Manual of Diagnostic 
Tests and Vaccines for Terrestrial Animals Procedure.  The reference antigens 
were propagated in polysorbate-80 bovine albumin media for 4-8 days and 
diluted to working strength on the day of the test.   Serum was screened at a 1:50 
dilution (in phosphate buffered saline) in a volume of 50µl in wells of a 96-well flat 
bottom plate containing 50µl of diluted antigen.  The final serum dilution was 
therefore 1:100.   The plate was incubated at room temperature for 1½ hours.  
After incubation the plates were examined for agglutination using dark-field 
microscopy.  A reaction was deemed positive when 50% of the antigen was 
agglutinated.  Control sera from horses with known titers were run concurrently 
on each day of testing.  Sera that demonstrated at least 50% agglutination at the 
screening dilution of 1:100 were serially diluted with their respective antigen to 
determine an endpoint titer.   Leptospira reference serovars used included 
Grippotyphosa, strain Andaman and Pomona, strain Pomona.   
 
4.9.2.2 HO-1 Analysis 
Serum samples for HO-1 analysis were acquired as followed: Frozen 
serum samples for control, field samples and pregnant mares over time (Group 
Two) were provided by Dr. Barry Ball, University of Kentucky, Professor of 
Veterinary Science, Lexington, Kentucky (samples collected between 2013-
2018); frozen serum samples from leptospiral positive mares who aborted (Group 
Three) were provided by Dr. John Timoney, University of Kentucky Professor of 
Veterinary Science, Lexington, Kentucky (samples collected between 1991-
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1998).  Fresh serum samples submitted to UKVDL between November 2017 and 
January 2018 were also analyzed.      
Samples for HO-1 analysis were processed as follows:  samples were 
analyzed by ELISA for the following: Equine HO-1, Catalog#MBS019561 
(MyBioSource, San Diego, CA; https://www.mybiosource.com).  ELISA was 
carried out following manufacturer’s instructions; both standards and samples 
were run in duplicate.  The sensitivity of the HO-1 ELISA kit is 0.1ng/ml and 
range of detection is 0.625-20ng/ml.  Both the intra- and inter-assay coefficient of 
variation is less than 15%.   
 
4.9.3 Statistical Analysis 
 One of the primary reasons for this study was to determine the normal 
levels of HO-1 in horses in order to identify changes related to stressors such as 
pregnancy and illness.  A power analysis for one-way independent ANOVA was 
performed to determine the number of animals needed for a significant difference 
at p=0.05, 216 animals were included with a total of 340 samples analyzed for 
HO-1.  All HO-1 samples were analyzed using ELISA kits from the same lot 
number. 
 UKVDL samples were analyzed using a one-way ANOVA for differences 
between MAT serovars, and serovar/HO-1 results.  The effect of serovar and titer 
was determined by Standard Least Squares.  Nine samples taken a month apart 
were analyzed using Matching Pair.   
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 Field samples were analyzed using one-way ANOVA for non-pregnant 
control mares and time of estrous.  Field samples overtime were analyzed using 
MANOVA.  Tukey’s Means Comparison was used to analyze any differences 
amongst field samples and between leptospiral survey samples.  All samples 
were analyzed using JMP v13.2 (SAS, Cary, NC).  Significance was set to 
p≤0.05.     
 
4.10 Results 
4.10.1 Group One:  UKVDL Leptospiral Survey Samples 
 Results for HO-1 are in Table 4.6.  There were no differences seen with 
serovar/MAT and HO-1 outcome. 
 











Pomona 62 None None 8.3 
Grippotyphosa 3 None None 5.5 
            *p=0.0437  
 
Serovar Pomona had significantly higher titers compared to serovar 
Grippotyphosa (p<0.0437).  Additionally, 9 animals had serum analyzed a month 
from the initial sample.  Seven of these were mares and 2 were foals.  Eight had 
elevated titers to serovar Pomona (two foals and 6 mares), and 1 to 













Table 4.7: Matched Paired MAT/HO-1  











































*Taken one month after first sample 
**ng/ml 
***Above standard curve, both removed prior to statistical analysis 
 
 
Using Matching Pair analysis within and among pairs by titer and HO-1, a 
significant difference was seen (p=0.0411).  As titer went down HO-1 went up in 
5/7 mares, all were still pregnant at the time of the second blood collection.  One 
mare (#9) had an increased MAT titer, but HO-1 decreased.  The second sample 
was taken after she aborted.  MAT titers and HO-1 levels for both foals 
decreased.  There was no change looking at differences by serovar overtime.  A 
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Oneway analysis and using Tukey-Kramer HSD Means Comparisons of HO-1 by 
titer showed a significant difference between mares with MAT titers of 102,400 
and 51,200 (p=0.0412). 
 
 
4.10.2 Group Two 
 
 Results for control mares (healthy and not pregnant) can be found in 
Table 8.  The mean HO-1 levels for control mares were 5.6µg/ml.  There were 
12/39 (23.5%) samples above the standard curve, excluded from statistical 
analysis and not included in Table 4.8.  There were no significant differences in 





































1  3 
3  8.1 
4  6.7 
5  1.7 
6  2 
7  11.4 
8  0.85 
10  1.8 
11  1 
12  3.6 
13 12 0.44 
15  3.2 
16  2.9 
17  8.3 
18  4.5 
20 6 4.1 
21 8 4.5 
22 3 15 
23 2 9.2 
25 12 1.7 
26 12 3.1 
27 0 1.8 
28  4 
29 1 8.5 
30 12 3.4 
33  2.3 
34  2.9 
35  2.2 
36 8 7.2 
37 14 13 
38 6 19.7 
39 12 4.2 
41 6 4.9 
44 6 2.8 
45 9 3.5 
48 12 17.6 
49 10 17.9 
50 6 3.1 
51  3 
         *ng/ml 
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 Samples were acquired from mares in the Field group (pregnant with and 
without supplement, and case) over a period of four months, starting in 
December of 2013 through May 2014 (actual start date of samples varied from 
mare to mare).  Comparison of means for initial, midway and the last blood 
sample taken (time of foaling/abortion) are in Table 4.9.  Comparing mares in this 
group only (those with and without supplement) to case mares, there were no 
significant differences over time between or within groups using MANOVA.   









Control  6.6    
NS  6.2 7.3 8.1 
S  5.6 6.3 6.4 
Case 6.8 7.6 6.1 5.7 
          NS=No supplement 







Mean HO-1 results for field samples (no supplement, supplement and case) of all 
samples taken over 4 months are in Table 4.10.  There were no significant 
differences between groups. 
 
Table 4.10:  Field Study No Supplement, Supplement and Case HO-1  
Group HO-1* 
No Supplement 7.2 
Supplement 6.1 
Case 6.8 
          *ng/ml 
Results for mares pregnant over time are in Table 4.11.  There were 18 
mares in this group.  Blood samples were drawn on the following days of 
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gestation:  15, 75, 250, 310, 325 and 340 depending on time of foaling.  Results 
were averaged according to the day of sample collection.  There was no 
significant difference regardless of days of gestation.   
        
                         Table 4.11: Mares Pregnant Over Time-HO-1  







                *ng/ml 
Results for control, pregnant overtime and field samples (combined no 




           
Table 4.12: Control, Pregnant Overtime and Field Sample  
Group HO-1*  
Control 4.7 




                            *ng/ml 
 
 Results from control, pregnant mares overtime, field samples (no 
supplement, supplement and case) and leptospirosis survey samples can be 
found in Table 4.13.  There was a significant difference between leptospirosis 
survey samples and control (p<0.0017) and pregnant overtime (p<0.0011). 
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Table 4.13:  Field, Pregnant Overtime and Leptospira Survey 
Group HO-1*  
Not Pregnant (Control) 4.7 
Pregnant Overtime 5.4 
Field  
No Supplement 7.2 
Supplement 6.1 
Case 6.8 
Leptospirosis Survey Samples 8.3**+ 
*ng/ml 
**p<0.0017 to Not Pregnant (Control)  
+p<0.0011 to Pregnant OT 
 
  
   
All field (no supplement and supplement) carried to term.  The average days of 
gestation in the field group with no supplement was 333.4 days compared to 
328.4 days in the supplement group.  Field case mares had 6 abortions (2 never 
made it to start of study, no blood samples were taken).  A total of 18/24 mares in 
the case group carried to full term.   The average gestation was 342 days, 
although including 6 mares who aborted the average gestation was 332.3 days.  
Comparing gestation days (including all case mares and those that aborted) 
there was no statistical difference within the field group.  However, if the 6 mares 
who aborted using Tukey-Kramer HSD means comparisons are excluded, there 
is a significant difference between case/supplement (p=0.0067). 













   Table 4.14: HO-1 Levels:  Field, Pregnant Overtime, Leptospirosis 
     Survey and Leptospirosis/Mares Aborted 
Group HO-1*  
Not Pregnant (Control) 4.7 
Pregnant Overtime 5.4 
Field  
No Supplement 7.2 
Supplement 6.1 
Case 6.8 
Leptospirosis/Mares Aborted  5.2 
Leptospirosis Survey Samples 8.3**+# 
             *ng/ml  
  *p<0.0016 to Not Pregnant (Control)  
            +p=0.001 Pregnant OT 
            #p=0.0232 Leptospirosis/Mares Aborted 
 
 
4.10.3 Group Three 
When samples from mares who had been identified with leptospirosis and 
aborted were compared to all others there was a significant difference only for 





 The role of HO-1 in horses has not previously been elucidated.  A pilot 
study was conducted in 2015 to determine if HO-1 levels could be detected in the 
serum of horses.  HO-1 levels in non-pregnant mares were significantly lower 
compared to pregnant mares.  These results are consistent with literature in both 
humans, rats and mice showing an increase in HO-1 levels during pregnancy 
[282, 299, 317].  The last sample taken (day 295) was after foaling and shows a 
decrease in HO-1 similar to what has been shown in other mammals [313, 328].  
These data concur with HO-1 levels in other mammals that are pregnant and 
 
 120 
have underlying maladies such as PE, hypertension and other disease entities 
[318, 328, 329].     
The first part of this project examined HO-1 levels in pregnant mares 
screened for leptospirosis through UKVDL.  By the time the second study was 
initiated an equine leptospiral vaccine, specific for serovar Pomona had been on 
the market for two years.  Data have shown MAT titers post-vaccination in horses 
are around 1600, but titers up to 6400 have been seen [330].  Because of this, 
horses submitted were required to have titers	≥25,600.  Regardless of serovar or 
MAT titer, HO-1 mean level was the same for Pomona and Grippotyphosa.  
Sixty-four horses were included in this part of the study and only 9 had an 
additional sample analyzed for comparison.  The small sample size (N=9) makes 
it difficult to conclude if there truly is no difference between the dominate serovar 
and HO-1 levels.  The host and its response to the prevailing serovar will 
determine the severity of infection by MAT [331].  Differences in host response 
have been seen depending on infective serovar [86, 157, 185].  The HO-1 
response to bacterial virulence can be detrimental to the host (Vasil 1999; Chung 
2008). A larger study is needed to determine the extent to which the infective 
serovar affects HO-1 levels.   
 Seven mares and two foals had two samples analyzed a month apart.  
MAT levels in 8/9 animals decreased over one month, however only 4/9 showed 
a decrease in HO-1 levels.  Decreased levels in 3/4 were the foals and a mare 
who had aborted.  These three show a similar trend seen in other mammals.  
Both animals and humans have shown a decrease in HO-1 right before and after 
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abortion has occurred [283, 285, 314].  HO-1 has been shown to decrease 
overtime after infections [332, 333].  The small subset of animals (N=9) and 
smaller number who showed a decrease in HO-1 (N=3), makes it impossible to 
determine if this is the same in horses.  A larger study is needed to determine if 
this is also true in horses.  The second MAT titer analyzed from the mare who 
aborted increased while HO-1 decreased, showing pregnancy may influence HO-
1 levels more than infection in horses.  Increases in HO-1 levels in 5/9 mares 
whose MAT titers decreased also shows the influence pregnancy has on HO-1 
levels.  This has been seen in other pregnant mammals with bacterial infections 
[324, 334, 335].         
 Estrous cycle in Group Two-healthy nonpregnant mares showed no 
differences in HO-1 levels compared to mares not in estrous.  These results are 
different compared to other mammals such as mice and rats.  In both rats and 
mice HO-1 has been shown to increase during estrous [336, 337].  In mice higher 
levels of HO-1 occur during metestrus [337].  Mares in the field group were 
divided into 3 groups (control no supplement, control supplement and case).  
Control mares with or without supplement and case mares showed no significant 
differences in HO-1 levels over a period of 20 weeks.  This concurs with results 
seen in the leptospiral survey group.  Pregnancy seems to play a greater role in 
HO-1 levels than infection.  A majority of mares in the case group (79%) had 
placentitis, regardless their HO-1 levels were very similar to mares who had no 
known health issue.     
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 Mares pregnant overtime also showed no significant differences 
regardless of the day of gestation.  Nor were there any differences comparing 
this group to the field mares, this strengthens the concept HO-1 levels are 
influenced more by pregnancy.  Case mares who aborted did not show any 
decrease in HO-1 levels prior to abortion, seen in other mammals.   
 The leptospirosis survey samples had significantly higher HO-1 when 
compared to non-pregnant and pregnant overtime mares.  The significantly 
higher HO-1 in leptospiral survey mares maybe due to the type of bacterial 
infection in addition to pregnancy.  The length of gestation of mares in the 
leptospiral survey group were unknown, which could also have influenced HO-1 
levels.  Both field case and leptospiral survey mares had significantly higher HO-
1 levels when compared to nonpregnant mares.  In other mammals HO-1 is 
upregulated during infection [274, 279, 338].  Increased HO-1 levels have been 
shown in infections caused by Corynebacterium, Pseudomonas, Listeria, 
Acinetobacter and others [339-341].  Bacteria, viruses and fungi also have heme 
oxygenase, including those bacteria previously mentioned [339, 342].  The HO 
found in bacteria is needed for the breakdown of heme and uptake of iron.  Iron 
is essential for the bacteria’s pathogenicity, virulence, colonization and survival 
[341].  The host attempts to limit free iron by the use of iron-binding molecules, 
however bacteria have developed ways to circumvent the limited availability.  
Some bacteria have outer membrane receptors for ferrous iron such as 
Campylobacter jejuni [341].  Other bacteria, such as Pseudomonas, secrete 
siderophores that bind ferrous iron and can transport it back into the bacteria 
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[343].  Still others acquire iron by the degradation of heme through heme 
oxygenase.  Leptospira have HO and require it for the breakdown of heme in vivo 
and to establish colonization in the host [344-346].  Leptospira can bind to heme 
through the hemin-binding protein (HbpA) [347-349].  Heme oxygenase gene in 
pathogenic Leptospira (hemO) is also required for host pathogenicity [345].  
Leptospira acquire iron from heme needed for growth in vivo from the host [350].   
Both case and leptospiral survey groups had higher levels of HO-1.  This could 
be due to additional breakdown of heme by the bacteria or viral infections 
ongoing in these mares.  Specifically, the leptospiral survey group had 
significantly higher levels of HO-1 than any other group analyzed.  Leptospira 
have been shown to be one of the leading causes of placentitis leading to 
abortion in central Kentucky [255].  Leptospira cause a consistent diffuse 
placentitis compared to any other causes of placentitis.   Large numbers of 
spirochetes can be found throughout the placenta and this diffuse placentitis 
originates from hematogenous [255].  It is possible with the increased flux of 
blood caused by Leptospira in the placenta, host HO-1 is also upregulated, and a 
feedback loop occurs by Leptospira causing increased bleeding and spirochetes 
utilizing heme, thereby increasing their proliferation.  A similar feedback loop has 
been proposed in Pseudomonas [351].  The upregulation of HO-1 and cytokines 
by pregnant mares with leptospiral infection may also protect from abortion.   
In Pseudomonas and Neisseria infections, heme oxygenase (HemO) have 
a smaller solvent-accessible surface when compared to human HO.  Both have 
less than 15% homology to human HO-1 [270].  Small antimicrobial molecules 
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against this site may have potential to inhibit these bacteria from pathogenicity 
and proliferation.  In Pseudomonas’s HemO an additional binding site has been 
identified, where a small molecule with a lipophilic group can possibly bind the 
hydrophobic pocket [270].  The binding would impair the HemO stability/activity 
of the enzyme by stopping the initial hydroxylation of the heme group [352].  
Recently the use of a gallium(III)-salophen has shown promise to inhibit both the 
HO and iron uptake in Pseudomonas [351].  Similar structures are now being 
investigated with Leptospira [346].  The crystal structure of Leptospira HemO 
shows several key areas used to block the enzyme activity.  By targeting these 
differences found only in bacterial heme oxygenase may be one method to stop 
progression of infection.    
HO-1 in other mammals is upregulated in the placenta under normal 
pregnancy [311, 353].  HO-1 gene (HMOX1) has been detected in the placenta 
of mares [354].  HMOX1 in the equine placenta is upregulated and appears to 
stay constant through gestation.  A study evaluating gene expression in the 
equine placenta from 45 days gestation to 10 months showed no difference in 
HMOX1 during this time period [354].   
Serum HO-1 levels in this study ranged from 0.44ng/ml to 47ng/ml.  Non-
pregnant mares had the lowest HO-1 average (4.7ng/ml).  HO-1 levels in 
humans have been shown to range from below 0.5ng/ml to 10.1ng/ml [355-357].  
HO-1 average serum levels in pregnant healthy women in one study was 
1.9ng/ml, while non-pregnant controls levels averaged 3.5  [355].  Another study 
showed average HO-1 levels in healthy pregnant women was 1.8ng/ml [356].  
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There can be several reasons for the differences between HO-1 levels seen in 
humans vs horses in this study.  ELISA kits from different manufacturers were 
used which can lead to discrepancies.  Also, the differences in RBC and 
hemoglobin between humans and horses can be contributing factors.  Rouleaux 
formation, increased number of RBCs and lower oxygen binding in horses may 
all be contributing factors in higher HO-1 levels compared to humans.            
 The mare’s gestation is unique compared to other mammals, including 
humans.  Relaxin is produced in the mare’s placental trophoblast cells and 
concentrations increase in late gestation and increase further during labor [358, 
359].  Whereas in swine the corpora lutea is the major site of relaxin during 
pregnancy [360].  Breed differences of relaxin have been seen in horses during 
pregnancy.  Relaxin in Thoroughbreds was undetectable until day 80, levels rise 
till day 175 then decline to day 225 and increase until foaling [359].  Whereas in 
Standardbreds increases occurred till day 150 and slowly declined until foaling.  
Relaxin in humans and mares is important in for vasodilation and maintaining the 
placenta during pregnancy [361, 362].  In women and dogs, lower levels of 
relaxin occur when symptoms of approaching miscarriage during early pregnancy 
are seen [360].  The mare has a specialized area between the yolk sac and 
chorioallantois forming the chorionic girdle made up of trophoblastic cells, which 
is visible ~gestation day 25 [363].  The chorionic girdle transports nutrients and 
hormones between the uterus and placenta.  Trophoblast cells in humans 
contribute to HO-1 levels in the placenta [353].  The HO-1 levels in this study 
tended to show an increase till mid-late gestation followed by a decrease and an 
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increase towards foaling.  This is not what has been shown in other mammals.  
The HO-1 levels seem to follow relaxin levels shown in pregnant mares.  The 
increase in trophoblasts between the yolk sac and chorioallantois may also be 
contributing to these differences HO-1 levels in mares.  Vascular endothelial 
growth factor (VEGF) has been shown to require HO-1 activity [309].  Relaxin 
has also been shown to be strongly associated with VEGF [364-366].  Both 
relaxin and HO-1 are critical in regulation of angiogenesis during pregnancy and 
are regulated by MAPK and p38 pathways [309, 365].  Relaxin gene (RLN) in the 
horse has been shown to be highly upregulated from 45 days to 10 months of 
gestation [354].  The importance of both HO-1 and relaxin in angiogenesis 
increases their association during pregnancy in mares.  Further studies are 
needed to ascertain the connection between relaxin and HO-1 in mares.  
 Limitations of this study include the use of several studies from different 
years.  Not having a study from start to finish carried out is subject to additional 
variations, including sample handling and storage and variation of parameters in 
studies.     
This study showed HO-1 in the serum of horses is upregulated in both 
mares pregnant with significant leptospiral MAT titers and with placentitis.  
Further studies are needed to determine HO-1 progression before, during and 
after normal pregnancy and any complications during pregnancy.  Additional 
studies are also needed to ascertain the increase in HO-1 levels in mares who 
are pregnant and have high MAT titers to Leptospira, and complications that may 
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occur if HO-1 levels decline.  The importance of HO-1 in infection in horses and 

























Discussion and Future Studies 
5.1 Discussion and Future Studies 
 Leptospirosis in mammals continues to cause global morbidity, mortality, 
animal welfare concerns, and economic losses.  Developing countries, which can 
least afford the economic losses, are the most affected.  Developed countries 
including the United States (US) have seen an increase in the past 20 years in 
morbidity, especially among domestic animals.  The low incidence of 
leptospirosis in humans in the US led to CDC removing it from the notifiable 
disease list in 1990s.  However, leptospirosis was placed back on the list in 2013 
due to a rise in both animal and human cases.  
Compared to developing countries, the US has typically reported low 
numbers of leptospiral cases for both animals and humans.  A concern is that 
leptospirosis is not being considered in the differential diagnosis list.  In many 
parts of the world, leptospirosis is considered endemic, therefore the diagnosis 
and tracking of outbreaks are routine.  The value of a near-real-time monitoring 
system for disease outbreaks has been underscored by the recent COVID-19 
pandemic.  Because leptospirosis is a zoonotic disease, monitoring incidence in 
animals is critical.  Improved understanding of the epidemiology and clinical 
presentation of leptospirosis by both veterinarians and physicians will aid in 
successfully identification of cases.   
  The changing climate, including increasing temperature and precipitation, 
favors the increased presence of leptospires in the environment [150].  Several 
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recent peer-reviewed scientific articles have cited climate change as an 
accelerator of active clinical cases of leptospirosis [73, 246].  Therefore, tracking 
and confirming diagnoses is increasingly more important, not only for 
leptospirosis, but other endemic and emerging microbial diseases.  Even with the 
advent of vaccines, animal cases have been on the rise.  There are some data 
suggesting that leptospirosis vaccines are not widely utilized.  For example, in 
dogs the vaccine can cause a mass to form at the injection site, causing some 
owners and veterinarians to want to avoid the vaccine. Other possible causes of 
perceived decreased effectiveness of the vaccines are serovar drift, increased 
testing, urbanization and climate change.     
 Chapter Two examined the frequency of leptospiral diagnosis in equine 
and bovine cases by AAVLD laboratories in the US.  The number of submissions 
for leptospiral testing in 17 states varied by a wide margin, from 1 up to 
2731/year.  This discrepancy likely reflects the difference in testing from state to 
state or lack of centralized reporting of the disease.  As has been mentioned, the 
inconsistency in the number of cases tested and diagnosed in the US may reflect 
the lack of suspicion of cases by veterinarians, meaning the incidence may be 
higher.  More active surveillance for the disease over time would provide a 
clearer representation of leptospirosis in animals.  Additionally, educating the 
general public about leptospirosis, risk of infection, and preventive measures 
(e.g. vaccines), would increase awareness and could lead to decreasing 
infections in both animals and humans.    
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 Equine leptospirosis continues to be a problem in Central Kentucky.  
However, with the advent of a vaccine in 2015 an apparent decrease in the 
number of abortions has been seen.  However, controlled studies need to be 
done on horse farms to determine the ability of the vaccine to prevent and control 
equine leptospirosis.  Chapter Three emphasized leptospiral seroprevalence in 
the general equine population of Central Kentucky.  Over 25% of horses tested 
have a positive titer ≥200, suggesting that horse exposure to Leptospira is 
common in Central Kentucky.  A significantly greater number of females had 
titers compared to males.  Separating out females in pastures may help eliminate 
exposure/re-exposure.  Decreasing exposure to wildlife can also help mitigate 
exposure and risk for becoming infected by Leptospira.   
Since 2009, 89 leptospiral abortions have been confirmed by  the  UK 
Veterinary Diagnostic Laboratory, most of which occurred in Central Kentucky 
[367].  Serovar Pomona str. kennewicki is the main cause of equine abortions in 
Central Kentucky, with Grippotyphosa playing a minor role.  Seroconversion to 
serovar Bratislava has been seen in Central Kentucky since the mid-1980s [87].  
Identification of serovar Bratislava by culture has never been reported in the US 
equine population yet the serovar has been isolated frequently in Ireland and 
Great Britain [157, 177].  Early papers published from samples collected in 
Central Kentucky from aborted fetuses showed an occasional abortion caused by 
serovar Bratislava diagnosed by MAT [254].  One plausible reason the strain of 
serovar Bratislava seen in the US hasn’t been isolated could be it is transient in 
horses and does not colonize any organs.  Increased titers to the serovar which 
 
 131 
occur often could be from repeated environmental exposure only.  Bratislava may 
not colonize the kidneys therefore short or long-term shedding is not seen.  A 
recent paper looking at colonization of serovar Bratislava could not isolate the 
organism after repeated inoculations, however increased titers were seen [368].  
One reason for this outcome could have been the strain used was isolated from a 
pig in 1989 with repeated freeze/thawing.  The swine strain used may not be able 
to colonize the horse at all and increased titers showed seroconversion only, 
which is frequently seen.  The study didn’t start collecting samples until day 3 
possibly missing the time of shedding.  To truly know whether serovar Bratislava 
is a problem in horses the organism needs to be isolated and studied to 
determine its’ ability to colonize in an organ.  Studies looking at shedding should 
start at day zero (inoculation day) to see if the organism is passing through 
immediately (between days 0-3) indicating an immune response but no 
colonization.  The horse has long thought to be host adapted to serovar 
Bratislava; however recent genotyping has found this may not be true [157].      
Since 1985 the change in precipitation and temperature in Central 
Kentucky has been significant.  Looking at 5-year increments, 
precipitation/temperature has changed from 40.3”/55.4oF in 1985-1989 to 
56.3”/57.7oF in 2015-2019, Figure 5.1.  Temperature was not seen as significant 
by statistical analysis, but a change in over 2oF is considered significant in this 
period of time [67].  This change maybe causing environmental pressure on 




Figure 5.1: Five-Year Averages for Temperature and Precipitation in 
Fayette County, Kentucky 1985-2020 
 
     p=0.0446 between 1985-1989 and 2015-2019 
Changes in serovar prevalence on samples submitted to a diagnostic laboratory 
have occurred in the state over time from 
Icterohaemorrhagiae/Bratislava/Grippotyphosa/Pomona (49.1%, 76.3%, 20.1% 
and 15.9% respectively) in 1989/1990 to Bratislava/Grippotyphosa/Pomona  
(18.1%, 4.2% and 2.8% respectively) in this study (Table 1) [230].   





Icterohaemorrhagiae 49.1  
Bratislava 76.3 18.1 
Grippotyphosa 20.1 4.2 
Pomona 15.9% 2.8% 
 
Isolation and molecular identification of Bratislava in horses has been reported 
but not in the US [184, 188].  Reproductive problems and poor health in horses 
has been associated with serovar Bratislava [184, 369].  Further studies in the 














their possible association with serovar Bratislava.  Exposure and increased titers 
to serovar Bratislava may not cause abortion but could be associated with 
reproductive and general poor health in horses. 
 Methods to attempt to detect and prevent leptospiral abortion was the 
focus of the research in Chapter Four.  Heme oxygenase-1 (HO-1) and its’ role in 
pregnancy and infection has been studied in humans and several other 
mammalian species, but until now, not in horses.  HO-1 in horses does not fully 
follow what occurs in other mammals.  This study showed it is significantly 
upregulated in horses who have elevated leptospiral MAT titers and are 
pregnant.  Pregnant horses had increased HO-1 levels as compared to non-
pregnant mares and increased further in mares who are pregnant and have 
placentitis.  Compared to other mammals, HO-1 in mares in this study didn’t 
decrease prior to foaling.  The decrease in other mammals appears to be part of 
the preparation of the placenta for labor.  Why this doesn’t occur in horses 
requires further research.  HO-1 in the mare could be closely tied to relaxin which 
also does not decrease prior to foaling but increases similar to HO-1.  Further 
studies are indicated in the role HO-1 contributes not only to pregnancy, but also 
with infection in the horse.   
  Leptospirosis continues to remain a challenge for the equine industry in 
the US but also globally in humans and animals.  It appears that the changing 
climate will increase these challenges as this bacterium continues to change and 
adapt to its environment, potentially making it more difficult to prevent 












Table One:  US Leptospiral Vaccines 
Species Zoetis Boehringer Ingelheim Elanco Merck 
























Ovine     
Caprine     



















































Table Two:  Non-US Leptospiral Vaccines 








































































Polysorbate 80  
Disodium phosphate (buffering agent) 1gram 
Monopotassium phosphate (buffering agent) 0.3gram 
Sodium chloride 1gram 
Thiamine (growth factor)  0.005gram 













BD/BBL Leptospira Enrichment Media** 
 
Ingredient Purpose 
Long-chain fatty acids Carbon and energy source 
Thiamine B1) Growth and energy 
Cyanocobalamin (B12)  

















EMHJ Base Medium 
Ingredient 
Disodium hydrogen orthophosphate 
(buffering) 
Monopotassium phosphate (buffering) 
Sodium chloride (osmotic equilibrium and 
essential ions) 
Ammonium chloride (essential nutrients 
for growth) 
Thiamine 
pH (25oC) 7.5±0.2 
 
 
Himedia:  Leptospira Enrichment Media (add 1vial/180ml sterile water then add 

















***http://www.himedialabs.com/TD/FD066.pdf  (enrichment website) 
 














Horsnby and Nally Media++ 
HAN media 
BSA 10g 
Thiamine chloride 1ml,   0.5g/100ml water 
Calcium chloride  1ml,   3g/100ml 
Magnesium chloride   1ml, 3g/100ml 
Zinc sulphate   1ml, 0.4g/100ml 
Hemin     10ml, 6.52mg/100ml 
Vitamin B12    1ml, 0.02g/100ml 
Tween 80    12.5ml, 10ml/100ml 
Glycerol    1ml, 10% solution in water 
Ammonium Chloride  1ml, 25% solution in water 
Disodium phosphate  1g 
Monopotassium phosphate 0.3g 
Sodium chloride    1g 
Sodium pyruvate   0.1g 
5-Fluoruracil    100ug/ml 
Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12 200ml 
pH 7.4Made up to 1L and filtered sterilized 
 
 
++Hornsby, R.L., D.P. Alt, and J.E. Nally, Isolation and propagation of leptospires 


























Survey Sent to AAVLD Accredited Laboratories 
 
1. Does your lab run MAT for leptospirosis? 
! If YES to #1 what serovars can/does your lab run 
! If YES to #1, on average, about how many serum samples does 
your lab receive per year for MAT testing    
" Break out numbers for bovine and equine samples 
2. On abortion necropsies, does your lab run an FA or PCR to rule-in/out 
leptospiral abortion? 
3. On average, how many lepto abortions are confirmed in your laboratory 
each year 
! Break out numbers for bovine and equine samples 
4. On equine uveitis cases, does your lab run a FA or PCR on aqueous 
humor to rule-in/out a leptorspiral etiology?  
5. On average, how many equine recurrent uveitis cases does your lab 
diagnose each year? 
Would your lab be willing to participate in a necropsy-based study to 













AAVLD Accredited Laboratories* 
 
State Serovar PCR FA IHC 
Alabama Canicola, Hardjo, Pomona, Grippotyphosa, Icterohaemorrhagiae Yes   
Arizona Send Out    
California Canicola, Hardjo, Pomona, Bratislava, Grippotyphosa, Icterohaemorrhagiae Yes   
Colorado Canicola, Hardjo, Pomona, Bratislava, Grippotyphosa, Icterohaemorrhagiae Yes   
Connecticut  Yes   
Florida Canicola, Hardjo, Pomona, Grippotyphosa, Icterohaemorrhagiae Yes  Yes 
Georgia-
Athens 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae  Yes  
Georgia-Tifton 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae, 
Autumnalis 
   
Illinois 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae, 
Autumnalis 
Yes  Yes 
Indiana 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae, 
Autumnalis 
Yes   
Iowa Canicola, Hardjo, Pomona, Bratislava, Grippotyphosa, Icterohaemorrhagiae Yes  Yes 
Kansas Canicola, Hardjo, Pomona, Bratislava, Grippotyphosa, Icterohaemorrhagiae    
Kentucky-
Lexington 
Canicola, Hardjo, Pomona, Grippotyphosa, 
Icterohaemorrhagiae Yes Yes  
Kentucky-
Murray 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae, (Other) Yes   
Louisiana Canicola, Hardjo, Pomona, Bratislava, Grippotyphosa, Icterohaemorrhagiae Yes   
Michigan Canicola, Hardjo, Pomona, Bratislava, Grippotyphosa, Icterohaemorrhagiae Yes   
Minnesota Canicola, Hardjo, Pomona, Grippotyphosa, Icterohaemorrhagiae, Bratislava Yes  Yes 
Mississippi-
Starkville/Pearl 
Starkville-Refer to TVMDL 
Pearl-PCR Yes   
Missouri Canicola, Hardjo, Pomona, Bratislava, Grippotyphosa, Icterohaemorrhagiae Yes   
Montana 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae, 
Autumnalis 
  Yes 
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Nebraska Canicola, Hardjo, Pomona, Grippotyphosa, Icterohaemorrhagiae, Bratislava Yes  Yes 
New York-
Ithaca 
Canicola, Hardjo, Pomona, Grippotyphosa, 




Canicola, Hardjo, Pomona, Grippotyphosa, 
Icterohaemorrhagiae, Autumnalis, Bratislava Yes  Yes 
North Dakota  Yes  Yes 
Ohio Canicola, Hardjoprajitno, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae Yes  Yes 
Oklahoma Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae Yes   
Pennsylvania-
New Bolton 
Canicola, Hardjo, Pomona, Grippotyphosa, 
Icterohaemorrhagiae (either Autumnalis or 
Bratislava); Canine-does all 7 
Yes Yes  
Pennsylvania-
PSU 
 Yes Yes  
Pennsylvania-
PVL 
Canicola, Hardjo, Pomona, Grippotyphosa, 
Icterohaemorrhagiae (either Autumnalis or 
Bratislava); Canine-does all 7 
Yes Yes  
South Dakota Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae Yes   
Texas-College 
Station 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae, 
Autumnalis, Sejroe 
Yes   
Texas-Canyon Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae, 
Autumnalis, Sejroe 
   
Utah-Logan  Yes   
Virginia-
Blacksburg 
Nothing listed on test/fee pdf (lcrvth@vt.edu)    
Washington-
Pullman 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae (Canine 
additionally Autumnalis) 
Yes Yes  
Washington-
Puyallup 
Avian only    
Wisconsin-
Madison 
Canicola, Hardjo, Pomona, Bratislava, 
Grippotyphosa, Icterohaemorrhagiae (will also 
run Autumnalis and Sejroe) 
Yes   
Wisconsin-
Barron 
Probably Madison only but didn’t list    
Wyoming Canicola, Hardjo, Pomona, Grippotyphosa, 




















Microagglutination Test (MAT) 




























AP-1, Nrf2 and NF-κB are localized in cytosol under normal conditions. Under 
stress, they are activated and translocate to the nucleus. In the nucleus they bind 
specifically to the DNA sequence which leads to the HO-1 transcription. 
 
*Waza, A. A.: Z. Hamid, S. Ali, S. A. Bhat, and M. A. Bhat, M. A review on heme 











1. Hartskeerl, R., et al., Classification of Leptospira from the eyes of horses 
suffereing from recurrent uveitis. J. Vet. Med, 2004. 51: p. 110-115. 
2. Malalana, F., et al., Equine uveitis in the UK: a retrospective study (2008-
2018). Vet Rec, 2019. 186(3): p. 1-7. 
3. Sehgal, S., Epidemiological patterns of leptospirosis. Indian J Med 
Microbiol, 2006. 24(4): p. 310-311. 
4. Ristow, P., et al., Biofilm formation by saprophytic and pathogenic 
leptospires. Microbiology, 2008. 154: p. 1309-1317. 
5. Costa, F., et al., Patterns in Leptospira Shedding in Norway Rats (Rattus 
norvegicus) from Brazilian Slum Communities at High Risk of Disease 
Transmission. PLoS Negl Trop Dis, 2015. 9(6): p. e0003819. 
6. Langston, C.E. and K.J. Heuter, Leptospirosis. Veterinary Clinics of North 
America: Small Animal Practice, 2003. 33(4): p. 791-807. 
7. Bharti, A.R., et al., Leptospirosis: a zoonotic disease of global importance. 
The Lancet Infectious Diseases, 2003. 3(12): p. 757-771. 
8. Lloyd-Smith, J.O., et al., Cyclical changes in seroprevalence of 
leptospirosis in California sea lions: endemic and epidemic disease in one 
host species? BMC Infect Dis, 2007. 7: p. 125. 
9. Ellis, W.A., Current Topics in Microbiology and Immunology, in Leptospira 
and Leptospirosis, B. Adler, Editor. 2015, Springer: New York. p. 295. 
10. Sanhueza, J.M., et al., Estimation of the burden of leptospirosis in New 
Zealand. Zoonoses Public Health, 2020. 67(2): p. 167-176. 
11. Faine, S., Virulence in Leptospirae, III. Comparison of sensitivities of 
virulent and of avirulent Leptospira icterohaemorrhagiae to cultural 
conditions. J Bacteriol, 1958. 77(5): p. 599-603. 
12. CDC. Leptospirosis. March 13, 2019 [cited 2021 February 12]; Available 
from: https://www.cdc.gov/leptospirosis. 
13. Adler, B., History of leptospirosis and leptospira. Curr Top Microbiol 
Immunol, 2015. 387: p. 1-9. 
14. Adler, B. and A. de la Pena Moctezuma, Leptospira and leptospirosis. Vet 
Microbiol, 2010. 140(3-4): p. 287-96. 
15. Levett, P.N., Leptospirosis. Clin Microbiol Rev, 2001. 14(2): p. 296-326. 
16. Cameron, C., Leptospiral Structure, Physiology, and Metabolism, in 
Current Topics in Microbiology and Immunology (Leptospira and 
Leptospirosis), B. Adler, Editor. 2015, Springer: New York. p. 21-42. 
17. Bierque, E., et al., A systematic review of Leptospira in water and soil 
environments. PLoS One, 2020. 15(1): p. e0227055. 
18. Fouts, D.E., et al., What Makes a Bacterial Species 
Pathogenic?:Comparative Genomic Analysis of the Genus Leptospira. 
PLoS Negl Trop Dis, 2016. 10(2): p. e0004403. 
19. Picardeau, M., Genomics, proteomics, and genetics of leptospira. Curr 
Top Microbiol Immunol, 2015. 387: p. 43-63. 
20. Guerra, M.A., Leptospirosis: public health perspectives. Biologicals, 2013. 
41(5): p. 295-7. 
 
 145 
21. Cachay, E. and J.M. Vinetz, A Global Research Agenda for Leptospirosis. 
J Postgrad Med, 2005. 51: p. 174-178. 
22. Haake, D.A. and P.N. Levett, Leptospirosis in humans. Curr Top Microbiol 
Immunol, 2015. 387: p. 65-97. 
23. Harkin, K.R., et al., Use of PCR to identify Leptospira in kidneys of big 
brown bats (Eptesicus fuscus) in Kansas and Nebraska, USA. J Wildl Dis, 
2014. 50(3): p. 651-4. 
24. Ogawa, H., et al., Molecular epidemiology of pathogenic Leptospira spp. in 
the straw-colored fruit bat (Eidolon helvum) migrating to Zambia from the 
Democratic Republic of Congo. Infection, Genetics and Evolution, 2015. 
32: p. 143-147. 
25. Torten, M., E. Shenberg, and J. van der Hoeden, The role of birds in the 
epidemiology of leptospirosis. Trop Geogr Med, 1965. 17(4): p. 353-358. 
26. Jobbins, S.E. and K.A. Alexander, Evidence of Leptospira sp. infection 
among a diversity of African wildlife species: beyond the usual suspects. 
Trans R Soc Trop Med Hyg, 2015. 109(5): p. 349-51. 
27. Turner, L., Leptospirosis III Maintenance, isolation and demonstration of 
leptospires. Trans R Soc Trop Med Hyg, 1970. 64(4): p. 623-646. 
28. Parrah, J.D., et al., Importance of urinalysis in veterinary practice – A 
review. Veterinary World, 2013: p. 640-646. 
29. Grimm, K., et al., Evidence of Leptospira serovars in wildlife and 
leptospiral DNA in water sources in a natural area in east-central Illinois, 
USA. J Wildl Dis, 2020. 56(2): p. 1-12. 
30. Gellin, G., Serological Survey for Potential Occupational Exposure to 
Leptospirosis in Kentucky Horse Farm Workers and Veterinarians, in 
Public Health. 2010, University of Kentucky. p. 77. 
31. Rousk, J. and E. Baath, Growth of saprotrophic fungi and bacteria in soil. 
FEMS Microbiol Ecol, 2011. 78(1): p. 17-30. 
32. Barragan, V., et al., Critical knowledge gaps in our understanding of 
environmental cycling and transmission of Leptospira spp. Appl Environ 
Microbiol, 2017. 83(19): p. 1-10. 
33. Cerqueira, T., et al., Renal Involvement in Leptospirosis-New Insights into 
Pathophysiology and Treatment. The Brazilian Journal of Infectious 
Diseases, 2008. 12(3): p. 248-252. 
34. Hornsby, R.L., D.P. Alt, and J.E. Nally, Isolation and propagation of 
leptospires at 37 degrees C directly from the mammalian host. Sci Rep, 
2020. 10(1): p. 9620. 
35. Karpagam, K.B. and B. Ganesh, Leptospirosis: a neglected tropical 
zoonotic infection of public health importance—an updated review. 
European Journal of Clinical Microbiology & Infectious Diseases, 2020. 
36. Palaniappan, R., S. Ramanujam, and Y.F. Chang, Leptospirosis: 
pathogenesis, immunity, and diagnosis. Curr opin infect dis, 2007. 20: p. 
284-292. 
37. Cumberland, P., et al., Persistence of anti-leptospiral IgM, IgG and 
agglutinating antibodies in patients presenting with acute febrile illness in 
Barbados 1979-1989. Eur. J. Epidemiol., 2001. 17: p. 601-608. 
 
 146 
38. Romero, E.C., C.R. Caly, and P.H. Yasuda, The persistence of leptospiral 
agglutinins titers in human sera diagnosed by the microscopic 
agglutination test. Rev Inst Med trop S. Paulo, 1998. 40(3): p. 183-184. 
39. Everard, C.O.R. and S. Bennett, Persistence of leptospiral agglutinins in 
Trinidadian survey subjects. Eur. J. Epidemiol., 1990. 6(1): p. 40-44. 
40. Bajani, M.D., et al., Evaluation of four commercially available rapid 
serologic tests for diagnosis of leptospirosis. J Clin Microbiol, 2003. 41(2): 
p. 803-9. 
41. Ebani, V., et al., Seroprevalence of Leptospira spp. and Borrelia 
Burgdorferi sensu lato in Italian horses. Ann Agric Environ Med, 2012. 
19(2): p. 237-240. 
42. Shropshire, S.B., et al., Evaluation of the Leptospira species microscopic 
agglutination test in experimentally vaccinated cats and Leptospira 
species seropositivity in aged azotemic client-owned cats. J Feline Med 
Surg, 2016. 18(10): p. 768-72. 
43. Andre-Fontaine, G., Diagnosis algorithm for leptospirosis in dogs: disease 
and vaccination effects on the serological results. Vet Rec, 2013. 172(19): 
p. 502. 
44. Bolin, C. and D.P. Alt, Use of monovalent leptospiral vaccine to prevent 
renal colonization and urinary shedding in cattle exposed to Leptospira 
borgpetersenii serovar hardjo. Am J Vet Res, 2001. 62(7): p. 995-1000. 
45. Niloofa, R., et al., Diagnosis of Leptospirosis: Comparison between 
Microscopic Agglutination Test, IgM-ELISA and IgM Rapid 
Immunochromatography Test. PLoS One, 2015. 10(6): p. e0129236. 
46. Brandao, A., et al., Macroscopic Agglutination test for rapid diagnosis of 
human leptospirosis. J Clin Microbiol, 1998. 36(11): p. 3138-3142. 
47. Stoddard, R.A., et al., Detection of pathogenic Leptospira spp. through 
TaqMan polymerase chain reaction targeting the LipL32 gene. Diagnostic 
Microbiology and Infectious Disease, 2009. 64(3): p. 247-255. 
48. Stoddard, R.A., Detection of pathogenic Leptospira spp. through real-time 
PCR (qPCR) targeting the LipL32 gene. Methods Mol Biol, 2013. 943: p. 
257-66. 
49. Ricaldi, J.N. and J.M. Vinetz, Leptospirosis in the tropics and in travelers. 
Curr Infect Dis Rep, 2006. 8: p. 51-58. 
50. Djadid, N.D., et al., A simple and rapid nested polymerase chain reaction-
restriction fragment length polymorphism technique for differentiation of 
pathogenic and nonpathogenic Leptospira spp. Diagn Microbiol Infect Dis, 
2009. 63(3): p. 251-6. 
51. Kralik, P. and M. Ricchi, A Basic Guide to Real Time PCR in Microbial 
Diagnostics: Definitions, Parameters, and Everything. Front Microbiol, 
2017. 8: p. 108. 
52. Ahmed, A. and M. P. Grobusch, Molecular Approaches in the Detection 
and Characterization of Leptospira. Journal of Bacteriology & 
Parasitology, 2012. 03(02). 
 
 147 
53. Podgorsek, D., et al., Evaluation of real-time PCR targeting the lipL32 
gene for diagnosis of Leptospira infection. BMC Microbiol, 2020. 20(1): p. 
59. 
54. Nassi, F., et al., Leptospirosis diagnosis using nested-PCR. Braz J 
Microbiol, 2003. 34: p. 90-92. 
55. Waggoner, J.J. and B.A. Pinsky, Molecular diagnostics for human 
leptospirosis. Curr Opin Infect Dis, 2016. 29(5): p. 440-5. 
56. Caimi, K., et al., A combined approach of VNTR and MLST analysis: 
improving molecular typing of Argentinean isolates of Leptospira 
interrogans. Mem Inst Oswaldo Cruz, Rio de Janeiro, 2010. 107(5): p. 
644-651. 
57. Caimi, K. and P. Ruybal, Leptospira spp., a genus in the stage of diversity 
and genomic data expansion. Infect Genet Evol, 2020. 81: p. 104241. 
58. Guglielmini, J., et al., Genus-wide Leptospira core genome multilocus 
sequence typing for strain taxonomy and global surveillance. PLoS Negl 
Trop Dis, 2019. 13(4): p. e0007374. 
59. Thibeaux, R., et al., Biodiversity of Environmental Leptospira: Improving 
Identification and Revisiting the Diagnosis. Front Microbiol, 2018. 9: p. 
816. 
60. Martins, E.A.L., et al., Revisiting the taxonomy and evolution of 
pathogenicity of the genus Leptospira through the prism of genomics. 
PLOS Neglected Tropical Diseases, 2019. 13(5). 
61. Casadevall, A., Climate change brings the specter of new infectious 
diseases. J Clin Invest, 2020. 130(2): p. 553-555. 
62. Wheeler, N. and N. Watts, Climate Change: From science to practice. 
Curr Envr Health Rpt, 2019. 5: p. 170-178. 
63. McMichael, C., Climate change-related migration and infectious disease. 
Virulence, 2015. 6(6): p. 548-53. 
64. Booth, M., Climate Change and the Neglected Tropical Diseases. Adv 
Parasitol, 2018. 100: p. 39-126. 
65. WAFB. Gonzales residents take buyouts to move from flood-prone area. 
Commnuity 2019  [cited 2020 12-1]; Available from: 
https://www.wafb.com/2019/10/03/residents-gonzales-forced-move-flood-
prone-area/. 
66. NPR. After California’s Camp Fire, Some People from Paradise Put Down 
Roots in Tennessee. National 2020  [cited 2020 12-1]; Available from: 
https://www.npr.org/2020/07/26/894129669/after-californias-camp-fire-
some-people-from-paradise-put-down-roots-in-tennesse. 
67. NASA. The Effects of Climate Change. Facts 2020  [cited 2020 
September 2]; Available from: http://climate.nasa.gov/effects. 
68. Watts, N., et al., The 2019 report of The Lancet Countdown on health and 
climate change: ensuring that the health of a child born today is not 




69. Diesch, S.L., et al., Environmental studies on the survival of leptospires in 
a farm creek following a human leptospirosis outbreak in Iowa. Wildl Dis, 
1969. 5(3): p. 166-73. 
70. Narkkul, U., et al., Optimization of Culture Protocols to Isolate Leptospira 
spp. from Environmental Water, Field Investigation, and Identification of 
Factors Associated with the Presence of Leptospira spp. in the 
Environment. Trop Med Infect Dis, 2020. 5(2). 
71. EPA. Climate Change Indicators.  [cited 2020 September 10]; Available 
from: https://www.epa.gov/climate-indicators/climate-change-indicators-
us-and-global-precipitation. 
72. Kentucky|WKU, M. Kentucky Mesonet|WKU.  [cited 2020 April 1]; 
Available from: http://www.kymesonet.org  
73. Goarant, C., et al., Leptospirosis under the bibliometrics radar: evidence 
for a vicious circle of neglect. J Glob Health, 2019. 9(1): p. 010302. 
74. Lau, C.L., et al., Climate change, flooding, urbanisation and leptospirosis: 
fuelling the fire? Trans R Soc Trop Med Hyg, 2010. 104(10): p. 631-8. 
75. Henry, R.A. and R.C. Johnson, Distribution of the genus Leptospira in soil 
and water. Appl Environ Microbiol, 1978. 35(3): p. 492-499. 
76. Saito, M., et al., PCR and culture identification of pathogenic Leptospira 
spp. from coastal soil in Leyte, Philippines, after a storm surge during 
Super Typhoon Haiyan (Yolanda). Appl Environ Microbiol, 2014. 80(22): p. 
6926-32. 
77. Schneider, A.G., et al., Quantification of pathogenic Leptospira in the soils 
of a Brazilian urban slum. PLoS Negl Trop Dis, 2018. 12(4): p. e0006415. 
78. Lall, C., et al., Correlation Between Physicochemical Properties of Soil 
and Presence of Leptospira. Ecohealth, 2018. 15(3): p. 670-675. 
79. Mason, M.R., et al., Distribution and Diversity of Pathogenic Leptospira 
Species in Peri-domestic Surface Waters from South Central Chile. PLoS 
Negl Trop Dis, 2016. 10(8): p. e0004895. 
80. Perez, J., et al., Rodent abundance dynamics and leptospirosis carriage in 
an area of hyper-endemicity in New Caledonia. PLoS Negl Trop Dis, 2011. 
5(10): p. e1361. 
81. Kumar, K.V., et al., Coexistence and survival of pathogenic leptospires by 
formation of biofilm with Azospirillum. FEMS Microbiol Ecol, 2015. 91(6). 
82. Kumar, K.V., et al., Coaggregation and biofilm formation of Leptospira with 
Staphylococcus aureus. Microb and Immuno, 2019. 63: p. 147-150. 
83. Vinod Kumar, K., et al., Molecular detection of pathogenic leptospiral 
protein encoding gene (lipL32) in environmental aquatic biofilms. Lett Appl 
Microbiol, 2016. 62(4): p. 311-5. 
84. Brihuega, B., et al., In vivo cell aggregations of a recent swine biofilm-
forming isolate of Leptospira interrogans strain from Argentina. Rev Argent 
Microbiol, 2012. 44: p. 138-143. 
85. Yamaguchi, T., et al., Characterizing interactions of Leptospira interrogans 




86. Ellis, W.A., Animal leptospirosis. Curr Top Microbiol Immunol, 2015. 387: 
p. 99-137. 
87. Donahue, J.M., et al., Prevalence and serovars of leptospira involved in 
equine abortions in central Kentucky during the 1991-1993 foaling 
seasons. J Vet Diagn Invest, 1995. 7: p. 87-91. 
88. Prescott, J., Canine leptospirosis in Canada: a veterinarian's perspective. 
CMAJ, 2008. 178(4): p. 397-8. 
89. CDC. Leptospirosis. Travelers’ Health  [cited 2020 November 18]; 
Available from: https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-
related-infectious-diseases/leptospirosis. 
90. Gonzalez-Astudillo, V., et al., Synanthropic Cockroaches (Blattidae: 
Periplaneta spp.) Harbor Pathogenic Leptospira in Colombia. J Med 
Entomol, 2016. 53(1): p. 177-82. 
91. Union, E. EU Case Definitions. Surveillance and Disease Data  [cited 
2021 February 12]; Available from: 
https://www.ecdc.europa.eu/en/surveillance-and-disease-data/eu-case-
definitions. 
92. Ward, M., L. Guptill, and C. Wu, Evaluation of environmental risk factors 
for leptospirosis in dogs: 36 cases (1997-2002). J Am Vet Med Assoc, 
2004. 225: p. 72-77. 
93. ProMED. Leptospirosis-Sri Lanka. 20080927.3058  [cited 2020 12-14]; 
Available from: https://promedmail.org. 
94. ProMED. Leptospirosis-Philippines. 20091026.3704 2009  [cited 2020 12-
14]; Available from: https://promedmail.org. 
95. ProMED. Leptospirosis, fatal-Ireland. 20100105.0041 2010  [cited 2020 
12-14]; Available from: https://promedmail.org. 
96. Gideon. Leptospirosis in Ireland. 2010  [cited 2020 12-14]; Available from: 
https://www.gideononline.com/2010/01/05/leptospirosis-in-ireland. 
97. ProMED. Leptospirosis. 2020  [cited 2020 May 21]; Available from: 
https://promedmail.org/promed-posts. 
98. ProMED. Leptospirosis-Japan military. 20141122.2982249 2014  [cited 
2020 12-14]; Available from: https://promedmail.org. 
99. ProMED. Leptospirosis-USA-Puerto Rico, fatal, flooding. 
20171024.5401879 2017  [cited 2020 12-14]; Available from: 
https://promedmail.org. 
100. ProMED. Leptospirosis-Isreal: human, animal, environment. 
20180923.6047216 2018  [cited 2018 9-23]; Available from: 
https://promedmail.org. 
101. Torgerson, P.R., et al., Global Burden of Leptospirosis: Estimated in 
Terms of Disability Adjusted Life Years. PLoS Negl Trop Dis, 2015. 9(10): 
p. e0004122. 
102. Brown, K. and J. Prescott, Leptospirosis in the family dog: a public health 
perspective. CMAJ, 2008. 178(4): p. 399-401. 
103. Stern, E.J., et al., Outbreak of leptospirosis among Adventure Race 
participants in Florida, 2005. Clin Infect Dis, 2010. 50(6): p. 843-9. 
 
 150 
104. Bolin, C. and P. Koellner, Human-to-human transmission of Leptospira 
interrogans by milk. J Infect Dis, 1988. 158(1): p. 246-247. 
105. Coghlan, J. and A. Bain, Leptospirosis in human pregnancy followed by 
death of the foetus. Brit Med J, 1969. 1: p. 228-230. 
106. Vinetz, J.M., et al., Sporadic urban leptospirosis. Ann Intern Med, 2001. 
125: p. 794-798. 
107. Morgan, J., et al., Outbreak of leptospirosis among triathlon participants 
and community residents in Springfield, Illinois, 1998. Clin Infect Dis, 
2002. 34: p. 1593-1599. 
108. Katz, A.R., et al., Assessment of the clinical presentation and treatment of 
353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. 
CID, 2001. 33: p. 1834-1841. 
109. James, A., et al., Serological Evidence of Exposure to Leptospira spp. in 
Veterinary Students and Other University Students in Trinidad and 
Tobago. Interdiscip Perspect Infect Dis, 2013. 2013: p. 719049. 
110. Sanhueza, J.M., et al., Prevalence and risk factors for Leptospira 
exposure in New Zealand veterinarians. Epidemiol Infect, 2015. 143(10): 
p. 2116-25. 
111. Wasinski, B. and J. Dutkiewicz, Leptospirosis-current risk factors 
connected with human activity and the environment. Ann Ag Environ Med, 
2013. 20(2): p. 239-244. 
112. Malalana, F., A. Stylianides, and C. McGowan, Equine recurrent uveitis: 
Human and equine perspectives. Vet J, 2015. 206(1): p. 22-9. 
113. Lau, C.L., et al., Emergence of new leptospiral serovars in American 
Samoa - ascertainment or ecological change? BMC Infect Dis, 2012. 12: 
p. 19. 
114. Kobayashi, Y., Human Leptospirosis: Management and Prognosis. J 
Postgrad Med, 2005. 51: p. 201-204. 
115. Guerra, M., Zoonosis Update: Leptospirosis. J Am Vet Med Assoc, 2009. 
234(4): p. 472-478. 
116. CDC. Summary of Notifiable Diseases, United States, 1994. 1995  [cited 
2020 11-28]; Available from: 
https://www.cdc.gov/mmwr/preview/mmwrhtml/00039679.htm. 
117. Vinetz, J.M., et al., Sporadic Urban Leptospirosis. Ann Intern Med, 1996. 
125: p. 794-798. 
118. CDC. National Outbreak Reporting System (NORS). 2019  [cited 2019 12-
31]; Available from: https://www.cdc.gov/nors. 
119. Traxler, R.M., et al., Leptospirosis-associated hospitalizations, United 
States, 1998-2009. Emerg Infect Dis, 2014. 20(8): p. 1273-9. 
120. Blacksell, S.D., et al., Limited diagnostic capacities of two commercial 
assays for the detection of Leptospira immunoglobulin M antibodies in 
Laos. Clin Vaccine Immunol, 2006. 13(10): p. 1166-9. 
121. Van De Maele, I., et al., Leptospirosis in dogs: a review with emphasis on 
clinical aspects. Vet Rec, 2008. 163: p. 409-413. 
122. White, A.M., et al., Hotspots of canine leptospirosis in the United States of 
America. Vet J, 2017. 222: p. 29-35. 
 
 151 
123. ProMED. Leptospirosis-USA-Utah, dog. 20190917.6678124 2019  [cited 
2019 9-17]; Available from: https://promedmail.org. 
124. Ghneim, G.S., et al., Use of a case-control study and geographic 
information systems to determine environmental and demographic risk 
factors for canine leptospirosis. Vet Res, 2007. 38(1): p. 37-50. 
125. Zaidi, S., et al., Urinary shedding of pathogenic Leptospira in stray dogs 
and cats, Algiers: A prospective study. PLoS One, 2018. 13(5): p. 
e0197068. 
126. Gomard, Y., et al., Feral cats do not play a major role in leptospirosis 
epidemiology on Reunion Island. Epidemiology and Infection, 2019. 147. 
127. Chan, K.W., et al., Serological and PCR detection of feline leptospira in 
southern Taiwan. Vector Borne Zoonotic Dis, 2014. 14(2): p. 118-23. 
128. Shophet, R., A serological survey of leptospirosis in cats. N Z Vet J, 1979. 
27: p. 236 & 245-246. 
129. Markovich, J., L. Ross, and E. McCobb, The prevalence of leptospiral 
antibodies in free roaming cats in Worcester County, Massachusetts. J 
Vet Intern Med, 2012. 26: p. 688-689. 
130. Palerme, J.S., et al., Seroprevalence of Leptospira spp., Toxoplasma 
gondii, and Dirofilaria immitis in Free-Roaming Cats in Iowa. Vector Borne 
Zoonotic Dis, 2019. 19(3): p. 193-198. 
131. Spangler, D., et al., Leptospiral shedding and seropositivity in shelter dogs 
in the Cumberland Gap Region of Southeastern Appalachia. PLoS One, 
2020. 15(1): p. e0228038. 
132. Millan, J., et al., Carriage of pathogenic Leptospira in carnivores at the 
wild/domestic interface. Pol J Vet Sci, 2019. 22(4): p. 589-598. 
133. Bryson, D. and W.A. Ellis, Leptospirosis in a British domestic cat. J Small 
Anim Pract, 1976. 17: p. 459-465. 
134. Alashraf, A.R., et al., First report of pathogenic Leptospira spp. isolated 
from urine and kidneys of naturally infected cats. PLoS One, 2020. 15(3): 
p. e0230048. 
135. Ojeda, J., et al., Evidence of interspecies transmission of pathogenic 
Leptospira between livestock and a domestic cat dwelling in a dairy cattle 
farm. J Vet Med Sci, 2018. 80(8): p. 1305-1308. 
136. Mason, R.W., S.J. King, and N.M. McLachlan, Suspected leptospirosis in 
two cats. Aust Vet J, 1972. 48: p. 622-623. 
137. Rodriguez, J., et al., Serologic and urinary PCR survey of leptospirosis in 
healthy cats and in cats with kidney disease. J Vet Intern Med, 2014. 28: 
p. 284-293. 
138. Arbour, J., et al., Clinical leptospirosis in three cats (2001-2009). J Am 
Anim Hosp Assoc, 2012. 48(4): p. 256-60. 
139. Hartmann, K., et al., Leptospira species infection in cats: ABCD guidelines 
on prevention and management. J Feline Med Surg, 2013. 15(7): p. 576-
81. 
140. Smith, D. and D. Perry, Bovine Leptospirosis. Can J Compara Med, 1952. 
16(8): p. 294-299. 
 
 152 
141. Leonard, F., P. Quinn, and W.A. Ellis, Association between cessation of 
leptospiruria in cattle and urinary antibody levels. Research in Veterinary 
Science, 1993. 55: p. 195-202. 
142. Gerritsen, M., M. Koopmans, and T. Olyhoek, Effect of streptomycin 
treatment on the shedding of and the serologic responses to Leptospira 
interrogans serovar hardjo subtype hardjobovis in experimentally infected 
cows. Vet Microbiol, 1993. 38: p. 129-138. 
143. York, C. and J. Baker, Vaccination for bovine leptospirosis. Am J Vet Res, 
1953. 14(5). 
144. Hanson, L., Bovine Leptospirosis. J Dairy Sci, 1975. 59(6). 
145. Alinaitwe, L., et al., Leptospira Seroprevalence Among Ugandan Slaughter 
Cattle: Comparison of Sero-Status With Renal Leptospira Infection. Front 
Vet Sci, 2020. 7: p. 106. 
146. Ellis, W.A., Leptospirosis as a cause of reproductive failure. Vet Clin North 
Am Food Ani Prac, 1994. 10(3): p. 463-478. 
147. Lilenbaum, W. and G. Martins, Leptospirosis in cattle: a challenging 
scenario for the understanding of the epidemiology. Transbound Emerg 
Dis, 2014. 61 Suppl 1: p. 63-8. 
148. Martins, G. and W. Lilenbaum, Leptospirosis in sheep and goats under 
tropical conditions. Trop Anim Health Prod, 2014. 46(1): p. 11-7. 
149. dos Santos, J.P., et al., Seroprevalence and risk factors for Leptospirosis 
in goats in Uberlandia, Minas Gerais, Brazil. Trop Anim Health Prod, 2012. 
44(1): p. 101-6. 
150. Effler, P., Leptospirosis: key things to know about this quintessential 
zoonotic pathogen. Microbiology Australia, 2020. 41(1): p. 19-22. 
151. Hathaway, S., et al., Leptospira interrogans serovar hardjo in pigs: a new 
host-parasite relationship in the United Kingdom. Vet Rec, 1983. 113(7): 
p. 153-154. 
152. Guernier, V., et al., A systematic review of human and animal leptospirosis 
in the Pacific Islands reveals pathogen and reservoir diversity. PLoS Negl 
Trop Dis, 2018. 12(5): p. e0006503. 
153. Ngugi, J.N., et al., Seroprevalence and associated risk factors of 
leptospirosis in slaughter pigs; a neglected public health risk, western 
Kenya. BMC Vet Res, 2019. 15(1): p. 403. 
154. Mori, M., et al., Reproductive Disorders and Leptospirosis: A Case Study 
in a Mixed-Species Farm (Cattle and Swine). Vet Sci, 2017. 4(4). 
155. Pedersen, K., et al., Widespread detection of antiboides to Leptospira in 
feral swine in the United States. Epidemiol Infect, 2015. 143: p. 2131-
2136. 
156. Bolin, C. and J. Cassells, Isolation of Leptospira interrogans serovars 
bratislava and hardjo from swine at slaughter. J Vet Diagn Invest, 1992. 4: 
p. 87089. 
157. Arent, Z., et al., Leptospira interrogans serovars Bratislava and Muenchen 
animal infections: Implications for epidemiology and control. Vet Microbiol, 
2016. 190: p. 19-26. 
 
 153 
158. Alt, D.P., et al., Complete Genome Sequence of Leptospira interrogans 
Serovar Bratislava, Strain PigK151. Genome Announc, 2015. 3(3). 
159. Zoetisus. Farrowsure Gold/Garrowsure Gold B. 2020  [cited 2020 12-6]; 
Available from: https://www.zoetisus.com/products/pork/farrowsure-
gold.aspx. 
160. Zoetisus. ER Bac L5 Gold. 2020  [cited 2020 12-6]; Available from: 
https://www.zoetisus.com/products/pork/er-bac-l5-gold.aspx. 
161. Vedros, N., et al., Leptospirosis Epizootic Among California Sea Lions. 
Science, 1971. 172(3989): p. 1250-1251. 
162. Knowles, S., D. Lynch, and N. Thomas, Leptospirosis in Northern Sea 
Otters (Enhydra lutris kenyoni) from Washington, USA. J Wildl Dis, 2020. 
56(2): p. 466-471. 
163. Zuerner, R.L., et al., Geographical dissemination of Leptospira interrogans 
serovar Pomona during seasonal migration of California sea lions. Vet 
Microbiol, 2009. 137(1-2): p. 105-10. 
164. Avalos-Tellez, R., et al., Pathogenic Leptospira Serovars in Free-Living 
Sea Lions in the Gulf of California and Along the Baja California Coast of 
Mexico. J Wildl Dis, 2016. 52(2): p. 199-208. 
165. ProMED. Leptospirosis-USA, California-sea lion, environmental links. 
20181109.6136190 2018  [cited 2018 11-8]; Available from: 
https://promedmail.org. 
166. Prager, K.C., et al., Asymptomatic and chronic carriage of Leptospira 
interrogans serovar Pomona in California sea lions (Zalophus 
californianus). Vet Microbiol, 2013. 164(1-2): p. 177-83. 
167. Morter, R., et al., Equine Leptospirosis. J Am Vet Med Assoc, 1969. 
155(2): p. 436-441. 
168. Heusser, H., Die periodische augenetzundung, eine Leptospirose? 
Schweiz Arch f Tierheilk, 1948. 90. 
169. Roberts, S., Sequelae of leptospirosis in horses on a small farm. J Am Vet 
Med Assoc, 1958. 133(4): p. 189-194. 
170. Roberts, S., C. York, and J. Robinson, An outbreak of Leptospirosis in 
horses on a small farm J Am Vet Med Assoc, 1952. 121(907): p. 237-242. 
171. Hall, C. and J. Bryans, A case of leptospirosis in a horse. Cornell Vet, 
1954. 44(3): p. 345-348. 
172. Yager, R., W. Gochenour, and P. Wetmore, Recurrent Iridocyclitis 
(Periodic Ophthalmia) of horses. J Am Vet Med Assoc, 1950. 117(882): p. 
207-209. 
173. Bryans, J., Studies on equine leptospirosis. Cornell Vet, 1955. 45(1): p. 
16-50. 
174. Hanson, L., et al., Equine Leptospirosis. Proc Annu Meet US Anim Health 
Assoc, 1969. 73: p. 169-180. 
175. Jackson, R., E. Jones, and D. Clark, Abortion in mares associated with 
leptospirosis. J Am Vet Med Assoc, 1957. 131(12): p. 564-565. 
176. Donahue, J.M. and N.M. Williams, Emergent Causes of Placentitis and 
Abortion. Veterinary Clinics of North America: Equine Practice, 2000. 
16(3): p. 443-456. 
 
 154 
177. Ellis, W.A., et al., Leptospiral infection in horses in Northern Ireland: 
Serological and microbiological findings. Equine Vet J, 1983. 15(4): p. 
317-320. 
178. Nally, J.E., S. Artiushin, and J.F. Timoney, Molecular characterization of 
thermoinduced immunogenic proteins Q1p42 and Hsp15 of Leptospira 
interrogans. Infect Immun, 2001. 69(12): p. 7616-24. 
179. Barwick, R.M., HO; Atwill, ER; McDonough PL; White, ME, The 
Prevalence of Equine Leptospirosis in New York State. J. Equine Sci, 
1998. 9(4): p. 119-124. 
180. Schonberg, A., et al., The isolation and identification of Leptospira 
interrogans serovar Bratislava from a pig in Germany. J Vet Med B, 1992. 
39: p. 362-368. 
181. Ellis, W.A., J. Montgomery, and P. McParland, An experimental study with 
a Leptospira interrogans serovar bratislava vaccine. Vet Rec, 1989. 125: 
p. 319-321. 
182. Ellis, W.A., Control of canine leptospirosis in Europe: time for a change? 
Vet Rec, 2010. 167(16): p. 602-605. 
183. Cinco, M., et al., First human isolate of Leptospira interrogans as serovar 
bratislava in Italy. FEMS Microbio Immuno, 1989. 47: p. 499-504. 
184. Ellis, W.A., et al., Leptospiral infection in aborted equine foetuses. Equine 
Vet J, 1983. 15(4): p. 321-324. 
185. Baverud, V., et al., Leptospira seroprevalence and associations between 
seropositivity, clinical disease and host factors in horses. Acta Vet Scand, 
2009. 51: p. 15. 
186. Hamond, C., et al., Predominance of Leptospira interrogans serovar 
Bratislava DNA in vaginal fluid of mares suggests sexual transmission of 
leptospirosis. Anim Reprod Sci, 2014. 151(3-4): p. 275-9. 
187. Arent, Z., et al., Molecular studies on European equine isolates of 
Leptospira interrogans serovars Bratislava and Muenchen. Infect Genet 
Evol, 2015. 34: p. 26-31. 
188. Arent, Z., et al., Molecular studies on European equin isolates of 
Leptospira interrogans serovars Bratislava and Muenchen. Infection, 
Genetics and Evolution, 2015. 34: p. 26-31. 
189. Petersen, J.L., et al., Genetic diversity in the modern horse illustrated from 
genome-wide SNP data. PLoS One, 2013. 8(1): p. e54997. 
190. McGivney, B.A., et al., Genomic inbreeding trends, influential sire lines 
and selection in the global Thoroughbred horse population. Sci Rep, 2020. 
10(1): p. 466. 
191. Loureiro, A.P. and W. Lilenbaum, Genital bovine leptospirosis: A new look 
for an old disease. Theriogenology, 2020. 141: p. 41-47. 
192. Masri, S., et al., A polymerase chain reaction assay for the detection of 
Leptospira spp. in bovine semen. Can J Vet Res, 1997. 61: p. 15-20. 
193. Hamond, C., et al., Presence of Leptospiral DNA in Semen Suggests 
Venereal Transmission in Horses. Journal of Equine Veterinary Science, 
2013. 33(12): p. 1157-1159. 
 
 155 
194. Rodríguez, G., et al., Determinación molecular de Leptospira spp. en 
semen y líquido preseminal y estudio serológico de caballos criollos en el 
departamento de Cundinamarca (Colombia). Revista de Medicina 
Veterinaria, 2017(34). 
195. D, D.E.O., et al., Leptospira in breast tissue and milk of urban Norway rats 
(Rattus norvegicus). Epidemiol Infect, 2016. 144(11): p. 2420-9. 
196. Lewis, F.I., et al., Bayesian inference for within-herd prevalence of 
Leptospira interrogans serovar Hardjo using bulk milk antibody testing. 
Biostatistics, 2009. 10(4): p. 719-28. 
197. Vemulapalli, R., et al., Molecular detection of Leptospira kirschneri in 
tissues of prematurely born foal. J Vet Diagn Invest, 2005. 17: p. 67-71. 
198. Barwick, R.M., HO; Atwill, ER; McDonough PL; White, ME, Epidemiologic 
features of equine Leptospira interrogans of human significance. 
Preventive Veterinary Medicine 1998. 36: p. 153-165. 
199. Trimble, A.C., et al., Seroprevalence, frequency of leptospiuria, and 
associated risk factors in horses in Kansas, Missouri, and Nebraska from 
2016-2017. PLoS One, 2018. 13(10): p. e0206639. 
200. Fagre, A., et al., Seroprevalence of Leptospira spp. in Colorado equids 
and association with clinical disease. J Vet Diagn Invest, 2020. 32(5): p. 
718-721. 
201. Langoni, H., et al., Anti-Leptospire Agglutinins in Equine Sera, From 
SaoPaulo, Goias, and Mato Grosso Do Sul, Brazil, 1996-2001. J Venom 
Anim Toxins incl Trop Dis, 2004. 10(3): p. 207-218. 
202. Lees, V. and S. Gale, Titers to Leptospira species in horses in Alberta. 
Can Vet J, 1994. 35: p. 636-640. 
203. Carter, C., et al., Seroepidemiology of equine leptospirosis utilizing 
diagnostic laboratory specimens from 29 states (US) and one Canadian 
province, in Proc Am Assoc Vet Lab Dign, Ann Meeting; AAVLD/USAHA. 
2012: Greensbooro, NC. p. 51. 
204. Gellin, G., et al. US Survey of AAVLD Veterinary Diagnostic Laboratory 
Leptospirosis Diagnostic Capabilities. in 120th USAHA & 59th AAVLD 
Annual Meeting. 2016. Greensboro, NC. 
205. Verma, A., et al., LruA and LruB, novel lipoproteins of pathogenic 
Leptospira interrogans associated with equine recurrent uveitis. Infect 
Immun, 2005. 73(11): p. 7259-66. 
206. Allbaugh, R.A., Equine recurrent uveitis: A review of clinical assessment 
and management. Equine Veterinary Education, 2017. 29(5): p. 279-288. 
207. Sandmeyer, L. Understanding Equine Vision and Eye Disease. 2015  
[cited 2018 9/22/2018]. 
208. Kalsow, C. and A. Dwyer, Retinal immunopathology in horses with uveitis. 
Ocul Immunol Inflam, 1998. 6(4): p. 239-251. 
209. Deeg, C., et al., Immune responses to retinal autoantigens and peptides in 




210. Parma, A., et al., Experimental demonstration of an antigenic relationship 
between Leptospira and equine cornea. Vet Immunol Immunopathol, 
1985. 10: p. 215-224. 
211. Gilger, B.C., Equine recurrent uveitis: the viewpoint from the USA. Equine 
Vet J, 2010. 37: p. 57-61. 
212. Sandmeyer, L., Understanding equine vision and eye disease. Can Horse 
J, 2013. October: p. 1-23. 
213. Verma, A., et al., LruA and LruB antibodies in sera of humans with 
leptospiral uveitis. Clin Vaccine Immunol, 2008. 15(6): p. 1019-23. 
214. Gerding, J.C. and B.C. Gilger, Prognosis and impact of equine recurrent 
uveitis. Equine Vet J, 2016. 48(3): p. 290-8. 
215. Sandmeyer, L., et al., Equine recurrent uveitis in western Canadian prairie 
provinces: a retrospective study (2002-2015). Can Vet J, 2017. 58: p. 717-
722. 
216. Fritz, K.L., et al., Genetic risk factors for insidious equine recurrent uveitis 
in Appaloosa horses. Anim Genet, 2014. 45(3): p. 392-9. 
217. Kulbrock, M., et al., A genome-wide association study identifies risk loci to 
equine recurrent uveitis in German warmblood horses. PLoS One, 2013. 
8(8): p. e71619. 
218. Verma, A., B. Stevenson, and B. Adler, Leptospirosis in horses. Vet 
Microbiol, 2013. 167(1-2): p. 61-6. 
219. Wood, R. and G. Davis, The correlation of periodic ophthalmia with 
leptospira agglutinins in horses. Am J Ophthalmol, 1950. 33(6): p. 961-
962. 
220. Williams, R., et al., Experimental chronic uveitis ophthalmic signs following 
equine leptospirosis. Investigative Ophthalmology, 1971. 10(12): p. 948-
954. 
221. Curling, A., Equine recurrent uveitis: classification, etiology, and 
pathogenesis. Compend Contin Educ Vet, 2011. 33(6): p. E1-E4. 
222. Polle, F., et al., Role of Intraocular Leptospira Infections in the 
Pathogenesis of Equine Recurrent Uveitis in the Southern United States. 
Journal of Equine Veterinary Science, 2014. 34(11-12): p. 1300-1306. 
223. Lowe, R., Equine uveitis: a UK perspective. Equine Vet J, 2010. 37: p. 46-
49. 
224. Verma, A., et al., Cross-reactivity of antibodies against leptospiral 
recurrent uveitis-associated proteins A and B (LruA and LruB) with eye 
proteins. PLoS Negl Trop Dis, 2010. 4(8): p. e778. 
225. Malalana, F., et al., The role of Leptospira spp. in horses affected with 
recurrent uveitis in the UK. Equine Vet J, 2017. 49(6): p. 706-709. 
226. Shylaja, R., et al., Standardisation and application of polymerase chain 
reaction for detection of Lru A and Lru B gene of Leptospira interrogans in 
aqueous humors of uveitic patients. Ocul Immunol Inflamm, 2011. 19(5): 
p. 363-6. 
227. Verma, A., et al., Antibodies to a novel leptospiral protein, LruC, in the eye 
fluids and sera of horses with Leptospira-associated uveitis. Clin Vaccine 
Immunol, 2012. 19(3): p. 452-6. 
 
 157 
228. Gilger, B.C., Association of acute leptospirosis with systemic disease and 
uveitis in horses. Equine Veterinary Education, 2016. 30(3): p. 137-138. 
229. Gilger, B.C. and T.M. Michau, Equine recurrent uveitis: new methods of 
management. Vet Clin North Am Equine Pract, 2004. 20(2): p. 417-27, vii. 
230. Williams, D., et al., Serological and microbiological findings on 3 farms 
with equine leptospiral abortions. Equine Vet J, 1994. 26(2): p. 105-108. 
231. CDC. Zoonotic Diseases. One Health 2021  [cited 2020 12-1]; Available 
from: https://www.cdc.gov/onehealth/basics/zoonotic-diseases.html. 
232. WHO. Disease Outbreaks by Year. Emergencies preparedness, response 
2020; Available from: (https://www.who.int/csr/don/archive/year/en. 
233. Zinsstag, J., et al., Climate change and One Health. FEMS Microbiol Lett, 
2018. 365(11). 
234. Bertasio, C., et al., Detection of New Leptospira Genotypes Infecting 
Symptomatic Dogs: Is a New Vaccine Formulation Needed? Pathogens, 
2020. 9(6). 
235. Moore, G., et al., Canine leptospirosis, United States, 2002-2004. Emerg 
Infect Dis, 2006. 12(3): p. 501-503. 
236. Siqueira, C.C., et al., Seroprevalence and risk factors associated with 
equineleptospirosis in the metropolitan region of Salvador and Reconcavo 
Baiano region, Bahia state (NE Brazil). Trop Anim Health Prod, 2020. 
52(1): p. 31-39. 
237. Tsegay, K., et al., Circulating serovars of Leptospira in cart horses of 
central and southern Ethiopia and associated risk factors. Prev Vet Med, 
2016. 125: p. 106-15. 
238. Malalana, F., Leptospirosis in horses: A European perspective. Equine Vet 
J, 2019. 51(3): p. 285-286. 
239. Tagliabue, S., et al., Serological surveillance of Leptospirosis in Italy: 
twoyear national data (20102011). Vet Ital, 2016. 52(2): p. 129-38. 
240. Atxaerandio, R., et al., Serological evidence of Leptospira interrogans 
serovar Bratislava infection and its association with abortions in cattle in 
northern Spain. Vet Rec, 2005. 156: p. 376-380. 
241. Rodrigues, G., E. Muller, and J. de Freitas, Bovine Leptospirosis: serology 
at dairy farms in Londrina Region, Parana State, Brazil. Ciencia Rural, 
1999. 29(2): p. 309-314. 
242. Oliveira, A., et al., Seroprevalence of bovine leptspirosis in Garanhuns 
municipal district, Pernambuco State, Brazil. OJVR, 2001. 68: p. 275-279. 
243. Talpada, M., et al., Prevalence of leptospiral infection in Texas cattle: 
implications for transmission to humans. Vector Borne Zoonotic Dis, 2003. 
3(3): p. 141-147. 
244. Nally, J.E., et al., Isolation and characterization of pathogenic leptospires 
associated with cattle. Vet Microbiol, 2018. 218: p. 25-30. 
245. Favero, J.F., et al., Bovine leptospirosis: Prevalence, associated risk 
factors for infection and their cause-effect relation. Microb Pathog, 2017. 
107: p. 149-154. 
 
 158 
246. Hartskeerl, R.A., M. Collares-Pereira, and W.A. Ellis, Emergence, control 
and re-emerging leptospirosis: dynamics of infection in the changing 
world. Clin Microbiol Infect, 2011. 17(4): p. 494-501. 
247. Blessington, T., A.P. Schenck, and J.F. Levine, Frequency of Animal 
Leptospirosis in the Southern United States and the Implications for 
Human Health. South Med J, 2020. 113(5): p. 240-249. 
248. Carter, C. and J. Smith, A proposal to leverage high-quality veterinary 
diagnositc laboratory large data streams for animal health, public health, 
and One Health. J Vet Diagn Invest, 2021. 33(3): p. 399-409. 
249. Fang, F., et al., Shedding and seroprevalence of pathogenic Leptospira 
spp. in sheep and cattle at a New Zealand Abattoir. Zoonoses Public 
Health, 2015. 62(4): p. 258-68. 
250. Daud, A., et al., Leptospirosis seropositivity and its serovars among cattle 
in Northeastern Malaysia. Vet World, 2018. 11(6): p. 840-844. 
251. Gregoire, F., et al., Laboratory Diagnosis of Bovine Abortions Caused by 
Non-Maintenance Pathogenic Leptospira spp.: Necropsy, Serology and 
Molecular Study Out of a Belgian Experience. Pathogens, 2020. 9(6). 
252. Donahue, J.M., et al., Diagnosis and prevalence of leptospira infection in 
aborted and stillborn horses. J Vet Diagn Invest, 1991. 3: p. 148-151. 
253. Poonacha, K., et al., Leptospirosis in equine fetuses, stillborn foals, and 
placentas. Vet Pathol, 1993. 30: p. 362-369. 
254. Hong, C., et al., Equine abortion and stillbirth in central Kentucky during 
1988 and 1989 foaling seasons. J Vet Diagn Invest, 1993. 5: p. 560-566. 
255. Hong, C., et al., Etiology and pathology of equine placentitis. J Vet Diagn 
Invest, 1993. 5: p. 56-63. 
256. Erol, E., et al., A diagnostic evaluation of real-time PCR, fluorescent 
antibody and microscopic agglutination tests in cases of equine leptospiral 
abortion. Equine Vet J, 2015. 47(2): p. 171-4. 
257. Equine Science Program, U., 2012 Kentucky Equine Survey. 2013, 
University of Kentucky: Lexington, Kentucky. p. 1-20. 
258. Camargo, F. and J. Janes, Wobber Syndrome in Horses, in Cooperative 
Extension Service, C.o.A. University of Kentucky, Editor. 2010, 
Cooperative Extension Service, University of Kentucky College of 
Agriculture, Lexington, KY: Lexington, KY. p. 1-2. 
259. Kitson-Piggot, A. and J. Prescott, Leptospirosis in horses in Ontario. Can J 
Vet Res, 1987. 51: p. 448-451. 
260. Blatti, S., et al., Seroprevalence of Leptospira spp. in clinically healthy 
horses in Switzerland. Schweiz Arch Tierheilkd, 2011. 153(10): p. 449-56. 
261. Hathaway, S., et al., Leptospiral infection in horses in England: A 
serological study. Vet Rec, 1981. 108(18): p. 396-398. 
262. Bernard, W., Leptospirosis. Vet Clin North Am Equine Pract, 1993. 9(2): p. 
435-444. 
263. Milas, Z., et al., The occurrence and maintenance of Leptospira serovars 
Australis and Bratislava in domestic and wild animals in Croatia. 
Veterinarski Arhiv, 2013. 83(4): p. 357-369. 
 
 159 
264. Bernard, W., et al., Leptospiral abortion and leptopsiuria in horses from 
the same farm. J Am Vet Med Assoc, 1993. 202(8): p. 1285-1286. 
265. Richardson, D. and J. Gauthier, A serosurvey of leptospirosis in 
Connecticut peridomestic wildlife. Vector Borne Zoonotic Dis, 2003. 3(4): 
p. 187-193. 
266. Tan, C.G., et al., Neglected leptospirosis in raccoons (Procyon lotor) in 
Indiana, USA. Vet Q, 2014. 34(1): p. 1-10. 
267. Timoney, J.F., et al., A unique genotype of Leptospira interrogans serovar 
Pomona type kennewicki is associated with equine abortion. Veterinary 
Microbiology, 2011. 150(3-4): p. 349-353. 
268. Donahue, J.M., et al., Prevalence and serovars of leptospira involved in 
equine abortions in central Kentucky during the 1990 foaling season. J Vet 
Diagn Invest, 1992 
. 4: p. 279-284. 
269. Hamond, C., et al., Urinary PCR as an increasingly useful tool for an 
accurate diagnosis of leptospirosis in livestock. Vet Res Commun, 2014. 
38(1): p. 81-5. 
270. Fernandez-Fierro, A., et al., Immune Modulation by Inhibitors of the HO 
System. Int J Mol Sci, 2020. 22(1). 
271. Ozen, M., et al., Heme oxygenase and the immune system in normal and 
pathological pregnancies. Front Pharmacol, 2015. 6: p. 84. 
272. Rochette, L., et al., Redox Functions of Heme Oxygenase-1 and Biliverdin 
Reductase in Diabetes. Trends Endocrinol Metab, 2018. 29(2): p. 74-85. 
273. McCoubrey, W.K., T.J. Huang, and M. Maines, Isolation and 
characterization of a cDNA from the rat brain that encodes hemoprotein 
heme oxygenase-3. Eur. J. Biochem, 1997. 247: p. 725-732. 
274. Ryter, S.W. and A.M. Choi, Targeting heme oxygenase-1 and carbon 
monoxide for therapeutic modulation of inflammation. Transl Res, 2016. 
167(1): p. 7-34. 
275. Intagliata, S., et al., Heme Oxygenase-2 (HO-2) as a therapeutic target: 
Activators and inhibitors. Eur J Med Chem, 2019. 183: p. 111703. 
276. Yachie, A., et al., Oxidative stress causes enhanced endothelial cell injury 
in human heme oxygenase-1 deficiency. J Clin Invest, 1999. 103(1): p. 
129-35. 
277. Kapturczak, M., et al., Heme oxygenase-1 modulates early inflammatory 
responses. Am J Pathol, 2004. 165(3): p. 1045-1053. 
278. Otterbein, L.E., R. Foresti, and R. Motterlini, Heme Oxygenase-1 and 
Carbon Monoxide in the Heart: The Balancing Act Between Danger 
Signaling and Pro-Survival. Circ Res, 2016. 118(12): p. 1940-1959. 
279. Pae, H.-O. and H.-T. Chung, Heme Oxygenase-1: Its therapeutic roles in 
inflammatory diseases. Immune Network, 2009. 9(1): p. 12-19. 
280. Drummond, G.S., et al., HO-1 overexpression and underexpression: 
Clinical implications. Arch Biochem Biophys, 2019. 673: p. 108073. 
281. Zenclussen, A.C., et al., Heme oxygenase as a therapeutic target in 
immunological pregnancy complications. Int Immunopharmacol, 2005. 
5(1): p. 41-51. 
 
 160 
282. Zhao, H., et al., Heme oxygenase-1 in pregnancy and cancer: similarities 
in cellular invasion, cytoprotection, angiogenesis, and immunomodulation. 
Front Pharmacol, 2014. 5: p. 295. 
283. Zenclussen, A.C., et al., Heme oxygenase is downregulated in stress-
triggered and interleukin-12-mediated murine abortion. Scand J Immunol, 
2002. 55: p. 560-569. 
284. George, E.M., et al., Induction of heme oxygenase-1 attenuates sFlt-1-
induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp 
Physiol, 2011. 301(5): p. R1495-500. 
285. Gallardo, V., et al., Role of heme oxygenase 1 and human chorionic 
gonadotropin in pregnancy associated diseases. Biochim Biophys Acta 
Mol Basis Dis, 2020. 1866(2): p. 165522. 
286. Wollborn, J., et al., Carbon Monoxide Exerts Functional Neuroprotection 
After Cardiac Arrest Using Extracorporeal Resuscitation in Pigs. Crit Care 
Med, 2020. 48(4): p. e299-e307. 
287. Ikenaka, Y., et al., Effects of environmental lead contamination on cattle in 
a lead/zinc mining area: changes in cattle immune systems on exposure 
to lead in vivo and in vitro. Environ Toxicol Chem, 2012. 31(10): p. 2300-5. 
288. Bainbridge, S.A. and G.N. Smith, HO in pregnancy. Free Radic Biol Med, 
2005. 38(8): p. 979-88. 
289. Morse, D. and M. Choi, Heme Oxygenase-1  The “Emerging Molecule” 
has arrived. Am J Respir Cell Mol Biol, 2002. 27: p. 8-16. 
290. Abraham, N.G., J.M. Junge, and G.S. Drummond, Translational 
Significance of Heme Oxygenase in Obesity and Metabolic Syndrome. 
Trends in Pharmacological Sciences, 2016. 37(1): p. 17-36. 
291. Singh, N., et al., Host heme oxygenase-1: Friend or foe in tackling 
pathogens? IUBMB Life, 2018. 70(9): p. 869-880. 
292. Sassa, S., Why heme needs to be degraded to iron, biliverdin IX⍶, and 
carbon monoxide? Antioxid Redox Signal, 2004. 5(5): p. 819-824. 
293. Ahmed, M.H., M.S. Ghatge, and M.K. Safo, Hemoglobin: Structure, 
Function and Allostery. Subcell Biochem, 2020. 94: p. 345-382. 
294. Olson, J.S., Lessons Learned from 50 Years of Hemoglobin Research: 
Unstirred and Cell-Free Layers, Electrostatics, Baseball Gloves, and 
Molten Globules. Antioxid Redox Signal, 2020. 32(4): p. 228-246. 
295. Giardina, B., et al., Differences between horse and human haemoglobins 
in effects of organic and inorganic anions on oxygen binding. Biochem J, 
1990. 266: p. 897-900. 
296. Bunn, H., Regulation of hemoglobin function in mammals. Amer Zool, 
1980. 20: p. 199-211. 
297. Thorn, B., et al., Evidence that human and equine erythrocytes could have 
significant roles in the transport and delivery of amino acids to organs and 
tissues. Amino Acids, 2020. 52(5): p. 711-724. 
298. Lording, P.M., Erythrocytes. Vet Clin North Am Equine Pract, 2008. 24(2): 
p. 225-37, v. 
 
 161 
299. Peoc'h, K., V. Puy, and T. Fournier, Haem oxygenases play a pivotal role 
in placental physiology and pathology. Hum Reprod Update, 2020. 26(5): 
p. 634-649. 
300. Chiang, S.K., S.E. Chen, and L.C. Chang, A Dual Role of Heme 
Oxygenase-1 in Cancer Cells. Int J Mol Sci, 2018. 20(1). 
301. Lee, T. and L. Chau, Hem oxygenase-1 mediates the anti-inflammatory 
effect of interleukin-10 in mice. Nat Med, 2002. 8(3): p. 240-246. 
302. Cheng, S.B. and S. Sharma, Interleukin-10: a pleiotropic regulator in 
pregnancy. Am J Reprod Immunol, 2015. 73(6): p. 487-500. 
303. Dong, Z., et al., Heme oxygenase-1 in tissue pathology, the yin and yang. 
Am J Pathol, 2000. 156(5): p. 1485-1488. 
304. Gozzelino, R. and M.P. Soares, Coupling heme and iron metabolism via 
ferritin H chain. Antioxid Redox Signal, 2014. 20(11): p. 1754-69. 
305. Andrews, S.C., A.K. Robinson, and F. Rodríguez-Quiñones, Bacterial iron 
homeostasis. FEMS Microbiology Reviews, 2003. 27(2-3): p. 215-237. 
306. Balla, G., et al., Ferritin: A cytoprotective antioxidant strategem of 
endothelium. J. Biol. Chem., 1992 
. 267(25): p. 18148-18153. 
307. Maines, M., The heme oxygenase system: a regulator of second 
messenger gases. Annu Rev Pharmacol Toxicol, 1997. 37: p. 517-554. 
308. Ricchetti, G.A., L.M. Williams, and B.M. Foxwell, Heme oxygenase 1 
expression induced by IL-10 requires STAT-3 and phosphoinositol-3 
kinase and is inhibited by lipopolysaccharide. J Leukoc Biol, 2004. 76(3): 
p. 719-26. 
309. Kim, Y., et al., Heme oxygenase in the regulation of vascular biology: from 
molecular mechanisms to therapeutic opportunities. Antioxid Redox 
Signal, 2011. 14(1): p. 137-167. 
310. Seidman, D., et al., The role of the heme catabolic pathway in pregnancy. 
Am J Obstet Gynecol, 1997. 176(1): p. S103. 
311. Levytska, K., et al., Heme oxygenase-1 in placental development and 
pathology. Placenta, 2013. 34(4): p. 291-8. 
312. Appleton, S.D., et al., Effect of glucose and oxygen deprevation on heme 
oxygenase expression in human chorionic villi explants and immortalized 
trophoblast cells. Am J Physiol Regul Integr Comp Physiol, 2003. 285: p. 
R1453-R1460. 
313. Watanabe, S., et al., Marked developmental changes in heme oxygenase-
1 (HO-1) expression in the mouse placenta: correlation between HO-1 
expression and placental development. Placenta, 2004. 25(5): p. 387-95. 
314. Zenclussen, A.C., et al., Heme oxygenases in pregnancy II: HO-2 is 
downregulated in human pathologic pregnancies. Am J Reprod Immunol, 
2003. 50: p. 66-76. 
315. Yuan, B., et al., Contribution of inducible nitric oxide synthase and 
cyclooxygenase-2 to apoptosis induction in smooth chorion trophoblast 
cells of human fetal membrane tissues. Biochem Biophys Res Commun, 
2006. 341(3): p. 822-7. 
 
 162 
316. Varol, F., et al., VEGFR-1, Bcl-2, and HO-1 Ratios in Pregnant Women 
With Hypertension. Clin Appl Thromb Hemost, 2015. 21(3): p. 285-8. 
317. Kahlo, K., et al., HO-1 as modulator of the innate immune response in 
pregnancy. Am J Reprod Immunol, 2013. 70(1): p. 24-30. 
318. Kroisel, P.M., et al., Targeted enrichment sequencing in two midterm 
pregnancies with severe abnormalities on ultrasound. The Lancet, 2017. 
389(10081): p. 1857-1858. 
319. Zenclussen, M.L., et al., Haem oxygenase-1 dictates intrauterine fetal 
survival in mice via carbon monoxide. J Pathol, 2011. 225(2): p. 293-304. 
320. Schumacher, A., et al., Blockage of heme oxygenase-1 abrogates the 
protective effect of regulatory T cells on murine pregnancy and promotes 
the maturation of dendritic cells. PLoS One, 2012. 7(8): p. e42301. 
321. Schumacher, A. and A.C. Zenclussen, Effects of heme oxygenase-1 on 
innate and adaptive immune responses promoting pregnancy success and 
allograft tolerance. Front Pharmacol, 2014. 5: p. 288. 
322. Zenclussen, M.L., et al., Over-expression of heme oxygenase-1 by 
adenoviral gene transfer improves pregnancy outcome in a murine model 
of abortion. J Reprod Immunol, 2006. 69(1): p. 35-52. 
323. Gambling, L., et al., Effect of iron deficiency on placental cytokine 
expression and fetal growth in the pregnant rat. Biol Reprod, 2002. 66: p. 
516-523. 
324. Tachibana, M., et al., Protective role of heme oxygenase-1 in Listeria 
monocytogenes-induced abortion. PLoS One, 2011. 6(9): p. e25046. 
325. Lawler, D.F., J. Hopkins, and E.D. Watson, Immune cell populations in the 
equine corpus luteum throughout the oestrous cycle and early pregnancy: 
an immunohistochemical and flow cytometric study. J Reprod Fertil, 1999. 
117: p. 281-290. 
326. Tallmadge, R.L., et al., Expression of essential B cell genes and 
immunoglobulin isotypes suggests active development and gene 
recombination during equine gestation. Dev Comp Immunol, 2009. 33(9): 
p. 1027-38. 
327. Fedorka, C.E., et al., Alterations of Circulating Biomarkers During Late 
Term Pregnancy Complications in the Horse Part I: Cytokines. J Equine 
Vet Sci, 2021. 99: p. 103425. 
328. Vitoratos, N., et al., Antepartum and postpartum serum heme oxygenase-
1 levels in preeclamptic and normotensive pregnant women. in vivo, 2011. 
25: p. 445-450. 
329. Arck, P.C. and K. Hecher, Fetomaternal immune cross-talk and its 
consequences for maternal and offspring's health. Nat Med, 2013. 19(5): 
p. 548-56. 
330. Wood, P.L., et al., Lipidomic analysis of immune activation in equine 
leptospirosis and Leptospira-vaccinated horses. PLoS One, 2018. 13(2): 
p. e0193424. 
331. Zuerner, R.L., Host response to leptospira infection. Curr Top Microbiol 
Immunol, 2015. 387: p. 223-50. 
 
 163 
332. Rockwood, N., et al., Mycobacterium tuberculosis Induction of Heme 
Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects 
Treatment Outcomes. Front Immunol, 2017. 8: p. 542. 
333. Saha, S., et al., An Overview of Nrf2 Signaling Pathway and Its Role in 
Inflammation. Molecules, 2020. 25(22). 
334. Penha-Goncalves, C., R. Gozzelino, and L.V. de Moraes, Iron overload in 
Plasmodium berghei-infected placenta as a pathogenesis mechanism of 
fetal death. Front Pharmacol, 2014. 5: p. 155. 
335. Woudwyk, M.A., et al., Study of the uterine local immune response in a 
murine model of embryonic death due to Tritrichomonas foetus. Am J 
Reprod Immunol, 2012. 68(2): p. 128-37. 
336. Cella, M., et al., Heme oxygenase-carbon monoxide (HO-CO) system in 
rat uterus: effect of sexual steroids and prostaglandins. J Steroid Biochem 
Mol Biol, 2006. 99(1): p. 59-66. 
337. Zenclussen, M.L., et al., Hormonal Fluctuations during the Estrous Cycle 
Modulate Heme Oxygenase-1 Expression in the Uterus. Front Endocrinol 
(Lausanne), 2014. 5: p. 32. 
338. Buechler, C., R. Pohl, and C. Aslanidis, Pro-Resolving Molecules-New 
Approaches to Treat Sepsis? Int J Mol Sci, 2017. 18(3). 
339. Runyen-Janecky, L.J., Role and regulation of heme iron acquisition in 
gram-negative pathogens. Front Cell Infect Microbiol, 2013. 3: p. 55. 
340. Giardina, B.J., et al., Heme uptake and utilization by hypervirulent 
Acinetobacter baumannii LAC-4 is dependent on a canonical heme 
oxygenase (abHemO). Arch Biochem Biophys, 2019. 672: p. 108066. 
341. Richard, K.L., B.R. Kelley, and J.G. Johnson, Heme Uptake and Utilization 
by Gram-Negative Bacterial Pathogens. Front Cell Infect Microbiol, 2019. 
9: p. 81. 
342. Anzaldi, L.L. and E.P. Skaar, Overcoming the heme paradox: heme 
toxicity and tolerance in bacterial pathogens. Infect Immun, 2010. 78(12): 
p. 4977-89. 
343. Vasil, M.L. and U.A. Ochsner, The response of Pseudomonas aeruginosa 
to iron: genetics, biochemistry and virulence. Mol Microbiol, 1999. 34(3): p. 
399-413. 
344. Murray, G.L., et al., Leptospira interrogans requires a functional heme 
oxygenase to scavenge iron from hemoglobin. Microbes Infect, 2008. 
10(7): p. 791-7. 
345. Murray, G.L., et al., Leptospira interrogans requires heme oxygenase for 
disease pathogenesis. Microbes Infect, 2009. 11(2): p. 311-4. 
346. Soldano, A., et al., Structural and mutational analyses of the Leptospira 
interrogans virulence-related heme oxygenase provide insights into its 
catalytic mechanism. PLoS One, 2017. 12(8): p. e0182535. 
347. Asuthkar, S., et al., Expression and characterization of an iron-regulated 
hemin-binding protein, HbpA, from Leptospira interrogans serovar Lai. 
Infect Immun, 2007. 75(9): p. 4582-91. 
 
 164 
348. Sridhar, V., et al., Diagnostic potential of an iron-regulated hemin-binding 
protein HbpA that is widely conserved in Leptospira interrogans. Infect 
Genet Evol, 2008. 8(6): p. 772-6. 
349. Kurilung, A., et al., Genomic analysis of Leptospira interrogans serovar 
Paidjan and Dadas isolates from carrier dogs and comparative genomic 
analysis to detect genes under positive selection. BMC Genomics, 2019. 
20(1): p. 168. 
350. Lo, M., et al., Transcriptional response of Leptospira interrogans to iron 
limitation and characterization of a PerR homolog. Infect Immun, 2010. 
78(11): p. 4850-9. 
351. Centola, G., et al., Gallium(III)-Salophen as a Dual Inhibitor of 
Pseudomonas aeruginosa Heme Sensing and Iron Acquisition. ACS Infect 
Dis, 2020. 6(8): p. 2073-2085. 
352. Hom, K., et al., Small molecule antivirulents targeting the iron-regulated 
heme oxygenase (HemO) of P. aeruginosa. J Med Chem, 2013. 56(5): p. 
2097-109. 
353. Zenclussen, M.L., et al., Heme oxygenase-1 is critically involved in 
placentation, spiral artery remodeling, and blood pressure regulation 
during murine pregnancy. Front Pharmacol, 2014. 5: p. 291. 
354. Dini, P., et al., Landscape of Overlapping Gene Expression in the Equine 
Placenta. Genes (Basel), 2019. 10(7). 
355. Eide, I.P., et al., Decidual expression and maternal serum levels of heme 
oxygenase 1 are increased in pre-eclampsia. Acta Obstet Gynecol Scand, 
2008. 87(3): p. 272-9. 
356. Qiu, C., et al., Maternal serum heme-oxygenase-1 (HO-1) concentrations 
in early pregnancy and subsequent risk of gestational diabetes mellitus. 
PLoS One, 2012. 7(11): p. e48060. 
357. Hara, Y., et al., Clinico-pathological analysis referring hemeoxygenase-1 
in acute fibrinous and organizing pneumonia patients. Respiratory 
Medicine Case Reports, 2015. 14: p. 53-56. 
358. Ousey, J.C., Hormone profiles and treatments in the late pregnant mare. 
Vet Clin North Am Equine Pract, 2006. 22(3): p. 727-47. 
359. Stewart, D.R., et al., Breed differences in circulating equine relaxin. Biol 
Reprod, 1992. 46: p. 648-652. 
360. Ryan, P.L., et al., Evaluation of systemic relaxin blood profiles in horses 
as a means of assessing placental function in high-risk pregnancies and 
responsiveness to therapeutic strategies. Ann N Y Acad Sci, 2009. 1160: 
p. 169-78. 
361. Conrad, K.P., Maternal vasodilation in pregnancy: the emerging role of 
relaxin. Am J Physiol Regul Integr Comp Physiol, 2011. 301(2): p. R267-
75. 
362. Ousey, J.C. and A.L. Fowden, Prostaglandins and the regulation of 
parturition in mares. Equine Vet J Suppl, 2012(41): p. 140-8. 
363. Pozor, M., Equine placenta - A clinician's perspective. Part 1: Normal 
placenta - Physiology and evaluation. Equine Veterinary Education, 2016. 
28(6): p. 327-334. 
 
 165 
364. Hu, X.Q. and L. Zhang, Angiogenesis during pregnancy: all routes lead to 
MAPKs. J Physiol, 2017. 595(14): p. 4571-4572. 
365. Klein, C., Early pregnancy in the mare: old concepts revisited. Domest 
Anim Endocrinol, 2016. 56 Suppl: p. S212-7. 
366. Waza, A.A., S.A. Bhat, and Z. Hamid, Relaxin: A Magical Therapy for 
Healthy Heart. International Journal of Current Pharmaceutical Research, 
2018. 10(1). 
367. University of Kentucky, V.D.L. Epidemiology Information-Equine 
Leptospirosis Abortions Current 2021  [cited 2021 May 15]; Available from: 
http://vdl.uky.edu:8080/informer/DashboardViewer.html?locale=en_US&e
mbedToken=f6d47393-13ac-4ea0-b9e4-3d9f6fa0feb5. 
368. Zilch, T.J., et al., Equine leptospirosis: Experimental challenge of 
Leptospira interrogans serovar Bratislava fails to establish infection in 
naive horses. Equine Vet J, 2021. 
369. Pinna, M., et al., Seropositivity to Leptospira interrogans serovar 
Bratislava associated to reproductive problems without significan 
biochemical or hematological alterations in horses. Ciencia Rural, 2010. 







































USDA-ARS-FAPRU, Lexington, KY                     January 2007-February 2020 
Biological Science Technician, Microbiology 
 
University of Kentucky, Lexington, KY                April 2005-January 2007 
Research Associate, Molecular and Cellular Biochemistry 
 
University of Kentucky, Lexington, KY                       January 2004-March 2005 
Research Analyst, Center on Aging  
 
Laura’s Lean Beef, Lexington, KY                    May 2003-August 2003 
Scientific Consultant 
 
BD Biosciences San Diego, CA                                          March 2002-June 2003 
(formerly Lexington, KY) 
Research Associate III 
  
University of Kentucky, Lexington, KY   February 1988-March 2002 
Research Analyst, Department of Surgery                                                                       
 
University of Kentucky, Lexington, KY         1987-1988  
Principal Laboratory Technician, Department of Animal Science                                         
 
University of Kentucky, Lexington, KY            1983-1986 
Graduate Student and Teaching Assistant, Department of Animal Science  
 
Michigan State University, East Lansing, MI              September 1979-July 1983 





Doctoral Candidate               August 2013-present 
Gluck Equine Center 




MPH, Master of Public Health, Epidemiology        2010 
 
 167 
University of Kentucky 
Lexington, Kentucky 
College of Public Health, Department of Epidemiology 
 
MS, Master of Science, Microbiology                                      1986 
University of Kentucky 
Lexington, Kentucky   
Department of Animal Sciences 
 
BS, Bachelor of Science          1979 
University of Kentucky 
Lexington, Kentucky 
Department of Animal Sciences 
 
AAS, Associates of Applied Science, Veterinary Technology     1977 
Morehead State University 
Morehead, Kentucky  
 
Pre-veterinary medicine (45 credit hours)          1974-1975 
Purdue University 






Delta Epsilon Iota Academic Honor Society              2009-Present 
Honorary Diplomate of American Veterinary 








Research Activity Grant, University of Kentucky College of Agriculture  2009 
Southeast Center for Agricultural Health and Injury Prevention, Via NIOSH/CDC  
Cooperative Agreement (U50OH007547), University of Kentucky,  
Serological Survey for Potential Occupational Exposure to Leptospirosis in 
Kentucky Horse Farm Workers and Veterinarians                     
 
 
Southeast Center for Agricultural Health and Injury Prevention, Via NIOSH/CDC 
Cooperative Agreement (U50OH007547), University of Kentucky, Equine 




Zoetis, Florham Park, NJ, Detection of Leptospiral DNA and Antibodies in Horses    
Submitted to the University of Kentucky Veterinary Diagnostic Laboratory for 
Necropsy          2015 
                    
PUBLICATIONS 
 
1.   Gellin G, Langlois BE, Dawson KA and Aaron DK:  Antibiotic resistance of 
gram-negative enteric bacteria from pigs in three herds with different histories of 
antibiotic exposure.  Appl Enviro Microbiol 55: 2287-2292, 1989. 
2.   Toursarkissian B, Endean E, Aziz S and Gellin G:  b-FGF alters polyamine 
metabolism in vascular smooth muscle cells. Surgical Forum 63: 352-354,1993. 
3.   Arden WA, Barker DE, Strodel WE, Record K, Leader G, Derbin M, Gellin G 
and Schwartz RW:  Effect of cardiogenic shock on pharmacokinetics and tissue 
distribution of ampicillin-sulbactam. Circ Shock 44: 138-147, 1995. 
4.   Endean E, Toursarkissian B, Buckmaster M, Aziz S, Gellin G and Hill B:  
Regulation of  polyamine synthesis and transport by fibroblast growth factor in 
aortic smooth muscle cell.  Growth Factors 13:  229-242, 1996. 
5.   Buckmaster M, Aziz S, Hill B, Gellin G and Endean E: Polyamines regulate 
rat aortic smooth muscle cell proliferation.  Surgical Forum 67: 392-394, 1996. 
6.   Baskaya MK, Muralikrishna R, Dogan A, Donaldson D, Gellin G and 
Dempsey RJ: Regional brain polyamine levels in permanent focal cerebral 
ischemia.  Brain Research 744(2):  302-308, 1997. 
7.   Bernard AC, Fitzpatrick EA, Maley ME, Gellin GL, Tsuei B, Arden WA, 
Boulanger BR, Kearney P, Ochoa JB.  Beta adrenoceptor regulation of 
macrophage arginase activity.  Surgery 127(4): 412-418, 2000. 
8.   Ochoa J, Strange J, Kearney P, Charash W, Gellin G, Endean E and 
Fitzpatrick E: The effects of L-  arginine on proliferation of T- lymphocyte 
subpopulations. JPEN J Parenter Enteral, Nutr Jan-Feb 25(1):  23-29, 2000.   
9.   Barksdale AR, Gellin GL, Endean ED.  Smooth Muscle Cell Polyamine and 
Nitric Oxide Synthesis are Dependent on Cell Density.  Journal of the American 
College of Surgeons, Surgical Forum Supplement. Vol 195 (3), 2002. 
10. Barksdale AR, Bernard AC, Maley ME, Gellin GL, Kearney PA, Boulanger 
BR, Tsuei BJ, Ochoa JB.  Regulation of arginase expression by T-helper II 
cytokines and isoproterenol. Surgery, 135(5): 527-35, 2004. 
11. Earing JE, Durig AC, Gellin GL, Flythe MD, Lawrence LM. Bacterial 
Colonization of the Equine Gut; Comparison of Mares and Foal Pairs by PCR-
DGGE. AiM Vol 2: 79-86, 2012. 
12. Flythe MD, Harrison B, Kagan IA, Klotz JL, Gellin GL, Goff BM, Aiken GE. 
Antimicrobial activity of red clover (Trifolium pretense L.) extracts on caprine 
hyper ammonia-producing bacteria. Agric Food Anal Bacteriol 3:176-185, 2013. 
13. Harlow BE, Lawrence LM, Flythe MD, Hayes SH, Gellin GL, Strasinger LA, 
Brummer M, Fowler AL. Microbial Species Richness of Equine Fecal Microflora in 
Horses Challenged with Antibiotics. J Eq Vet Sci, 33(5):331, 2013. 
14. Flythe MD, Aiken GE, Gellin GL, Klotz JL, Goff BM. Hops (Humulus lupulus) b-Acid 
as an Inhibitor of Caprine Rumen Hyper Ammonia-Producing Bacteria In Vitro. Agric 
 
 169 
Good Anal Bacteriol, Vol 5, Issue 1:29, 2015. 
15. Flythe MD, Harlow BE, Aiken GE, Gellin GL, Kagan IA. Pappas J. Inhibition of 
Growth and Ammonia Production of Rumen Hyper Ammonia-Producing Bacteria by 





1.  Gellin G, Langlois BE, Dawson KA and Jackson L:  Antibiotic resistance of 
gram-negative fecal bacteria, from three swine herds with different histories of 
antibiotic exposure.  J Anim Sci 6 (Suppl. 1): 411, 1986. 
2.  Endean E, Aziz S W, Ain KB, Gellin G, Lipke DW:  The Antineoplastic effects 
of polyamine transport inhibitor in cultured thyroid cancer cells. FASEB J 9: A94, 
1995.   
3.  Arden WA, Gellin G, Oremus R, Yavorski C:  Neuropeptide GCRP modulates 
LPS - and cytokine-induced smooth muscle NO formation.  Shock 7 (Suppl) 66: 
218, 1997. 
4.  Arden WA, Oremus R, Gellin G:  Capsaicin sensitive neurons participate in 
LPS-induced NO formation.   FASEB J 12(4): A403, 1998.   
5.  Arden W A, Gellin G, Oremus R, Yavorski C:  Cellular mechanisms by which 
CGRP enhances LPS - and cytokine-induced vascular nitric oxide production.  
Shock 9 (Suppl.) 56:189, 1998. 
6.  Arden WA, Oremus R, Gellin G:  CGRP Modulates LPS - and cytokine-
induced iNOS/NO formation.  New Horizons in CGRP and Related Peptides 
Research.  Landes Press, London, UK, 1998. 
7.  Flythe MD, Klotz JL, Strickland JR, Gellin GL, Brown KR, Matthews JC, Boling 
JA. The effect of toxic tall fescue on cellobiose-utilizing populations in the bovine 
rumen. Presented at the 108th American Society for Microbiology, Boston, MA, 
2008. 
8.  Strasinger LA, Lawrence LM, Flythe MD, Gellin GL, Brumer M, Davis BE, 
Good LR. The effects of coprophagy on the hindgut bacterial community of 
neonatal foals.  J. Anim. Sci 90 (Suppl. 3): 549, 2012. 
9. Harlow BE, Lawrence LM, Flythe MD, Hayes SH, Gellin GL, Strasinger LA, Brummer 
M, Fowler AL. Microbial Species Richness of Equine Fecal Microflora in Horses 
Challenged with Antibiotics. J Equine Vet Sci 33 (Issue 5):331, May 2013. 
10. Strasinger LA, Fowler AL, Hayes S, Gellin GL, Flythe MD, Lawrence LM. The 
Relationship of Coprophagy to Fecal Microbial Species Richness in Neonatal Foals. J 




1.   Gellin G, Langlois BE, Dawson KA and Jackson L: Antibiotic resistance of 
gram-negative fecal bacteria, from three swine herds with different histories of 
antibiotic exposure.  78th Annual Meeting of the American Society of Animal 
Science, Kansas State University, Manhattan, KS (1986). 
2.   Toursarkissian B, Endean E, Aziz S and Gellin G:  b-FGF alters polyamine 
 
 170 
metabolism in vascular   smooth muscle cells.  79th Clinical Congress of the 
American College of Surgeons Surgical Forum, San Francisco, CA (1993).  
3.   Endean E, Aziz SW, Ain KB, Gellin G and Lipke DW: Antineoplastic effects of 
polyamine transport inhibitor in cultured thyroid cancer cells.  109th annual 
meeting of Experimental Biology, Atlanta, GA (1995). 
4.   Endean ED, Lipke DW, Aziz SM and Gellin G:  Polyamine inhibition modifies 
extracellular matrix deposition.  Joint Annual Meeting of SVS/ISCVS, New 
Orleans, LA (1995). 
5.   Buckmaster MJ, Endean ED, Aziz S, Gellin G.  Nitric oxide inhibits smooth 
muscle cell proliferation and alters polyamine metabolism.  Frederick A. Coller 
Surgical Society Annual Meeting, Bolton Landing, NY (1995). 
6.   Buckmaster MJ, Aziz S, Hill B, Gellin G, Endean E: Polyamines regulate rat 
aortic smooth muscle cell proliferation.  82nd Clinical Congress of the American 
College of Surgeons Surgical Forum, San Francisco, CA (1996). 
7.   Wignakumar V, Oremus R, Gellin G, Negabhushan M, Arden W, Charash W, 
Kearney P, Ranjan D and Ochoa J:  Surgery alters lipopolysaccharide-induced 
nitric oxide production.  Kentucky Chapter of the American College of Surgeons, 
Lexington, KY (1997). 
8.   Buckmaster M J, Aziz SM, Gellin G L and Endean ED:  Effect of nitric oxide 
on polyamines in aortic smooth muscle cells.  Poster, Joint Annual Meeting of 
SVS/ISCVS, Boston, MA (1997). 
9.   Ochoa JB, Kearney P, Charash W, Gellin G and Endean E:  L-arginine 
preferentially enhances the proliferation of killer-t lymphocytes in anti-CD3 
stimulated cell cultures.  Poster, AAS, Waikoloa, HI (1997). 
10. Figert P, Oremus R, Gellin G, Arden WA, Park A, Kearney P and Ochoa J: L-
arginine supplementation suppresses nitric oxide production in mice subjected to 
an exploratory laparotomy.  Kentucky Chapter of the American College of 
Surgeons, Louisville, KY (1998). 
11. Figert P, Gellin G, Arden WA, Park A, Kearney P, Ochoa J:  A possible 
explanation for suppressed nitric oxide production in trauma patients. 84th 
Clinical Congress of the American College of Surgeons Surgical Forum, Orlando, 
FL (1998). 
12. Arden WA, Gellin G, Smart ET:  eNos translocation from caveolae:  an 
important mechanism in sepsis-induced endothelial cell dysfunction.  The 4th 
International Shock Congress, Philadelphia, PA (1999).  
13. Arden WA, Gellin G, Oremus R, Yavorski C:  Cellular mechanisms by which 
CGRP enhances LPS- and cytokine- induced vascular nitric oxide formation. The 
4th International Shock Congress, Philadelphia, PA (1999).  
14. Bernard AC, Gellin G, Maley ME, Ochoa J, Endean E, Arden WA.  Cytokines 
TNF/IFN and neuropeptide CGRP suppress smooth muscle arginase activity.   
The 4th International Shock Congress, Philadelphia, PA (1999). 
15. Gellin G, Barksdale AR, Whitman S, Moreno P, Ochoa JB.  TGF-B and IL-13 
induce arginase activity in foam cells.  Presented at the Kentucky Chapter of the 
American College of Surgeons, Louisville, KY (2001).  
16. Barksdale AR, Gellin GL, Whitman SC, Moreno PR, Ochoa JB.  TGF-B and 
IL-13 induce arginase activity in foam cells. Presented at the 35th Annual 
 
 171 
meeting of the Association for Academic Surgery, Milwaukee, WI (2001). 
17. Barksdale AR, Gellin GL, Endean ED.  Smooth Muscle Cell Polyamine and 
Nitric Oxide Synthesis are Dependent on Cell Density.  Presented at the 88th 
Clinical Congress of the American College of Surgeons Surgical Forum, San 
Francisco, CA, 2002. 
18. Bernard AC, Gellin G, Ochoa J, Mentzer R, Arden W.  Tumor necrosis factor 
(TNF) suppresses arginase I gene expression during induced nitric oxide (NO) 
synthesis in rat aortic vascular smooth muscle.  Presented at the 89th Clinical 
Congress of the American College of Surgeons Surgical Forum, Chicago, IL, 
2003. 
19. Gellin G, Caldwell G, Branscum A, Steinman M, Timoney JF, Fettinger M, 
Carter C.  Serological survey for potential occupational exposure to leptospirosis 
in Kentucky horse farm workers and veterinarians. Presented at the University of 
Kentucky College of Public Health Research Day in conjunction with the 3rd 
Public Health Systems and Services Research Keeneland Conference, 
Lexington, KY, 2010.     
20. Earing JE, Durig AC, Gellin GL, Flythe MD, Lawrence LM. Profiling the 
change in fecal microbial populations of mares and foals over time. Presented at 
the 102nd American Society of Animal Science, Denver, CO, 2010. 
21. Flythe M, Kagan I, Gellin G, Goff B, Aiken G, Cheeke P. Phytochemicals that 
modulate amino acid and peptide catabolism by caprine rumen microbes. Presented at 
2011 congress on Gastrointestinal Function, Chicago, IL. 
22. Davis BE, Lawrence LM, Flythe MD, Hayes SH, Gellin GL, Strasinger LA, 
Brummer M, Fowler AL. Effects of antibiotics on the microflora and fermentative 
characteristics of equine feces. Presented at the University of Kentucky 2nd 
Annual College of Agriculture Animal and Food Sciences Graduate Associates 
Poster Symposium, Lexington, KY, 2012. 
23. Strasinger LA, Lawrence LM, Flythe MD, Gellin GL, Brumer M, Davis BE, 
Good LR. The effects of coprophagy on the hindgut bacterial community of 
neonatal foals. Presented at the University of Kentucky 2nd Annual College of 
Agriculture Animal and Food Sciences Graduate Associates Poster Symposium, 
Lexington, KY, 2012. 
24. Davis BE, Lawrence LM, Flythe MD, Hayes SH, Gellin GL, Strasinger LA, 
Brummer M, Fowler AL. Antibiotic therapy disrupts equine fecal microflora. 
ADSA-AMPA-ASAS-CSAS-WSASAS Joint Annual Meeting, Phoenix, AZ, 2012.  
25. Gellin G. Serological Survey for Potential Occupational Exposure to 
Leptospirosis in Kentucky Horse Farm Workers and Veterinarians. Presented at 
the 62nd Annual James Steele Conference on Diseases in Nature Transmissible 
to Man, San Antonio, TX, 2012.  
26. Gellin G, Carter C, Caldwell G, Timoney JF, Steinman M, Fardo D, 
Sanderson W. Serologic evidence of potential occupational exposure to 
Leptospirosis in Kentucky horse farm workers and veterinarians. Poster, 
Presented at the 140th American Public Health Association Meeting, San 
Francisco, CA, 2012. 
 
 172 
27. Gellin G, Carter C, Smith J, Erol E. Survey of AAVLD Veterinary Diagnostic 
Laboratory Leptospirosis Diagnostic Capabilities. Presented at the 120th USAHA 
& 59th AAVLD Annual Meeting, Greensboro, NC, 2016. 
 
 
 
 
